Solid phase approach towards the synthesis of ubiquitin by Holden, Robert W.
A SOLID PHASE APPROACH TOWARDS 
THE SYNTHESIS OF UBIQUITIN 
by 
ROBERT W. HOLDEN 
Ph. D. 
University of Edinburgh 
August 1989 
To my parents, Bill and Muriel 
ACKNOWLEDGEMENTS 
I would like to thank Professor R. Ramage for the 
provision of research facilities and to express my 
appreciation of his advice and constant encouragement 
throughout this work. I wish to thank Mr. K. Shaw for 
his assistance in the technical aspects of the solid 
phase synthetic work described herein, and I also thank 
those involved in the departmental analytical and 
spectroscopic services for their rapid and efficient 
work; special thanks are also due to Mrs. L. Marouf for 
her sterling efforts in typing this thesis. Grateful 
acknowledgement is made of the Science and Engineering 
Research Council for the provision of a research grant. 
Finally, I would like to express warm thanks and 
appreciation to all my colleagues and friends in the 
department, both past and present, for helping to make 
my time in Edinburgh such an enjoyable one. 
A previously developed novel linking group, 
4-hydroxymethy1-3-(trjmethylsi1y1)hydrocjnnmjc acid, 
has been modified further for use in the solid phase 
synthesis of fully protected peptides to facilitate a 
fragment assembly approach to the synthesis of 
ubiquitin, a biologically very important polypeptide. An 
organosilyl benzyl ester is used as the peptide-resin 
link and this leads to a mild cleavage by fluoride ion 
thus providing the potential for an orthogonal 
protection scheme in conjunction with acid- and 
base-labile groups. The original linker molecule has 
been enlarged in different ways to enable an acceptable 
degree of its coupling to the solid support and of 
successful peptide chain construction to be obtained, 
and the feasibility of various strategies for achieving 
these aims has been investigated. This type of link has 
been applied to the syntheses of four peptides with good 
cleavage yields and acceptable purity of peptide 
products, culminating in the synthesis of fully 
protected ubiquitin (1-35). It has been utilised along 
with Fmoc Na _protection, t-butyl-derived side-chain 
protection, and symmetrical anhydride/active ester 
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aa 	 amino acid 
Acm 	 acetamidometnyl 
ATP 	 adenosine 5'-triphosphate 
Bnpeoc 	 2, 2-bis ( 4-nitrophenyl) ethoxycarbonyl 
Boc 	 t-butyloxycarbonyl 




DCCI 1, 3-dicyclohexylcarbodiimide 
DCM dichioromethane 
DCU 1,3-dicyclohexylurea 
Ddz ci,c-dimethy1-3 , 5-dimethoxybenzyloxy- 
ca rbony 1 




DNA 2'-deoxyribonucleic acid 
Dpp diphenyiphosphinyl 
Fmoc 9-fluorenylmethoxycarbonyl 
H-Aua-OH 11-aminoundecanoic acid, 	i.e. 	H2N(CH2)10C00H 




HPLC 	 high-performance liquid 
chromatography 
Me 	 methyl 
NMM 	 N-methylmorpholine 





Poc 2-ph enyl i sopropyloxycarbonyl 
-0 resin support 
TBAF tetrabutylammonium fluoride 
t-Bu tertiary-butyl 
Teoc 2-(trimethylsilyl)ethoxycarbony1 
TFA trifluoroacetic acid 
THF 	 tetrahydrofuran 
TLC 	 thin-layer chromatography 
TMS 	 trimethylsilyl 
Tmz 	 ,2,4 ,5-tetramethylbenzyloxycarbonyl 
Tos 	 . -toluenesuiphonyl 
Ub 	 ubiquitin 
X 	 Na-protecting group 
z 	 benzyloxycarbonyl 
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Ubiquitin (see Fig. 1.1) is a 76 amino acid 
residue protein (m.w. 8565) and was first reported by 
Goldstein et al.1 in 1975 during work on the isolation 
of thymic hormones. It was shown subsequently to occur 
in all living cells and its amino acid sequence is 
conserved to an extent unparalleled among known 
proteins2'3; the fact that there are only 3 amino acid 
residue variations between yeast and human ubiquitin 
(see Fig. 1.2) illustrates the almost total 
conservation of its primary structure across the whole 
spectrum of species. 
These observations clearly suggested that 
ubiquitin is involved in basic cellular functions, 
although it took several years before a clear picture 
began to emerge, in no small part due to the fact that 
information about the biological roles of ubiquitin was 
furnished from seemingly unrelated areas of study, 
e.g. the isolation and characterisation of thymic 
hormones, the structure of chromatin, and proteolysis 
of cellular proteins. 
1.1.2 	The Ubiouitin Gene 
Cloning of ubiquitin-coding DNA sequences from a 
variety of eukaryotes has revealed that ubiquitin- 
H-Met-Gin-Il e-Phe-Vai-Lys-Thr-Leu-Thr-Gly-
Lys-Thr-I 1 e-Thr-Leu-Glu-Vai-G1u-pro-S er-
Asp-Thr-I 1 e-Giu-Asn-Val-Lys-Ala-Lys-I le-
Gin-Asp-Lys-Glu-Gly- lie-Pro-Pro-Asp-Gin-
Gln-Arg-Leu- Ii e-Phe-Ala-Giy-Lys-Gln--Leu-
Glu-Asp-Giy-Arg-Thr-L eu-S er-Asp-Ty r-Asn-
11e-Gln-Lys-Glu-Ser-Thr-Leu-Hjs-Leu-Vai- 
L eu-Arg -L eu-Arg-Gly-Gly-0H 
Figure 1.1 - Amino Acid Sequence of Human Ubiquitin 
Ubiquitin Source 
Residue No. Animala Piantb Yeast 
19 Pro Ser Ser 
24 Glu Asp Asp 
28 Ala Ala Ser 
57 Ser Ala Ser 
Animal refers to ubiquitin isolated from man, 
cattle, mouse, chicken, toad and fly. 
Plant refers to ubiquitin isolated from oat and 
barley. 
Figure 1.2 - Amino Acid Sequence Variants of Ubiquitin 
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coding elements are typically organised into 
head-to-tail arrays with no internal spacers, and so it 
appears that ubiquitin is generated by the processing 
of a polyubiquitin precursor protein. 	Yeast 
polyubiquitin4 (see Fig. 1.3) starts with the 
N-terminal methionine residue of the mature (monomer) 
ubiquitin, and consists of 6 consecutive repeats of 
mature ubiquitin joined via Gly-Met bonds followed by a 
single extra residue, asparagine. The polyubiquitin 
precursor thus liberates mature ubiquitin upon 
proteolytic cleavage of Gly-Met and Gly-Asn bonds. 
Toad5, chicken6, human7 and plant8 cells also 
exhibit ubiquitin-coding genes with multiple 
consecutive repeats, and while this polyubiquitin 
organisation is a general feature of ubiquitin genes 
from yeast through to man, the number of ubiquitin- 
coding repeats per gene is not highly conserved, e.g. 
it varies from 6 in yeast, through 9 in man, to 
possibly more than 12 in toad, and indeed, it probably 
varies between cell types. 
A wide variation is also found in the extra, 
non-ubiquitin residue, it being asparagine in yeast, 
tyrosine in chicken and valine in human polyubiquitin. 
This blocking residue may be present to prevent 
participation of unprocessed polyubiquitin in 
ubiquitin-protein conjugation, although it may not be 
1 	76 	1 	76 	1 	76 	1 	76 	1 	76 	1 	76 
Met—G1y - Met—Gly - Met— Gly - Met—Gly - Met—Gly - Met—Gly - As 
Figure 1.3 - Structural Organisation of Polyubiquitin Precursor 
Protein in Yeast Deduced from the Nucleotide Sequence 
of the Yeast Ubiquitin Gene 
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an essential part of polyubiquitin precursor protein, 
since the clone from the toad Xenopus laevis has no 
extra amino acid residue. 
In addition, polyubiquitin genes are unusual in 
the fact that they encode identical amino acid 
sequences even though they may differ considerably in 
their nucleotide sequences, thus underlining the 
fundamental importance of ubiquitin over the huge 
time-span of eukaryote evolution. Also, it is thought 
that polyubiquitin genes are specifically required for 
cell resistance to stress9. 
As exceptions to the polyubiquitin organisation 
characteristic, however, ubiquitin-coding genes have 
been found in human'° and yeast9'1 - cells which encode 
"hybrid" proteins consisting of a ubiquitin unit bound 
to another short, basic protein. 	In humans, for 
example, a 516 base pair DNA encodes a protein 
consisting of ubiquitin attached to an 80 amino acid 
sequence that bears no obvious resemblance to 
ubiquitin, and indeed, there is a good deal of 
similarity between the basic, non-ubiquitin portions of 
the human and yeast proteins. The high basicity of the 
non-ubiquitin portion suggests that its intended 
destination is the cell nucleus. 
1.1.3 	Ubiouitin-Histone Coni uaation 
The structure elucidation of the chromosomal 
protein A24 (now called semihistone uH2A)12 provided 
the first clue to the functions of ubiquitin. 
Goldknopt, Busch and co-workers carried out detailed 
sequence analyses which showed that uH2A had a branched 
structure13114 in which the s-amino group of lysine 119 
of histone 2A forms an amide bond with the C-terminal 
glycine of ubiquitin, and subsequent work has shown 
similar ubiquitin conjugates with sub-types of histone 
2A and with histone 2B. 	Unlike other ubiquitin 
conjugates, however, it is not thought likely that they 
are intermediates in histone proteolysis15 (see later), 
since for example, most H2A moieties in uH2A are not 
degraded as a result of ubiquitin conjugation16. Thus, 
if ubiquitin is used to mark specific chromosomal 
regions, then recognition of ubiquitin in its 
conjugates to histones and other chromosomal proteins 
might be involved in processes other than proteolysis. 
The ubiquitin moiety in uH2A and uH2B is in a 
rapid equilibrium with a pool of free ubiquitin in 
interphase cells'7, and these semihistones represent 
about 10% of histone 2A18 and 1-2% of histone 2B19 and 
are heavily involved with the nucleosomes'8. Levels of 
uH2A throughout the cell cycle have been studied in 
various cell types, for example, the slime mould 
Physarum polycephalum20 11 a eukaryotic organism which 
facilitates precise observations as a result of the 
synchronous division of its nuclei. It was found in 
this case that in the early prophase uH2A.1, uH2A.z and 
uH2B were strongly present, only to disappear minutes 
later in metaphase and reappear again in anaphase. 
These results suggest that ubiquitin cleavage and 
recoupling is a very important event in the cell cycle. 
At the present time, however, these and other similar 
results and their implications for the role of 
ubiquitination of histones in chromatin structure are 
not fully understood, and certainly further study is 
necessary. 
1.1.4 	Ubiquitin in Proteolysis 
This is the most active area of ubiquitin 
research, and Hershko, Rose and Haas have been in the 
forefront of the increasing understanding of 
ubiquitin's biological role in an ATP-dependent 
proteolytic system'6. It has been established that 
ubiquitin becomes covalently bonded to proteins bound 
for ATP-requiring degradation21 and proposed that 
multiple ubiquitin attachment is a prerequisite22 for 
the degradation of the substrate protein by proteases. 
In common with the nuclear protein uH2A-4, the covalent 
bond involves the C-amino groups of lysine residues22. 
The ubiquitin-dependent proteolytic pathway23 is 
non-lysosomal in nature, as is the degradation of 
short-lived and abnormal intracellular proteins under 
normal metabolic conditions, and indeed the ubiquitin-
dependent system has been shown to act upon abnormal 
-b- 
proteins and is believed to be involved in the 
degradation of short-lived proteins24. 
When proteins destined for degradation conjugate 
to ubiquitin, multiple conjugates are found in which a 
single substrate molecule is bound to several molecules 
of ubiquitin22'25, but these high molecular weight 
species are quickly degraded by the ubiquitin system26. 
Conjugates with a greater than expected molecular 
weight, however, have been observed25 1,26 e.g. lysozyme 
contains 7 amino groups (6 lysine residues and the 
N-terminus) and the calculated molecular weight of 
Ub7-lysozyme is 74,000, but electrophoresis showed more 
than 12 bands, of which the highest has an apparent 
molecular weight of over 100,000. Blocking of the 
amino groups of ubiquitin by methylation with 
formaldehyde and sodium cyanoborohydride25 prevented 
formation of these higher molecular weight conjugates. 
These results indicate that ubiquitin can form a 
conjugate with an amino group of another ubiquitin 
molecule which is already bound to the protein 
substrate, so possibly increasing the degradation rate 
of the substrate. Reductive methylation of ubiquitin 
and subsequent conjugation to 1251-labelled lysozyme 
supported this conclusion when only 7 prominent bands 
were observed on electrophoresis. Cyanogen bromide 
treatment of the ubiquitin-lysozyme conjugates failed 
to cleave any 1251-labelled ubiquitin, so eliminating 
the possibility that multiply ubiquitinated lysozyme 
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was obtained from head-to-tail polyubiquitin, as the 
gene sequence might suggest. 
While the formation of conjugates between the 
C-amino groups of lysine residues and the C-terminus of 
ubiquitin is well documented, N-terminal conjugation to 
ubiquitin has also been shown27 and even appears to be 
essential for degradation to take place. Degradation 
of globin and lysozyme by the ubiquitin proteolytic 
system was prevented by selective modification of the 
a-amino groups, thus supporting this conclusion. In 
addition, however, a-amino-blocking of proteins 
prevents ubiquitin conjugation to C-amino groups, and 
in proteins where the F--amino groups are blocked but 
the a-amino group is free, degradation does occur but 
at a slower rate. This would suggest that a free 
a-amino group is an essential requirement for 
degradation and that conjugation of ubiquitin to this 
a-amino group initiates the formation of 6-amino 
conjugates and subsequent degradation. Thus, 
degradation of proteins in vivo may be prevented by 
their acetylation. 
Further studies on C-amino-blocked lysozyme28  
found that degradation in an ATP-dependent proteolytic 
system was stimulated by ubiquitin addition without, 
however, the presence of an a-amino-ubiquitinated 
derivative being observed. 	These results are in 
accordance with the hypothesis that several ATP-
dependent proteolytic pathways exist29, and that 
ubiquitination of substrates is not essential. 
Substrates that cannot undergo ubiquitin conjugation, 
i.e. proteins with blocked amino groups, can still 
compete with substrates which can be ubiquitinated for 
binding to the enzymes that promote ubiquitin 
conjugation of recognised potential substrates of the 
ubiquitin pathway30. The fact that these amino-blocked 
proteins have inhibiting properties in turn suggests 
that recognition of the polypeptide backbone may be a 
common factor in binding to ubiquitin-conjugating 
enzymes (see later). 
To help elucidate the functional importance of 
N-terminal ubiquitination of proteins, a gene for 
encoding ubiquitin bound to the N-terminus of the 
bacterial protein -galactosidase, a long-lived 
protein, was constructed. The resulting hybrid protein 
in the yeast Saccharornyces cerevisiae3' was cloned, but 
as soon as the gene product was made, the cells cleaved 
the ubiquitin from the -galactosidase. So, by changing 
a gene, a selection of hybrids with different amino 
acids at the N-terminus of -galactosidase was made in 
an attempt to fool the enzyme responsible for cleaving 
the hybrid; but to no avail. As before, deubiquitin-
ation occurred, irrespective of the N-terminus of the 
-galactosidase. Although this was a disappointment, a 
nevertheless completely unexpected result was obtained. 
Synthesis of 13-galactosidase variants could be carried 
out with any N-terminal amino acid, in contrast to the 
standard methionine residue (which every protein must 
have since AUG, the genetic base code for methionine, 
is also the start signal for protein synthesis). In 
addition, they then discovered that the in vivo 
half-lives of the 3 -galactosidase proteins were 
dependent on the N-terminal amino acid, varying between 
more than 20 hours and less than 3 minutes. This 
enabled them to propose a simple rule for the stability 
of proteins, viz, the "N-end rule" (see Fig. 1.4). This 
rule agrees with the known half-lives of all known 
cellular proteins with identified N-termini, although 
these are almost all long-lived proteins due to the 
difficulty in synthesising and sequencing unstable 
proteins. 
1.1.5 	Ubiquitin and the Heat-Shock Response 
One of the most interesting aspects of the 
heat-shock response is the communication between the 
environment and the genetic apparatus: somehow the cell 
detects a rise in ambient temperature, or some other 
environmental stress, and rapidly and specifically 
alters its pattern of gene expression, i.e. heat-shock 
proteins are produced. This response has the effect of 
accumulating denatured or damaged proteins within the 
cell. In normal circumstances these proteins would be 
quickly degraded by the ubiquitin proteolytic system, 
but after heat-shock, efficient degradation of abnormal 
Residue Y in Uh-Y-B-Galactosidase 
Met, Ser, Ala, Thr, Val, Gly 
Ile, Glu 
Tyr, Gin 
Phe, Leu, 1st, Lys 
Arg 
Half-life of Y-B-Galactosidase 
> 20 hours 
" 30 minutes 
, 10 minutes 
.", 	3 minutes 
r., 2 minutes 
Figure 1.4 - Stability of Proteins 
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proteins does not occur. 
Recent studies on fruit fly, mouse and chicken 
cells32'16'6, while demonstrating the involvement of 
the ubiquitin systen, have failed to identify 
positively the trigger for the heat-shock response, 
i.e. whether it is a lack of free ubiquitin or a 
failure to ubiquitinate proteins. The behaviour of 
temperature-sensitive mouse cells (ts85) argues against 
the first possibility, since at the non-permissive 
temperature they cannot couple ubiquitin to anything, 
and so presumably have high levels of free ubiquitin. 
One theory33, however, suggests that in normal cells a 
heat-shock transcription factor is suppressed by 
ubiquitination, an analogous situation to that of the 
histones being in equilibrium with a pool of free 
ubiquitin. 	Treatments of the cell which either 
inhibit ubiquitinating enzymes or produce a large pool 
of abnormal protein substrate would allow accumulation 
of non-ubiquitinated active factor so promoting 
transcription of heat-shock genes. A simplified version 
of this theory34 suggests that ubiquitinated histones 
by themselves may be enough to prevent heat-shock gene 
transcription. 	A system such as this would be 
inherently self-regulating: as soon as either 
degradation of the abnormal proteins or increased 
synthesis of ubiquitin made sufficient free ubiquitin 
available, the synthesis of heat-shock proteins would 
be repressed. 
More recent work35 into chicken cells, however, 
does not support hypotheses invoking ubiquitin as a 
factor in stress protein induction. Schlesinger and 
co-workers found the change in the free ubiquitin pool 
during stress to be insignificant compared to its size, 
i.e. during stress there is still an ample supply of 
ubiquitin. This led them to postulate a model in which 
stress turns on signals, as yet undefined, which lead 
to a shutdown of nuclear activity. When the stress 
conditions are removed, the cell returns to its 
original metabolic state, with the heat-shock proteins 
providing for some of those functions that are needed 
to re-establish the former state of the cell. Since 
heat-shock proteins also serve to protect cells from 
damage imposed by the stress, this model proposes a 
dual function for stress proteins. 
1.1.6 	Ubiguitin at the Cell Surface 
In contrast to all the previously mentioned 
functions of ubiquitin which take place in the cell 
nucleus or cytoplasm, recent studies have shown 
ubiquitin's influence to extend to the outer membrane 
of the cell. Weissman and his colleagues36'37 1,38 have 
shown that ubiquitin is part of the receptor by which 
lymphocytes home in on and enter the lymph nodes, an 
activity that is necessary for normal immune responses. 
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They also showed the existence of a series of 
ubiquitinated cell surface proteins, including the 
glycopeptide example with a molecular weight of 90,000 
involved in the lymphocyte receptor, and so it would 
appear that ubiquitination of cell surface proteins is 
fairly widespread. 
Lymphocytes enter the lymphoid organs through 
specialised blood vessels called postcapillary high 
endothelial venules, and Weissman's studies suggest 
that the ubiquitin moiety may be critical for the 
lymphocyte-endothelial cell interaction that is 
mediated by the homing receptor. They also indicate 
that its conformation at the homing receptor is 
different from that of free ubiquitin or of ubiquitin 
bound to other proteins. Such conformational changes 
may be a result of interactions with the glycoprotein 
part of the homing receptor and might enable ubiquitin 
to contribute to specific receptor interactions. Such 
an explanation needs to be advanced as the presence 
alone of ubiquitin, whose distribution is widespread, 
does not seem to provide the basis for the highly 
selective recognition factor required of lymphocyte 
homing receptors. 
As to how ubiquitin gets to the cell surface, 
Weissman suggests that it is added to the receptor 
protein in the cytoplasm during the protein synthesis 
when it is exposed to ubiquitin, before being 
transported to the cell membrane. 
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1.1.7 	Ubiquitin Structure 
The three-dimensional structure of human 
erythrocytic ubiquitin has been determined by Cook and 
his colleagues by X-ray analysis at 2.8A 
resolution39, with a further refinement to 1.8A 
resolution40. Similar crystal structures4' are found 
with the yeast and oat ubiquitin sequence variants. 
A compact globular structure for ubiquitin, stable 
over a wide pH and temperature range, was indicated by 
NMR investigations42 1,43, and the X-ray analysis 
supported this in revealing a markedly hydrophobic core 
and a tightly hydrogen-bonded secondary structure. The 
prominent features of this secondary structure include 
3.5 turns of os-helix (residues 23 to 34), a short piece 
of 310-helix (residues 56 to 59), a mixed s-sheet that 
contains 5 strands, and 7 reverse turns, thus providing 
a significant contrast to previous circular dichroism 
studies44. 
The C-terminal region protrudes from the globular 
structure rather like a tail and thus is not involved 
with the remainder of the structure by means of either 
hydrophobic interactions or hydrogen bonding. This 
means that the active centre of the molecule can be 
accessed easily by the enzymes involved in the 
formation and cleavage of isopeptide bonds. This is 
consistent with amide bonding between the ubiquitin 
C-terminus and lysine E-amino groups which is a common 
-14- 
factor in the various biological functions of 
ubiquitin. Electron density maps of the C-terminal 
region are of poorer definition than the rest of the 
molecule since this region requires and has a 
considerable freedom of motion, and also the ease of 
proteolysis of the C-terminal GlyGly dipeptide in 
ubiquitin isolation45 probably gives rise to a crystal 
sample which is heterogeneous. 
The N-terminal methionine residue is hidden deep 
in the hydrophobic core of the molecule, effectively 
making the N-terminus inaccessible and so preventing 
proteolysis of ubiquitin by its own pathway. Looking 
at the structure of the ubiquitin gene, however, with 
the precursor protein having head-to-tail repeat units 
of ubiquitin joined C-terminus of one molecule to 
N-terminus of the next, considerable changes in 
conformation must be forced upon the liberated 
individual ubiquitin molecules. 
A recent study46 of mutants of ubiquitin has shown 
that in almost every case investigated, the mutations 
only affected the overall structure at the points where 
they occurred, and that these minor changes only 
affected the biological activity when they occurred at 
points of contact between ubiquitin and enzymes of its 
pathway. Mutations of the C-terminal region completely 
destroyed ubiquitin's biological activity. This should 
thus provide an interesting model for further study of 
protein-protein interactions during enzymatic 
reactions. 
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1.1.8 	Ubiguitin Fragment Synthesis 
The hexadecapeptide fragment 59-74 of ubiquitin 
has been chemically synthesised by two groups using 
different synthetic strategies. Schlesinger et al.47  
used Merrifield's solid phase strategy48, employing 
Boc-protected amino acids49 activated with DCCI50. 
Abiko and Sekino51 on the other hand employed a 
solution phase strategy involving three fragment 
couplings. Again, they used ci-amino-Boc protection, 
with the stepwise couplings being carried out with 
1-ethyl-3-(3-dimethylaminopropyl)-carbodiimjde 52 and 
HOBt53. The fragment couplings were performed using 
the azide method of carboxyl activation. 
The products of both syntheses were biologically 
assayed, and in both cases the fragments were found to 
have a significant proportion of the activity of 
ubiquitin. 	It was deduced, therefore, that the 
synthetic fragment incorporates the portion of 
ubiquitin necessary for biological activity, and that 
the full tertiary structure of ubiquitin is not 
essential for activity in the assays undertaken. These 
results, however, would seem to contradict the 
evolutionary conservation of the ubiquitin molecule 
which suggests that there are very strong reasons as to 
why the sequence is so highly conserved. Also, the lack 
of the C-terminal GlyGly dipeptide, which is required 
for activity54'551 from the fragment casts doubts over 
the dependability of these results. 
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1.2 SOLID PHASE PEPTIDE SYNTHESIS 
1.2.1 Introduction 
Peptides are a class of naturally occurring 
compounds having important and varied roles in biology; 
for example, as hormones, releasing factors, growth 
factors, ion carriers, antibiotics, toxins and 
neuropeptides. This biological importance has prompted 
a great amount of study into peptide synthesis with a 
view to understanding the effect of peptide structure on 
biological activity. 
In 1903 Fischer provided the breakthrough when he 
synthesised the first peptide and coined the term56. 
The basic requirements of this achievement were to block 
the carboxyl group of one amino acid and the amino group 
of the other amino acid to prevent formation of a whole 
family of possible products. Subsequent activation of 
the free carboxyl group would then facilitate the 
formation of the peptide bond, and then selective 
removal of the two protecting groups would give the free 
dipeptide. Fischer, however, never managed to find a 
suitable temporary protecting group for the amino 
function, but a former student of his, Bergmann, along 
with Zervas, successfully produced such a group57 in 
1932. Their use of the Z group helped considerably in 
the production of peptide chains, and as a result, this 
versatile urethane-type amino protection was modified 
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extensively to suit a wide variety of conditions in the 
following years58. 
Further advances were made in peptide synthesis 
in 1951 when Wieland published results on amino acid 
carboxyl activation by formation of mixed anhydrides 
with ethyl chloroformate59 and by formation of active 
esters with thiophenol60. The mixed anhydride approach 
was also described at the same time by Boissonnas6' 
using ethyl chioroformate, and by Vaughan62 using 
isobutyl chloroformate. These developments contributed 
to du Vigneaud's 1954 synthesis of oxytocin63, the first 
reported synthesis of a peptide hormone. 
A major leap forward, however, was made in 1963 
when Merrifield conceived the idea of synthesising 
peptides on an insoluble polymeric support48, a 
development which earned him the Nobel Prize in 
198464. This technique, the first example of the use 
of polymers in performing organic synthetic 
transformations, was developed to combat problems faced 
by solution phase methodology, such as possible poor 
solubility of large or protected peptides. Also, the 
steps of protection, coupling, deprotection, isolation 
and characaterjsatjon of intermediates are time-
consuming and are a discouragingly repetitive exercise. 
1.2.2 The Solid Phase Principle 
In the solid phase system of peptide synthesis, 
the C-terminal amino acid of a desired peptide chain is 
attached to an insoluble solid support and the chain 
subsequently extended towards the N-terminus by stepwise 
coupling of activated amino acid derivatives. 
Filtration and washing removes any excess soluble 
reagents and by-products, and after the chain has been 
assembled it can be cleaved from the support and 
purified. This protocol confers several advantages: (a) 
intermediate purification is eliminated, (b) reactions 
can be driven to completion by using excess reagents, 
(c) vessel transfer is eliminated so cutting down 
mechanical losses and (d) automation is possible. 
There are several requirements, however, for the 
polymer to meet in order to be a suitable support. It 
must be insoluble to enable filtration, and rigid to 
give good mechanical properties. A significant degree 
of functionaljsation must be obtainable. Also, the 
matrix should swell in appropriate solvents, with good 
accessibility to solvents and reactants, whether swelled 
or rigid. Accessibility of the functional groups can be 
improved by incorporation of a handle or spacer molecule 
between the functional group and the polymer backbone. 
In addition, the functionalised support should have no 
side reactions, be physiochemically compatible with the 
bound substrate, reagents and solvents, and be able to 
be regenerated. Many varied supports and linkers/ 
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spacers have been developed with the above 
considerations in mind and these are described later. 
The standard system for solid phase peptide 
synthesis64 is shown in Scheme 1. The support is a 
synthetic resin made from copolymerisation of styrene 
with 1% divinylbenzene to give crosslinking48. 
Functionalisation is achieved using chloromethylation to 
introduce benzylic chloride groups into the polymer. 
Ester bond formation between the protected amino acid 
salt and the chloromethyl group of the resin (1) then 
anchors the first residue to the polymer. Subsequent 
removal .of the Boc group with 50% TFA in DCM followed by 
neutralisation of the resultant salt with a tertiary 
amine produces the free amino group of the resin-bound 
amino acid. The second amino acid in the chain is then 
activated with DCCI50 and coupled to the first residue, 
although this coupling can also be carried out using 
anhydrides65 or active esters66. To extend the peptide 
chain, the deprotection, neutralisation and coupling 
steps are repeated until the desired sequence has been 
constructed, and the completed peptide finally is 
deprotected and cleaved from the solid support. With 
the chemistry employed here, this is done using a strong 
anhydrous acid such as HF67. The free peptide product 
can then be purified and characterised. 
Ph-® 
C1CH2OCH3  I ZnC12  
C1CH2_Ph_® 
Boc-NHCH(R1 )COOCs 
Boc-NHCH( R' ) CO-OCH2 _Ph_® 
TFA 
TFA H3NCH(R1 )CO_OCH2_Ph_® 
R 3  N 
H2NCJ-[(11 )CO_OCH2-Ph--® 




ANCHOR FIRST RESIDUE 
DEPROTECT FIRST RESIDUE 
NEUTRALISE SALT 
COUPLE SECOND RESIDUE 
HF 	 CLEAVE PEPTIDE FROM SUPPOR' 
H2NCH(R2 )CO-NHCH(R1 ) COOH 
Scheme 1 
-20- 
All of these reactions are carried out under 
non-aqueous conditions in organic solvents that swell 
the resin and give acceptable reaction rates. DCM and 
DMF were found to be the best. 	Also, due to the 
presence of highly reactive acylating groups in excess, 
all functional groups on amino acid side-chains must be 
protected before being liberated again at the end of 
the synthesis. It is very important that the steps 
which are repeated proceed rapidly, in high yields, and 
with the minimum of side reactions so as to prevent 
accumulation of by-products. 
In nature, proteins are formed in a stepwise 
manner starting from the N-terminus and working towards 
the C-terminus, and one of the earliest attempts at 
solid phase peptide synthesis employed this strategy 
using activation of peptide intermediates in the form of 
mixed anhydrides and coupling to esters of single amino 
acids68. A major problem here, however, is the lack 
of protection against racemisation since the activated 
residues are not provided with a urethane-type 
protecting group for the amino function. In contrast, 
no significant racemisation occurs when constructing the 
chain from the C-terminus, the method of choice for 
solid phase peptide synthesis today. 
One other aspect which needs to be considered is 
that of reaction monitoring. The degree of completion 
of the deprotection and coupling reactions dictates the 
purity of the final peptide product, and even a 
departure of as little as 1% from completion can give 
deleted peptides and failure sequences. Thus, the 
deprotection and coupling steps must give at least 99% 
completion. Several analytical methods have been used 
to monitor the various steps, the most popular of which 
is the Kaiser ninhydrin test. This test can be used 
either qualitatively69 or quantitatively70 to monitor 
deprotection, coupling, or chain termination. Other 
methods include the fluorescamine test71, titration with 
perchloric acid72 or picric acid73, or continuous 
monitoring of the ultraviolet absorbance of the reaction 
solution74. Each of these methods has its pros and 
cons, although over the piece, the Kaiser ninhydrin test 
appears to be the most practical. As an additional aid 
to the above techniques, insertion of an unnatural amino 
acid as an internal reference75 helps to determine 
peptide loss from the resin by means of amino acid 
analysis. 
The major plus, however, concerning solid phase 
peptide synthesis is the possibility of automation, and 
indeed several automated peptide synthesisers are now on 
the market. Even so, automation can only go as far as 
the chemical constraints allow, and can only fulfil its 
true potential when these problems are under control. 
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1.2.3 The Solid Support 
A suitable solid support (see before) and a 
satisfactory method of binding the first amino acid to 
it are of crucial importance for successful solid phase 
syntheses. In the case of the Merrifield support, 1% 
divinylbenzene was found to afford the polymer the best 
mechanical properties; that with 2% was too rigid with 
insufficient swelling, while that with less than 1% was 
very soft and could not be filtered or manipulated in 
the usual way. A pure polystyrene polymer is soluble in 
the organic solvents used. The chioromethyl resin (1), 
however, has some problems associated with it. In the 
esterification procedure, a possible side reaction is 
the formation of quaternary ammonium salts on the resin, 
and these salts give the polymer the characteristics of 
an anion-exchange resin so possibly causing problems 
during the synthesis. Also, amino acids which contain 
easily alkylatable functional groups, e.g. histidine, 
cysteine and methionine, cause difficulties in the 
esterification reaction. 
These problems can all be avoided by altering the 
functional group on the resin (see Fig. 1.5). 	The 
chioromethyl group can be modified with potassium 
acetate and hydrazine76 to give a hydroxyrnethyl resin 
(2), or with potassium phthalimide and hydrazine77 to 
give an aminomethyl resin (3) which can also be produced 
directly from the polystyrene-1% divinylbenzene 
CICH20( 	 HOCH20 
(1) 	 (2) 
02N. 
H2 NCH20 c 	BrCH- CH3 
(3) 	 (4) 
H 2NCH-K(J® 	 HOC H 
O2Np 
(5) 	 (6) 
Figure 1.5 - Resins Based on Polystyrene-1% Divinylbenzene Copolymer 
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copolymer to avoid use of the carcinogenic chioromethyl 
methyl ether. Other modifications to the chioromethyl 
group by treatment with various alkylamines to produce a 
range of N-alkylamine resins have been performed and 
used to synthesise several peptide N-alkylamides78, but 
other workers have reported problems with additional 
crosslinking in such cases79 casting doubts over the 
widespread applicability of such resins. Also, a 
4-step modification of the copolymer has been carried 
out recently" to produce a photosensitive o-nitro(c-
methyl)bromobenzyl resin (4) allowing the synthesis of 
fully protected peptides to be performed. 
Treatment of the original copolymer with N-(a-
chlorobenzyl)phthalimide and hydrazine8' yields a 
benzhydrylamine resin (5) which is useful for preparing 
peptide amides, and again, a recent 2-step modification 
of the copolymer to produce a photosensitive 2'-nitro-
benzhydrol resin (6) has been reported82 resulting in a 
greater acid-stability than that of (5). 
A new direction was taken by Sheppard in 197583 
when he introduced polyamide resins onto the scene. In 
the early days of solid phase work, some sequences 
cropped up which defied all attempts to produce them in 
good yield. It was found with polystyrene resins that a 
significant fraction of the growing peptide chains 
apparently terminated and refused to couple with any 
subsequent activated Boc-amino acids. He suggested that 
these problems were due to the hydrophilic peptide and 
hydrophobic resin having incompatible solvation 
properties, i.e. solvents which swelled the resin 
collapsed the peptide chain so losing reactivity and 
those which opened up the peptide chain collapsed the 
matrix preventing reagent access. Thus, he developed 
polyamide resins similar in nature to peptide chains, 
enabling one solvent to solvate both equally, and they 
have proved to be useful in synthesising difficult 
peptide sequences. 
The first resin was a copolymer of a mixture of 
dimethylacrylamide (7) (the basic monomer), N,N'-bis-
acryloylethylenediamine (8) (the crosslinking agent) and 
N-t-butoxycarbonyl- -alanyl-N ' -acryloylhexamethylene-
diamine (9) (see Fig. 1.6). The last monomer acts as a 
spacer, provides an internal reference amino acid, and 
after the cleavage of the Boc protecting group, also 
provides a primary amino function for subsequent 
coupling to the first amino acid of a peptide chain. 
Problems were encountered, however, in the 
preparation of (9) and in its tendency to produce an 
amorphous rather than a beaded polymer, and so a new 
polymeric support was developed84'85 in which 
N-acryloysarcosine methyl ester (10) replaced (9) (see 
Fig. 1.6). 
The resultant polymer in this case was readily and 
reproducibly obtained in a beaded form, and although it 
C H2= CHCN (C H3 ) 
0 





C H2= CHCNH (C H2)6NHCCH C H2 NH-BOC 
11 	 11 
0 0 
CH3 
CH2 = CHCNCH2COOCH3 
11 
(10) 
Figure 1.6 - Monomers Involved in Polyarnide Resins 
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now carried methoxycarbonyl groups rather than protected 
primary amines, amino functions were readily obtained 
upon treatment with ethylene diamine. In addition, the 
close similarity in structure between (7) and (10) 
suggests a random distribution of (10) and hence 
functional groups throughout the matrix. Also, the 
swelling properties of these resins are excellent in a 
wide range of polar solvents including water, methanol, 
pyridine, DCM and DMF. 
Sheppard subsequently has gone on to prove the 
utility of these resins in a series of peptide 
syntheses, as have others with polystyrene resins, 
although it is difficult to make a comparison between 
the polyamide and polystyrene resins since there has 
been only one example, acyl carrier protein (ACP) 
(65-74), of a careful comparison between them, and 
similar good results were obtained85'86. Recently, 
however, Sheppard has reported the development of 
polyamide resin supported on kieselguhr87, opening up 
new possibilities for continuous-flow peptide synthesis, 
which he has indeed utilised. 
1.2.4 The Peptide-Resin Link 
The standard synthetic scheme for solid phase 
peptide synthesis (see Scheme 1) employs a benzyl ester 
linkage between the peptide and the resin. When the 
chloromethyl resin (1) is used, however, there are the 
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aforementioned problems with quaternary ammonium salt 
formation on the resin and the alkylation of certain 
amino acid side-chains. Utilisation of the 
hydroxymethyl resin (2) prevents this side-chain 
alkylation and this is a significant advantage. In this 
case, the esterification of the Soc-amino acid is 
mediated by DCCI with a catalytic amount of DMAP 
present88; too much DMAP can cause racemisation of 
amino acids89. 
The amino protected support thus obtained, 
however, is not completely stable under the acidic 
conditions repeatedly employed for Soc cleavage90 due to 
the electron-donating ability of the alkyl chain of the 
polystyrene resin. 	Using 50% TFA in DCM for 
deprotection results in premature cleavage of peptide of 
about 1.57. per cycle. 	This production of new 
hydroxymethyl functionalities can cause late initiation 
of peptides and formation of deletion peptides which 
have one or more C-terminal residues missing. Although 
this situation might be adrnissable in a short peptide 
synthesis, it is a major problem when large peptides are 
being considered. 
Several solutions to this problem have been 
successfully employed, including the use of (a) more 
acid-labile protecting groups, (b) base-labile 
protecting groups, or (c) a more acid-stable support. 
The last of these was described originally by 
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Merrifield48 when he nitrated or brominated the 
chlorornethyl resin (1). This produced a significantly 
more acid-resistant support through the introduction of 
electron-withdrawing groups on the aromatic ring of the 
resin. 	Indeed, the acid-stability of the nitrated 
support was too great in that saponification with sodium 
hydroxide was required to cleave the peptide. In the 
case of the brominated support, it did not swell 
adequately in DCM and DMF so preventing sufficient 
access of reagents to the beads, and thus was not 
satisfactory for general application. 
A far more flexible approach to support stability 
has been the development, and use in the solid phase 
synthesis of large peptides, of supports with some kind 
of linker or spacer molecule between the functional 
group on the resin and the peptide chain. By varying 
the nature of this linker molecule, varying degrees of 
acid- or base-lability, or indeed photolability or 
multidetachability, can be conferred upon the support. 
The phenylacetamidornethyl (Pam) resin (12) (see 
Scheme 2) introduced by Merrifield91 increases the 
stability of the peptide-resin link by a factor of 100 
over that of the classical system (see Scheme 1); this 
is due to the electron-withdrawing effect of the 
acetamido group in the para position of the phenyl ring 
to which the peptide is attached. This destabilises the 
developing carbocation so increasing the stability to 
(1 1 ) 	 CH3COOCH2- Ph-CH 2CQOH + H2 NCH  2_Ph_® 	(3) 
DCCI 
CH3C000H2 -Ph-CH2 -CONHCH2 -Ph 0 - 
N2H4  
HOCH2_ Ph-CH  2_CONHCH2_Ph_® 	(1 2) 
L Pam bridge 
Boc-aa-OH/DCCl/DMAP 
Boc-aa-OCH2 -Ph-CH2CONHCH2- Ph-(D 
Scheme 2 
TFA, while at the same time it has little effect on the 
SN2 cleavage of the peptide in liquid HF acidolysis. As 
a result of this, peptide chain loss during synthesis is 
reduced to less than 0.01% per cycle and hence 
production of new hydroxymethyl sites is similarly 
almost eliminated. In addition, peptide cleavage from 
the Pam support is almost quantitative92 under the mild 
cleavage conditions necessary for sensitive peptides93. 
The more convenient synthesis of the Pam resin (12) (see 
Scheme 2) involves acetylating the aminomethyl resin (3) 
with -acetoxyme thy 1phenylacetic acid (11) using DCCI, 
and removing the acetyl group using hydrazinolysis to 
yield the desired product. Boc-amino acids can then be 
esterified in a manner completely analagous to that used 
with the hydroxymethyl resin (2). 
As peptides become larger and more complex, their 
stability to harsh reagents such as HF and TFA 
decreases, and for this reason much study has gone into 
the use of more labile peptide-resin links which allow 
final peptide cleavage from the resin by a milder 
reagent. To meet this criterion, the Q-alkoxybenzyl-
alcohol resin (14) (see Scheme 3) was developed by 
Wang94; in this case, the peptide-resin link is made 
labile by the electron-donating ability of the ether 
oxygen in the para position on the ring. Final cleavage 
of the peptide from the resin is achieved with TFA in 
DCM, and hence this precludes the use of Boc-amino 
(13) 	 HOCH2-Ph-OH + C1CH2_Ph_® 	 (1) 
NaOCH3  
	
HOCH2 -Ph-OCR2- Ph-(D 
	
(14) 
(Fmoc- or) Bpoc-aa-OH/DCCl/DMAP 
(Fmoc- or)Bpoc_aa_OCH2_Ph_OCJ-12_Ph_® 
Scheme 3 
acids. Amino protection here is performed by the Bpoc 
group95, and this protocol allows the synthesis of 
protected peptide free acids if desired by the use of 
TFA-stable side-chain protection and avoiding exposure 
of the final peptide to strong acidic reagents such as 
HF. One possible drawback occurs if TFA-labile t-Bu-
derived side-chain protecting groups are used. During 
the final peptide cleavage reaction, the peptide is 
exposed to a large concentration of t-Bu carbocations 
which in some cases may be more harmful than exposure to 
HF, e.g. tryptophan may be alkylated. 	Use of this 
system also incurs the added complication of working 
with expensive Bpoc-amino acids, which as a result of 
their extreme lability require to be stored as salts. 
In spite of these drawbacks, however, this system's 
ability to produce protected peptide fragments, which 
can also be done using base-labile Fmoc-amino 
protection96 and benzyl-derived side-chain protection, 
is a distinct advantage. The synthesis of the -alkoxy-
benzylalcohol resin (14) has since been improved by 
Merrifield and co-workers97 and involves simply heating 
the chioromethyl resin (1) with -hydroxybenzylalcohol 
(13) and sodium methoxide under a precise set of 
conditions to minimise competing reactions. Bpoc-(or 
Fmoc-) amino acids can then be esterified (see Scheme 3) 
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as before in the case of the hydroxyrnethyl resin (2). 
Other acid-labile peptide-resin linkages have been 
developed including those involving modifications to the 
benzhydrylamine resin (5) used in producing peptide 
amides. The HF-stability of the peptide-resin link with 
the original resin (5) was found to be too great in some 
cases, and hence para-substitution of electron-donating 
groups in the free phenyl ring was carried out to give 
increased acid-lability. Two such moieties introduced 
were the methyl group98 and the methoxy group99. 
Protected peptide hydrazides can be made using a 
hydrazide resin (15), developed by Wang and 
Merrifield-00, with Fmoc-amino acids and benzyl-
derived side-chain protection. The hydrazide yielded on 
final TFA cleavage can then be used in subsequent 





Although the peptide-resin links mentioned so far 
all have been acid-labile, there are some which are 
cleaved under basic conditions. Acid-labile links have 
a limitation in that they cannot be used easily for the 
synthesis of fully protected peptide fragments when 
acid-labile protection is employed. As mentioned 
previously, the -alkoxybenzylalcohol resin (14) can be 
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used in an orthogonal system with base-labile protecting 
groups, but here a limitation is the small range of 
base-labile protecting groups available. In contrast, 
however, base-labile linkers or "handles" allow use of 
the large range of acid-labile protecting groups 
available, thus maintaining the orthogonality of the 
system. 
One such base-labile handle, 9-(hydroxymethyl)-
fluorene-4-carboxylic acid (H02CFmOH) (16) (see Fig. 
1.7), was developed recently by Mutter and Bellof101-, 
following on from the introduction of 9-fluorenylmethyl 
(Fm) esters as base-labile C-terminal protecting groups 
in peptide synthesis'02. One procedure for the use of 
this handle involves its binding to the arninomethyl 
resin (3) with DCCI followed by coupling of the amino 
protected C-terminal residue to the resulting 
hydroxymethyl resin with DCCI and DMAP as before. This 
handle is acid-stable, is cleaved readily with 15% 
piperidine in DMF and has been used in both solid phase 
and solution phase syntheses of peptides. 
Other handles which operate on the basis of base-
catalysed s -elimination have been developed by 
Tesser103 (17) and Schwyzer104 (18,19,20) (see Fig. 
1.7). In these cases cleavage is obtained by oxidation 
of the sulphur to the sulphone, if necessary, followed 
by base-catalysed s -elimination with sodium hydroxide, 
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Figure 1.7 - Handles Cleaved by Base-Catalysed 3-Elimination 
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may cause problems with some amino acid side-chains. 
A three-dimensional orthogonal system was 
introduced by Baranyl05 in which he used acid-labile 
side-chain protection, base-labile amino protection and 
a fluoride-labile peptide-resin link. He incorporated a 
fluoride-labile silicon-oxygen bond into the 2,4,5-
trichiorophenyl N-(3 or 4)-((4-(hydroxymethyi)phenoxy)-
tert-butylphenylsilyl)phenyl pentanedioate monoamide 
(Pbs) handle (21) thus producing a system which allowed 
the synthesis of protected peptide fragments. 	The 
involved multistep synthesis of (21), however, remains a 
considerable drawback in the use of this handle. 
HOCH200-Si 1 
(0  (21) 
Several photolabile handles have been developed, 
including the 3-nitro-4-bromomethylbenzoic acid (22) of 
Rich'06 and the (4-(2-chloropropionyl)phenyl)acetic 
acid (23) of Tjoengl07. Again, both of these handles 
were employed in the synthesis of protected peptide 







(22) 	 (23) 
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The peptide-resin links mentioned so far generally 
have had only one labile anchoring bond cleaved by only 
one or a few related methods, and as such have been 
applicable only to one synthetic strategy. This state 
of affairs has prompted the development of 
multidetachable systems designed to allow cleavage by a 
selection of reagents. Two such systems108, (24) and 
(25) (see Fig. 1.8), have been devised in which two 
selectively cleavable (orthogonal) ester bonds can be 
treated with a variety of reagents to give the peptide 
in various stages of deprotection. 
A further type of multidetachable resin (28) based 
on the benzhydrylamine resin (5) has been introduced by 
Tam109. It has two advantages over (5) in that it is 
made (see Scheme 4) from a chemically defined 
benzhydrylamine handle, N-Boc-(4--hydroxy)benzhydryl-
amine (27), which is purified and then attached to the 
resin support (26), and also it is a multidetachable 
resin which can produce protected peptide fragments. 
Although it is not as versatile as the POP and PON 
resins, this resin yields peptide amides and as such is 
complementary to the aforementioned resins. 
1.2.5 a-Amino Group Protection 
The principle of using carboxyl protecting groups 
for the protection of amino groups through their 
conversion into urethanes (29) was the most successful 
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innovation in peptide synthesis, and the introduction of 
the Z group in 1932 	has spawned a vast array of 
urethane-type amino protecting groups in the intervening 
years making them the most widely used amino protecting 
R 
R'-O-C - NH-CH-C-OH 
II 	 II 
0 0 
(29) 
agents in peptide synthesis today. Removal of these 
amino protecting groups starts with the scission of the 
urethane ester bond to give the carbamoic acid which 
then spontaneously decarboxylates to regenerate the free 
amine, and as an added bonus, urethane amino protection 
confers stability towards racemisation of the residue 
concerned upon activation. 
The most commonly used group is the Boc group49  
due to its convenient lability-stability characteristics 
and the easy availability of its derivatives. Also, the 
Z group is stable under the conditions for Boc cleavage 
hence allowing the use of Z side-chain protection with 
Boc Na-protection.  As mentioned before, however, there 
can be problems with the Boc group having a similar 
acid-stability to the peptide-resin link giving 
premature peptide cleavage, and also with the 
carbocations generated during cleavage giving unwanted 
side reactions. The latter necessitates the use of 
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cation scavengers such as anisole or dimethylsulphide. 
To circumvent the problem of premature peptide 
cleavage, the very acid-labile Bpoc group110 was 
developed. This group is several thousand times more 
labile to acidolysis than the Boc group and so Boc 
side-chain protection can be used with Bpoc 
N a-protection. Again, stable carbocations are formed 
upon cleavage thus requiring the use of scavengers. 
Also, the instability of the free Bpoc-amino acids is a 
drawback forcing them to be stored as salts and 
liberated immediately before use. 
Other protecting groups of intermediate 
acid-lability to the Boc and Bpoc groups have been 
developed, e.g. the Ddz group of Birr"1, the Poc 
group of Ragnarsson112 and the Tmz group of Matsueda 
and Stewart"3. The derivatives of all of these 
groups, however, are either very expensive or not 
commercially available and thus have not been widely 
adopted in synthesis. 
Foremost among the base-labile amino protecting 
groups is the Fmoc group96. Sheppard114 has used 
this group widely in the synthesis of peptides employing 
an orthogonal scheme with acid-labile (e.g. Boc) 
side-chain protection. Fmoc is usually cleaved with 20% 
piperidine in DMF, but this can give premature peptide 
cleavage from classical Merrifield resins, hence it is 
used with acid-labile (and thus base-stable) Wang94 or 
polyamide83 resins. 
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A rather different type of amino protecting group 
was developed by Kenner and Ramage in 1976115 when they 
introduced the Dpp group. It has an advantage over the 
urethane-type amino protecting groups in that no 
reactive intermediates are produced on deprotection so 
preventing unwanted side reactions. Also, it does not 
interfere with commonly used coupling procedures, and it 
allows only minimal racemisation to take place due to 
the prevention of oxazolone formation. 	Cleavage is 
brought about by a 6-fold excess of methanolic HC1 at 
35-50°C - its acid-lability is a lot less than that of 
Bpoc and slightly greater than that of Boc. Success has 
been achieved in solution phase peptide synthesis with 
the Dpp group, although the acidic conditions required 
for Dpp cleavage may pose problems with some handles and 
side-chain protecting groups in the solid phase 
synthesis of large peptides. 
1.2.6 Side-chain Protection 
The system with more acid-stable benzyl-derived 
side-chain blocking groups originally used by Merrifield 
has continued to be the most widely used along with more 
acid-labile Boc-amino acids. 	Currently, serine and 
threonine are adequately protected as benzyl ethers, 
while tyrosine 	requires 2,6-dichlorobenzyl ether 
protection, as the unsubstituted benzyl ether can give 
migration to the 3-position of the aromatic ring. 
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Aspartic and glutamic acids are protected as benzyl 
esters, but at the present time there appears to be no 
completely ideal group available for asparagine and 
glutamine and their side-chains are commonly left 
unprotected. Arginine is usually protected with nitro 
or tosyl groups, the latter also being used for 
histidine, while a urethane is formed with the side 
chain of lysine using the z or 2-chlorobenzyloxycarbonyl 
groups, and cysteine is protected as the Acm--6  
derivative or the S-benzyl ether. 
When the very acid-labile Bpoc or the base-labile 
Fmoc groups are used for Na-protection, side-chains may 
be blocked with more labile moieties such as t-Bu-
derived groups. A whole variety of protecting groups 
for the amino acids above, as well as methionine and 
tryptophan, have been developed including recent work in 
rr research group on arginine117'118 and aspartic and 
glutamic acids. Although these are not discussed here 
there are several excellent reviews on this 
topic119 ,120 
1.2.7 Coupling Methods 
Obtaining a quantitative coupling reaction 
presents the major technical difficulty in solid phase 
peptide synthesis. A coupling reaction requires to be a 
rapid and efficient acylation with a minimum of 
racemisation and other side reactions. To help achieve 
this end, a variety of strategies are employed, e.g. 
active ester, symmetrical anhydride, or mixed anhydride. 
Carbodiimide activation, however, remains the most 
widely used method. 
DCCI50 is the most popular carbodiimide and is 
considered to be the standard for the comparison of 
others. Carbodiimides give rapid acylation due to the 
high degree of activation afforded by the 0-acyl urea, 
but there are problems associated with their use, 
however; oxazolone formation can occur in fragment 
condensation and also the 0-acyl urea can rearrange 
easily to the unreactive N-acyl urea resulting in an 
undesirable loss of activated amino acid. The latter 
problem is worse in polar aprotic solvents such as DMF 
thus necessitating the use of a minimum amount of DMF in 
the coupling procedure. In common with all acylating 
agents, DCCI is required in excess, with 2.5 equivalents 
giving acylation within 30 minutes. 	As well as 
mediating the coupling reaction directly, DCCI is also 
used to prepare symmetrical anhydrides and active 
esters. Other carbodiimides are now coming to the fore, 
however, such as DICI which has 	 advantages 
over DCCI; whereas DCCI is a waxy solid, DICI is a 
liquid so making for easier handling, and also the urea 
by-product from DICI is more soluble than that from DCCI 
and is thus more easily removed from a solid phase 
system. 
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Preformed symmetrical anhydrides12' are widely 
utilised in peptide synthesis, although the method is 
wasteful in view of the excess of protected amino acid 
used to give quantitative acylation; 4 equivalents of 
protected amino acid are required to give 2 equivalents 
of symmetrical anhydride. Boc-anhydrides are usually 
prepared immediately before use due to their 
instability, although Fmoc-anhydrides are stable and can 
be made in advance and stored. They frequently give 
dramatically increased reaction rates in difficult 
coupling reactions, especially when an equivalent of 
tertiary amine is added to the acylation mixture, and 
they also prevent peptide chain termination by DCCI 
activation of any residual TFA or acetic acid remaining 
in the resin at the coupling step. 
Another modification of the carbodiimide reaction 
involves the use of active esters. In this case, HOBt 
esters53, either preformed or generated in situ, are 
the most popular and have improved substantially 
coupling reactions in some difficult sequences both in 
solution and solid phase syntheses. Other popular 
active esters are trichlorophenyl122 and pentachloro-
or pentafluorophenyl]-23 esters, although the last two 
have a possible problem with steric hindrance. 
Trichlorophenyl esters are stable and so can be used in 
the synthesis of activated handles which have to be 
purified before attachment to the resin, for example, 
-40- 
the Pbs handle of Barany105. A less popular active 
ester is the -nitrophenyl ester124; this is due to 
low reactivity requiring the use of a large excess of 
activated derivative coupled with a prolonged reaction 
time. 
A method not involving the use of carbodiimides 
has recently been reported; here, phosphinic-carboxylic 
mixed anhydrides have been utilised in both solution'25  
and solid phase126 synthesis. 	Both the diphenyl- 
phosphinyl chloride (DppCl)125 and l-oxo-1-chloro-
phospholane (CptCl)127 used for activation give a quick 
reaction and stability to disproportionation, an 
advantage over other mixed anhydrides. Also, the amine 
component attacks the mixed anhydride regiospecifically 
at the carbonyl group thus giving the desired amide with 
no side reactions. Unfortunately, however, there are 
problems associated with these two activating agents; 
DppCl is a hygroscopic liquid which can react with amide 
solvents and is difficult to handle so making it 
unsuitable for use in an automated system using large 
amounts of DMF, while the synthesis of CptCl is 
expensive and time-consuming. 
-41 - 
CHAPTER 2 : DISCUSSION 
2.1 INTRODUCTION 
As is evident from chapter one, there has been and 
is much research going into the development of handles 
with varying modes of cleavage and stability-lability 
properties, with a three-dimensional orthogonal system 
such as that used by Barany105 being the most versatile. 
In this context, we have attempted to develop a similar 
three-dimensional system by constructing a fluoride-
cleavable handle based on the principle of fragmentation 
of esters of 3-silylalcohol by fluoride ion. It has 
been reported128 that 3-trimethylsilylethyl esters of 
protected amino acids can be cleaved with fluoride ion 
and that they are stable over a wide variety of 
conditions encountered in peptide synthesis. Conversion 
of this system to a urethane-type amino protecting group 
was also carried out by Carpino129 when he introduced 
the Teoc group. 
A fluoride-cleavable handle (30) based on this 
fragmentation has been successfully developed in 0W 
research group130 and applied in peptide synthesis, 
giving a 62% yield after purification of an Na-protected 
hexapeptide. 	The strategy used to accomplish this 
synthesis (see Scheme 5) involved coupling the handle 
(30) to an amino acid protected as the phenyl ester; 
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this amino acid acting as an extension to the handle and 
an internal reference amino acid. Coupling of the first 
protected residue followed by deprotection of the phenyl 
ester gave the protected amino acid-handle-reference 
amino acid which was subsequently coupled to the 
aminomethyl resin (3) producing the required acylated 
support. 	Following the sequential synthesis of the 
desired peptide, treatment of the resin-bound product 
with dry TBAF in DMF liberated the peptide (see Scheme 
6) after 6 minutes. 
2.2 HANDLE STRATEGY 
In using the handle strategy, coupling the handle 
to the resin with the first protected amino acid already 
attached to the handle is advantageous in that the 
protected amino acid-handle can be isolated, purified 
and characterised before being coupled to the resin, and 
the formation of free hydroxymethyl sites is prevented, 
the presence of which can lead to deletion peptides, 
late initiation of peptides and trifluoroacetylation or 
acetylation of deprotected amino groups. The 
aminomethyl resin (3) allows the coupling reaction to be 
monitored using both the Kaiser test and microanalysis, 
as well as giving a stronger amide rather than an ester 
linkage. 
Initial attempts'3' to produce a protected amino 
acid-handle from the methyl ester of the handle 
floundered at the hydrolysis stage when quantitative 
p"~ZV 









cleavage of the benzyl ester linkage was obtained upon 
treatment with sodium hydroxide. It was thus decided to 
use the more labile phenyl ester. As a consequence of 
the presence of the methyl ester throughout the 
synthesis, however, it was considered easier to prepare 
the handle (30) and then couple an extra spacer, viz. 
an amino acid phenyl ester. Elongating the handle in 
this manner would also aid the hydrolysis if steric 
hindrance by the TMS group was a factor. 
This phenyl ester approach was indeed successful 
and two examples of the final derivatised handle, 
Dpp_Met_O_®_CO_Gly-OH and DpP_Leu_O_®_CO_Ala_OH,  
were produced. The former was quantitatively coupled to 
the aminomethyl resin (3) via the trichiorophenyl active 
ester, but subsequent peptide synthesis failed due to 
benzyl ester cleavage under the acidic conditions 
required for Dpp cleavage. Unfortunately, this clearly 
demonstrates that the handle (30) is not compatible with 
acid-labile N a- protection, and subsequently130 the 
base-labile Fmoc group was used. 
An alternative approach-3 - involving the direct 
coupling of a protected amino acid-handle-trichloro-
phenyl active ester to the aminomethyl resin (3) was 
also attempted. In this case a very poor coupling was 
achieved in contrast to the quantitative result obtained 
with the glycine extension example. Again, this may 
point to steric hindrance coming into consideration. 
-44- 
Extending the aminomethyl moiety on the resin by first 
adding phenylalanine to the resin before coupling the 
active ester resulted in a significant improvement, the 
coupling yield being 37% by amino acid analysis. These 
results tend to suggest that the carboxyl extension of 
the handle (30) is a desirable feature in attempting to 
maximise the coupling yield. 
2.3 EXTENDED HANDLE SYNTHESIS 
2.3.1 Benzhydryl Ester Approach 
A brief first attempt (see Scheme 7) was made to 
protect the handle (30) as the benzhydryl ester in an 
effort to produce a protected amino acid-handle with no 
carboxyl extension. 	Esterification of (30) with 
diphenyldiazomethane (31) gave the handle-ester (32) in 
88% yield. Coupling of Frnoc-glycine using DCCI with 
DMAP as catalyst then furnished the protected amino 
acid-handle-ester (33) in 98% yield. 	Subsequent 
treatment with TFA and phenol over a variety of 
concentrations and reaction times, however, resulted in 
either no reaction or a multispot TLC mixture from 
which the desired product could not be isolated. This 
line of approach was thus dropped in favour of the 
carboxyl extension strategy. 
2.3.2 Methyl Ester Approach 
In order to maximise any benefits gained from the 
carboxyl extension of (30), such as easier hydrolysis of 
(30) 	 HO_Ø_COOH Ph2CN2 	(31) 
HO_Ø_CO_OBzh (32) 




the final ester, more efficient coupling or easier 
reagent access after coupling, it was decided to use the 
long-chain, saturated 11-aminoundecanoic acid as the 
extension. Use of a methyl ester would also help to 
determine whether the earlier'3' hydrolysis failure 
was due to steric hindrance by the TMS group or to the 
methyl ester being too stable. The attempted synthesis 
(see Scheme 8) of the fully extended handle species 
commenced with the reaction of 11-aminoundecanoic acid 
with thioriyl chloride and methanol to produce the 
reference amino acid-ester-salt (34) in 81% yield. A 
DCCI coupling of (34) to (30) with NMM gave the handle-
reference amino acid-ester (35) in 40% yield, with a 
further DCCI coupling of Fmoc-glycine to (35) with 
catalytic DMAP giving the protected amino acid-handle-
reference amino acid-ester (36) in 64% yield. Treatment 
of (36) with sodium hydroxide resulted in the liberation 
of dibenzofulvene, i.e. the Fmoc group was being 
cleaved. 	This was obviously unacceptable and hence 
the methyl ester approach was discontinued in favour of 
that involving the phenyl ester. 
2.3.3 Phenyl Ester Approach-1 
The synthetic route here (see Scheme 9) to the 
fully extended handle species (47) was very similar to 
that employed in section 2.3.2, although the preparation 
of the reference amino acid-ester-salt (40,42) was more 
H-Aua-OH 
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HO_®_CO_Aua_Aua -OH (44) 
Scheme 9 
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involved. 	Firstly, 11-aminoundecanoic acid was 
N - Z-protected by reaction with benzyl chloroformate in 
sodium hydroxide and sodium bicarbonate solution to 
produce quantitatively the protected reference amino 
acid (37), although a curious solvent effect was 
observed here whereby use of dioxan instead of THF 
resulted in a yield of only 30%. Conversion of (37) to 
the phenyl ester (39) was achieved via a 2-step process 
using oxalyl chloride and catalytic DMAP to yield the 
acid chloride followed by phenol and NMM to give the 
protected reference amino acid-ester (39) in 91% yield. 
A first attempt to produce (39) directly from (37) using 
DCCI and phenol, both with and without pyridine, 
succeeded only in forming the symmetrical anhydride 
(38). Initially, the reference amino acid-ester-salt 
formed was the hydrobromide (40) in 76% yield with HBr 
in acetic acid, and indeed this was successfully coupled 
to (30) with DCCI and NMM to give the handle-reference 
amino acid-ester (43) in 50% yield; however, (40) was 
found to be unstable over a long time period even at 
refri gerator temperatures as was evidenced by its decay 
to the reference amino acid-salt (41) and the production 
of handle-(reference amino acid)2 (44) in later 
attempts at the handle coupling reaction. This problem 
was solved by turning to the tosylate (42) which was 
obtained in 75% yield from (39) by hydrogenation on a 
-47- 
palladium/charcoal catalyst with 2-tolu enesuiphonic 
acid. Again, this was coupled to (30) as for the 
hydrobromide (40) to give (43) in 68% yield. 
At this point, another development in our research 
group132 was incorporated into the synthesis, viz, the 
Bnpeoc protecting group. This base-labile protecting 
group is similar to, and indeed was developed as a 
cheaper alternative to, the Fmoc group. It is cleaved 
by DBN or DBU as well as by piperidine which is used to 
cleave the Fmoc group, and it appears also to be more 
stable towards alkali or primary amines. 
Fmoc 	 Bnpeoc 
c)c 00 
DBN 	 DBU 
Thus, Bnpeoc-glycine (45) was coupled to (43) with 
DCCI and catalytic DMAP, giving the protected amino 
acid-handle-reference amino acid-ester (46) in 91% 
yield. In the final hydrolysis with sodium hydroxide, 
it turned out to be a very painstaking exercise to 
optimise the conditions for the reaction; a whole host 
of variations of alkali concentration and amount, 
presence or absence and amount of peroxide, solvent and 
reaction time were attempted. 	The best conditions 
ultimately proved to be 1. equivalent of 0.1M sodium 
hydroxide and 2 equivalents of 100 volumes hydrogen 
peroxide in 20% aqueous acetone for 15 minutes at room 
temperature, which produced the required protected amino 
acid-handle-reference amino acid (47) in 65% yield. 
Undoubtedly, the reason for the great sensitivity of 
this reaction towards the conditions is the presence in 
a species such as (46) of several possible sites for 
hydrolysis, viz, the Na-protecting group, benzyl ester 
and phenyl ester. 
The Fmoc derivative corresponding to (46) was also 
made, the method being identical and giving Fmoc-Gly-O-
®_CO_Aua_OPh in 84% yield. In common with (46) the 
hydrolysis proved to be troublesome, and again after 
much experimentation the optimum conditions133 were 
found to be 1 equivalent of 1M sodium hydroxide and 1 
equivalent of 100 volumes hydrogen peroxide in 20% 
aqueous dioxan for 15 minutes at room temperature: this 
produced Fmoc-Gly-O- G -CO-Aua-OH in 60% yield, 
although this compound was put aside in favour of the 
Bnpeoc analogue. The difference in optimum conditions 
for the hydrolysis of the two analogues perhaps reflects 
-49- 
the difference in the acidity of the two 3-hydrogens or 
the different steric constraints of the two 
Na-protecting groups or a combination of both. 
The desired product (47) having been successfully 
obtained in acceptable yield and purity, it was then 
coupled to a modified aminomethyl resin (3) and utilised 
in a solid phase peptide synthesis (see later); however, 
the result of this synthesis was considered to be 
disappointing at the time and hence it was decided to 
look into the use of glycine as the carboxyl extension 
of the handle (30). 	It could be that the saturated 
chain in (47) was too long allowing the molecule too 
high a degree of freedom of movement once it was bound 
to the polymeric support so making access to the a-amino 
function more difficult for incoming activated amino 
acids. 
Another researcher'34, however, investigating a 
related extension strategy obtained a rather different 
result. He modified the Pam resin (12) by inserting two 
11-aminoundecanoic acid units into the amide link of the 
Pam bridge to produce a very large spacer chain between 
the polymer matrix and the functional group of the 
resin. When this modified Pam resin was applied to 
peptide synthesis a significant improvement in crude 
product yield was obtained together with a vast 
improvement in peptide product homogeneity resulting in 
a three-fold improvement in yield of the final purified 
peptide. One reason for these apparently contradictory 
results could be that the use of two 11-aminoundecanoic 
acid units gives enough clearance to the peptide chain 
to minimise peptide-polymer interactions while the use 
of one such unit, as in the case of (47), still allows 
significant peptide-polymer interactions to occur. 
2.3.4 Phenyl Ester Approach-2 
In this case, the synthesis (see Scheme 10) of the 
fully extended handle species (54) was almost identical 
to that for (47) except for a few minor differences. The 
protected reference amino acid (48) was prepared in 89% 
yield using benzyl chioroformate and sodium hydroxide 
solution'35, with the subsequent esterification being 
successfully carried out by DCCI, phenol and pyridirie'36  
to produce the protected reference amino acid-ester (49) 
in 78% yield. In view of the long-term instability of 
the previous hydrobromide (40), the reference amino 
acid-ester-salt made was the tosylate (51) - in exactly 
the same manner as (42) - in 74% yield. An attempt to 
form (51) using methanol as solvent in place of the 
usual DMF resulted in transesterification to give the 
methyl ester (50), in 62% yield, instead of the phenyl 
ester (51). 	Again, the following steps to produce 























and (46) with the respective yields being 65% and 87%. 
Similar problems were encountered once more in the final 
hydrolysis with the same lengthy experimentation 
required to find the optimum conditions; surprisingly, 
however, in spite of the considerable difference in size 
of the two carboxyl extensions, these turned out to be 
identical to those for (47), and the final product (54) 
was obtained in 81% yield. 
An alternative transesterification approach'37 to 
the hydrolysis of (53) was attempted and involved 
reacting (53) with 50% v/v dimethylaminoethanol in DMA 
at room temperature for 24 hours to replace the phenyl 
ester with the dimethylaminoethyl ester, and then 
hydrolysing this product with 15% v/v water in DMA and 
of 
catalytic imidazole  at room temperature for 24 hours to 
produce hopefully the desired acid (54). It was found, 
unfortunately, that almost quantitative production of 
the Bnpeoc-derived olefin had taken place, so indicating 
incompatibility of the Bnpeoc moiety with this system. 
Later studies138 on Bnpeoc solvent stability, however, 
showed that the quality of a solvent such as DMA was 
crucial to the long-term stability of the Bnpeoc moiety 
in its presence, thus it was possible that the failure 
of the transesterification system was in some part 
attributable to the quality of the DMA, although due to 
the success in producing (54) by other means, this 
possibility was not investigated. 
The purification of the fully extended handle 
species (47) and (54) also proved to be troublesome; wet 
flash silica chromatography (twice) followed by gel 
filtration was sufficient to purify (47), as the fatty 
nature of the carboxyl end ensured an adequate mobility 
on silica. On the other hand, the purification of (54) 
was an altogether different proposition; alumina 
quantitatively produced the olefin elimination product 
of the Bnpeoc group, while exposure to silica for any 
significant length of time caused the compound to stick 
quite badly to the column requiring unacceptable amounts 
of polar solvent to elute it, undoubtedly having an 
adverse effect on its stability. Attempts to purify 
(54) by differential solubility, treatment with an 
acidic buffer, or conversion to an amine salt all 
yielded no improvement, and treatment with charcoal and 
Celite suffered from the same problem as did the silica 
chromatography. Eventually, (54) was obtained in 
acceptable purity by gel filtration followed by rapid 
dry flash silica chromatography on a short 1" column. 
In the synthesis of (47) and (54) glycine was used 
as the first residue in the peptide chain for two 
reasons: firstly, glycine is the smallest and only 
achiral natural amino acid and so when it is used as the 
C-terminal residue in fragment condensation it gives 
-53- 
better coupling with no problem over racemisation; and 
secondly, because glycine is the least sterically 
hindered amino acid the relevant compounds in Schemes 9 
and 10 are the most vulnerable to unwanted side 
reactions, and hence success with glycine should mean 
that corresponding derivatives with other amino acids if 
desired should present no greater problem. 
2.4 RESIN LOADING OF EXTENDED HANDLE (47) 
Unfortunately, 11-aminoundecanoic acid was not 
detectable under amino acid analysis, hence another 
reference amino acid was required. To avoid confusion 
with the natural amino acids in any peptide being 
constructed, the unnatural amino acid norleucine was 
chosen. Fmoc-norleucine (see Scheme 11) was coupled 
(X4) to the aminornethyl resin (3) using DCCI and 
catalytic DMAP to give a negative Kaiser result for 
(55), i.e. quantitative coupling was achieved. 
Subsequent piperidine deprotection of the Fmoc group to 
give (56) and coupling (X2) of the extended handle (47) 
with DCCI and catalytic DMAP was then carried out. 
Kaiser testing indicated that functionalisation of the 
resin was incomplete and thus capping to a negative 
Kaiser test with acetic anhydride and triethylamine of 
any unreacted free amino groups on the resin was 
performed. Amino acid analysis of the resin-bound 
product (57) indicated a yield of 87%, while 
H2 NCH  2_Ph_® 	 (3) 
Fmoc-Nle-NHCH2-Ph-Ø 	 (55) 
H_Nle_NHCH2.Ph-® 	 (56) 
Bnpeoc_Gly_O_®_CO_Aua_Nle_NHCH2_Ph_® 	(57) 
H_Gly_O_®_CO_Aua_Nle_NHCH2 _Ph_® 	(58) 
Scheme 11 
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microanalysis of (57) gave a yield of 84%, i.e. 
consistent results. The resin-bound extended handle 
(57) was then prepared for peptide synthesis by 
deprotection of the Bnpeoc group with DBN and acetic 
acid to give the extended amino resin (58). 	All of 
these operations were performed on a continually-
inverting manual peptide synthesiserof our own design, 
and in common with all subsequent use of the aminomethyl 
resin (3), its initial functionality was determined by 
repeated microanalysis. 
2.5 STEPWISE RESIN LOADING OF EXTENDED HANDLE (54) 
2.5.1 Complete Fragmentation 
While the lengthy experimentation into the 
synthesis and purification of (54) was being carried 
out, an investigation was also undertaken into the 
possibility of loading (54) onto the resin in three 
stages (see Scheme 12) as a means of circumventing the 
problems involved in the production of (54) in 
acceptable purity. 
Acid chloride methodology was employed in the first 
attempt to couple Bnpeoc-glycine (45) to the aminomethyl 
resin (3). Refluxing (45) with thionyl chloride 
furnished the acid chloride (59), as confirmed 
by infrared spectroscopy, which was then coupled to (3) 
using NMM and catalytic DMAP to give the resin-bound 
product: microanalysis indicated a coupling yield of 
- H2 NCH  2-Ph_® 	 (3) 
Bnpeoc_Gly_NHCH2_Ph_® 	 (60) 
H-Gly-NHCH2-Ph-® 	 (61) 





83%. Replacement of NMM by pyridine in this procedure 
resulted in very little coupling. A similar result was 
obtained when (45) was coupled (X2) to (3) with DCCI. 
Kaiser testing indicated incomplete reaction so acetic 
anhydride/triethylamine capping was carried out to give 
the resin-bound product (60) in 90% yield from 
microanalysis. 
The Bnpeoc group was removed with DBU and acetic 
acid to give (61) which was then treated with (30) and 
DCCI. A negative Kaiser test was obtained on the 
product of this coupling which microanalysis indicated 
had gone to completion. 	This was convenient since 
capping could not be performed in this case due to the 
presence, in theory, of free hydroxyl groups on the 
resin. Subsequent coupling of (45) with DCCI (X2) and 
with DCCI, HOBt and catalytic DMAP produced no reaction 
- the infrared spectrum of the product was identical to 
that of the starting material. A similar outcome was 
achieved using the acid chloride approach as for 
production of (60); both the pyridine and NMM/catalytic 
DMAP approaches resulted in no incorporation of (45) 
onto the modified resin. 
This last result is in conflict with standard Wang 
resin methodology and with a resin loading carried out 
in the research group involving Bnpeoc- and Fmoc-amino 
acid chlorides and Wang's -a1koxybenzy1a1cohol resin 
(14). Recently there has been a revival of interest in 
-56- 
the use of acid chlorides139 as coupling agents in 
peptide 	synthesis, 	especially 	with 	hindered 
substrates140, and this prompted our solid phase study 
which successfully culminated in an apparently 
racemisation-free synthesis of a tripeptide'38. 
As part of this work, the acid chloride (65) of 
Bnpeoc-phenylalanine was 	prepared by 	ref luxing 
with thionyl chloride, formation being confirmed by its 
infrared spectrum. As in the coupling of Bnpeoc-glycine 
(45) to the aminomethyl resin (3), success in obtaining 
the resin-bound product (66) was achieved with NMM and 
catalytic DMAP while replacement of NMM with pyridine 
resulted in coupling failure 	microanalysis of (66) 
showed a yield of 30% after two couplings. This is 
consistent with other results from the group study132  






amino acids with sterically bulky side-chains 	Bnpeoc- 
glycine gave a considerably higher coupling yield under 
identical conditions. 
-57- 
A further consequence of this study was a 
differentiation between the methods of agitation 
employed in the resin loading procedure132. Mechanical 
stirring is the least desirable as this can possibly 
cause damage to the resin beads, and rotary agitation 
has problems in that there is a conflict between the 
requirements of low viscosity and optimum immersion of 
the reaction mixture for continual vessel inversion, and 
high concentration of reagents for optimum coupling. 
The former requires the reaction vessel to be about 
half-full which obviously contradicts the latter. There 
is also the problem of the "dead-volume" below the 
sinter which can effectively remove a small quantity of 
acylating agent from the reaction mixture. Sonication 
provides the least disruptive method of agitation and 
allows the use of the minimum amount of solvent giving 
high reagent concentration, although it has a 
disadvantage with respect to rotary inversion in that 
removal of the resin product from the vessel is 
necessary for washing, drying and repeat couplings if 
needed. Results showed, however that sonication was 
superior to rotary inversion, and in view of these 
findings, all of the resin modification steps in the 
attempted stepwise loading of the extended handle (54) 
were carried out using sonication for the first 
treatment and rotary inversion for any subsequent 
treatments so minimising mechanical losses of material. 
Also, while microanalysis was used as a more accurate 
measure of reaction yield, KBr disk infrared 
spectroscopy provided a qualitative guide to the 
proceedings, with particular attention being paid to the 
carbonyl region and the characteristic absorptions of 
the nitro groups of the Bnpeoc moiety. 
Returning to the stepwise resin loading of (54), 
standard Wang resin methodology and the research group 
acid chloride studies suggest by analogy that the final 
coupling in the sequence to produce (63) should have 
been successful, and the tact that it was not indicates 
that the product obtained from the coupling of (30) to 
(61) was not the desired product (62). The nature of 
this product is unclear, but as little could be done to 
remedy the situation, this line of approach was taken no 
further. 
2.5.2 Partial Fragmentation 
Other strategies for producing resin-bound (54) 
involving a two- rather than a three-fragment approach 
are outlined in Scheme 13. As can be seen from Schemes 
7 and 12, although the resin-bound carboxyl extension 
amino acid (61) can be obtained successfully, route A 
falls down on the inability to produce, without further 
lengthy experimentation, a protected amino acid-handle 
species with no carboxyl extension. 
(3) 
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As for route B, brief attempts to hydrolyse the 
phenyl ester (52) (and also (43)) using a similar 
protocol to that for (53) (and (46)) resulted in a 
similar outcome to that for (53) (and (46)), viz, a 
complex product mixture requiring further investigation 
to maximise the desired product yield. In the case of 
(43), NMR evidence indicated that the desired product, 
HO- ®_CO.-Aua-OH,  had been obtained thus suggesting that 
improvements in yield and purity could be obtained from 
further experimentation. While these initial brief 
attempts at the hydrolysis of (52) (and (43)) were being 
carried out, however, success was achieved in the direct 
coupling of (54) (and (47)) to the aminomethyl resin (3) 
and hence these stepwise approaches were abandoned. 
2.6 MONITORING OF RESIN LOADING 
Unlike the previous example with the resin loading 
of the extended handle (47) where amino acid analysis 
could be used as a simple and fairly accurate measure of 
the coupling yield, other methods must be employed with 
the extended handle (54) due to the fact that (54) 
contains only glycine and that no other different amino 
acid was coupled to the resin (3) prior to the loading 
of (54). 
When embarking on a solid phase synthesis utilising 
a handle strategy, it is vital to have at least an 
approximate idea of the extent to which the handle species 
has coupled to the resin in order to ensure that some 
coupling has indeed taken place and, having established 
that, to avoid unnecessary wastage of materials by 
adjusting the scale of subsequent reactions accordingly. 
In the case of the extended handle (54) being 
coupled to the aminomethyl resin (3), qualitative 
monitoring of the reaction was performed by Kaiser 
testing and KBr disk infrared spectroscopy of the 
product resin, with the appearance of the relevant 
carbonyl absorptions and characteristic Bnpeoc-nitro 
group absorptions at 1350 and 1520 cm' being 
particularly significant. Quantitatively, the coupling 
was monitored in three ways; microanalysis, amine 
determination by Kaiser testing, and olefin 
determination by deprotection and ultraviolet 
absorbance. The last of these methods, devised in the 
research group, involved deprotecting a sample of the 
product resin to give the Bnpeoc-derived olefin, 
measuring the ultraviolet absorbance of the resulting 
solution at a chosen wavelength and comparing this, 
absorbance with a previously measured standard to 
ascertain the amount of olefin liberated from the 
sample. To save on repeated arithmetical effort, BASIC 
computer programs for use on the Apple II microcomputer 
were written (see Appendix) to process the raw data from 
these quantitative tests and display the results in the 
form of a printout. 
The procedures for the quantitative tests were as 
-61 - 
f ol lows: ollow
Amine Determination usinQ the Kaiser Test70  
( I ) 
	
	Weigh the resin sample (ca. 2-3 mg) into a tared 
test-tube. 
Add the test solutions to an empty tube as a 
blank, and the sample, as follows: 
Solution 1 : 76% w/w phenol in ethanol (75 p1) 
Solution 2 : 0.002M potassium cyanide in pyridine 
(100 p 1) 
Solution 3 : 0.28M ninhydrin in ethanol (75 p1). 
Incubate the tubes in a heating block at 100°C for 
7 minutes. 
Remove the tubes from the block and immediately 
add 4.75 ml of 60% ethanol in water to give a 
final volume of 5.00 ml. 
Vortex the tubes to mix the solutions thoroughly 
and let the resin settle to the bottom of the 
tube. 
Zero an ultraviolet spectrophotometer at 570 nm 
with the 60% ethanol in water. 	Note the 
absorbance of the blank and the sample at 570 nm. 
For manual calculation, the expression 
(absorbance sample-absorbance blank) x dilution (ml) x 106 
extinction coefficient x mass of sample (mg) 
where dilution = 5 ml & extinction coefficient = 
15000 M' cm- 
-62-- 
gives the functionality of the resin sample with 
respect to free amino groups in micromoles per 
gram. 
(VIII) The program RESFUNC-KAISER then uses this 
expression to calculate the percentage coupling 
yield for the resin loading step and the 
functionality of the product resin in terms of the 
species being loaded. Sampling can be carried out 
either before the capping step or after the 
deprotection step. 
Olefin Determination 
Weigh the resin sample (ca. 2-3 mg) into a tared 
10 ml volumetric flask. 
Make up the volume to 10 ml with 20% v/v 
piperidine in DMF or DMA and sonicate for 30 
minutes before allowing the resin to settle to the 
bottom of the flask. Piperidine is used in 
preference to DBU/DBN as there are problems with 
the latter remaining in the resin matrix after 
washing. 
For Bnpeoc products, remove 1.00 ml of the 
solution, place in another 10 ml volumetric flask, 
and again make up the volume to 10 ml with the 
piperidine solution. This dilution is necessary 
in view of the Bnpeoc chromophore being an order 
of magnitude stronger than that of Fmoc and 
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dilution of the sample is preferable to reduction 
of the sample size. For Fmoc products, omit this 
dilution step. 
Record the ultraviolet spectrum of a blank and the 
sample between 350 and 280 nm. 	Note the 
absorbance of the sample relative to the blank at 
300 nm. 
The program RESFUNC-UV then compares this 
absorbance value with the previously measured 
standard to determine the amount of olefin 
released from the sample and hence calculate the 
percentage coupling yield for the resin loading 
step and the functionality of the product resin in 
terms of the species being loaded. Sampling can 
be carried out either before or after the capping 
step but before the deprotection step. 
Microanalysis 
The program RESFUNC-CHN uses the nitrogen 
percentages in the starting material and product resins 
to give the coupling yield and the product resin 
functionality. As before, sampling can be carried out 
either before or after the capping step but before the 
deprotection step. 
In all of the above quantitative tests, it is 
imperative to have the product sample absolutely dry as 
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the presence of solvent will give an inaccurate 
microanalysis and also, since the Kaiser and olefin 
tests depend for their results on a very small rass of 
sample, any error in this mass gives a grossly 
inaccurate final result for the coupling yield. The 
best way to ensure sample dryness is to give any sample 
a thorough washing with DCM before drying in either a 
vacuum desiccator, a vacuum oven, or a drying pistol for 
at least 24 hours. This ensures the removal of any 
traces of less volatile solvents, such as DMF, which 
otherwise can linger throughout the drying process. 
The tests are also complementary in the sense 
that both the microanalysis and olefin determination 
measure the amount of successfully coupled extended 
handle while, on the other hand, the Kaiser test - if 
performed before the capping step - measures the amount 
of unreacted amine sites remaining on the product resin. 
As for the accuracy of the tests, microanalysis suffers 
from the fact that the operational error of ± 0.3% is 
significant compared to the nitrogen percentages being 
dealt with, although repetition of the analysis helps to 
combat this. The olefin and Kaiser tests, as mentioned 
before, are very sensitive to the sample mass and so 
again repetition of the test allows a more confident 
result to be obtained. 
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2.7 DIRECT RESIN LOADING OF EXTENDED HANDLE (54) 
In an attempt to utilise the parent phenyl ester 
(53) for the resin loading as opposed to the acid (54), 
the phenyl ester (53) was applied directly to the 
aminomethyl resin (3) with sonication and reflux in both 
DCM and DMA. In both cases, however, microanalysis of 
the product resin showed that no coupling had taken 
place indicating that the phenyl ester (53) was too 
inactive for successful coupling in this manner. 
To cut down the number of steps involved in 
producing the functionalised resin (63) and for the 
possible steric reasons discussed at the end of section 
2.3.3, no additional reference amino acid was coupled to 
the resin (3) prior to its functionalisation with the 
acid (54) although, as mentioned before, this rules out 
amino acid analysis as a means of monitoring the 
coupling reaction. Successful coupling of the extended 
handle (54) to the aminomethyl resin (3) to give the 
desired resin-bound product (63) (see Scheme 12) was 
achieved with the active ester approach using DCCI and 
HOBt. Small scale studies showed that triple coupling 
was required and so this was implemented in the larger 
scale preparation of (63): sonication was used in all 
three couplings to maximise the coupling yield. Kaiser 
testing after the third coupling indicated incomplete 
reaction, thus capping to a negative Kaiser result with 
acetic anhydride and triethylamine was carried out (see 
Fig. 2.1 for quantitative test results). 
Coupling No. 
% Coupling from 	 1 	2 	3 	Capping 
Microanalysis 	 17 	39 	54 	37 
Olefin Determination 	18 	35 	42 	53 
Kaiser Testing 	 26 	60 	72 	45 
Figure 2.1 - Coupling Yields Observed in Synthesis of 
Functionalised Resin (63) 
While these results are not in complete accord, it 
is evident that, especially after capping, there is 
reasonably good agreement between all three tests; it is 
also clear that there is good agreement throughout 
between microanalysis and olefin determination, whereas 
Kaiser testing gives significantly higher couping 
yields, except after capping. It is interesting to note 
that Kaiser testing gives far better agreement after 
capping, since for the couplings it detects thc 
unreacted amino groups whereas after capping it detects 
the amino groups which had previously been coupled to by 
the desired product (54) and subsequently had the Bnpeoc 
group removed. Another interesting observation was that 
an attempt to use the coupling reaction as a 
purification step for the acid (54) by applying the 
crude product of a preparation of (54) directly to the 
resin without any chromatographic purification resulted 
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in none of the desired product (54) being coupled to the 
resin. 	A possible explanation for these last two 
observations is that after purification of (54) there 
remained a small amount of an unidentified impurity 
which occupied some amino sites on the resin during the 
coupling reactions - this would give the high Kaiser 
test results. Assuming that this impurity was small in 
relation to (54) and had an accessible, unprotected 
functional group, then capping would ensure that it took 
no further part in the proceedings and its small size 
would render olefin determination and microanalysis 
relatively insensitive to its presence. Thus the 
results from these two testing methods were considered 
more reliable. 
For the purposes of later peptide synthesis, the 
results from the microanalysis and olefin determination 
of the third coupling and the capping were averaged to 
give a yield of 47% for the resin loading step, and as 
can be seen from Fig. 2.1, this was in good agreement 
with the Kaiser test of the capped and deprotected 
resin-bound product (64) which gave a 45% yield. As the 
automated peptide synthesiser used in the subsequent 
solid phase work begins a synthesis with a deprotection 
step (see Experimental section), the resin-bound 
extended handle was left in the Na-protected form (63). 
A comparison between the coupling yields for the 
extended handles (54) and (47), viz. 47% and 86% 
respectively, shows a large difference in favour of 
(47). This suggests that while the long saturated chain 
of (47) may possibly be a disadvantage when it comes to 
peptide chain construction (see later), it may also cut 
down the steric hindrance in the coupling step by 
distancing the acid function from the bulky remainder of 
the molecule. 	Another factor which must also be 
considered in this instance, however, is the riorleucine 
extension to the aminomethyl resin (3) in the case of 
(47). 	It was seen earlier131- (see section 2.2) that, 
keeping all other factors constant, extending the 
functional group on the resin by precoupling a spacer 
amino acid resulted in a significant improvement in the 
coupling yield of an extended handle, and this may be 
the dominant effect in creating the difference in 
coupling yields. Obviously, a peptide synthesis 
utilising (54) and the norleucine resin extension is 
required to offer a direct comparison between the two 
extended handles, and although this has not yet been 
attempted, this system may provide the best balance 
between a high coupling yield and a good peptide 
synthesis with the added bonus of amino acid analysis as 
another monitor of the situation. 
A second interesting comparison can also be made 
between the coupling of (54) and previous work'3' on a 
similar system. Using the active ester protocol with 
DCCI and HOBt, the extended handle Fmoc-Leu-O--®- 
CO-Gly-OH was coupled to the aminomethyl resin (3) 
quantitatively. Since the only major difference here is 
the N U_ protectinggroup, this result suggests that use 
of the Bnpeoc group for Na-protection of the extended 
handle is detrimental and that a better coupling yield 
might be obtained through use of the Fmoc group. 
Coupling of the extended handle (54) to the Wang 
resin (14) was also attempted using the standard active 
ester approach which was successful with the aminomethyl 
resin (3). On this occasion, however, even after two 
couplings, microanalysis of the intended resin-bound 
product (67) demonstrated that negligible function-
alisation of the Wang resin (14) had been achieved. 
H_(OCH2_Ph)2_® 	(14) 
Bnpeoc_Gly_O_®_CO_Gly.- ( OCH-Ph) 	(67) 
This may be due to steric factors as in this case the 
functionality of the Wang resin (14) is 2.5 times that 
of the aminomethyl resin (3), hence the functional 
groups in (14) are more tightly packed so possibly 
preventing access of such a large molecule as (54). One 
way to establish it this was the case would be to couple 
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an extra spacer amino acid to the resin (14) prior to 
coupling (54) as was demonstrated successfully in 
previous work'3' in our research group (see section 
2.2). Another possibility would be to use an 
alternative active ester such as the trichiorophenyl 
ester or the more active pentafluorophenyl ester to see 
if varying the activity of the coupling ester made any 
difference to the outcome. 
As a footnote to all of the above resin loading 
studies, a recent publication'4' has justified the use 
of the traditional Merrifield-type polystyrene-1% 
divinylbenzene copolymer as the solid support in peptide 
synthesis. In a study to evaluate the influence of the 
chemical and physical constitution of the support on the 
coupling efficiency of protected peptides, the 
aforementioned polymer gave the best result when 
compared with four other polymers; a more porous one, a 
non-crosslinked one, a more polar one and one with a 
rigid matrix. Since the extended handles (47) and (54) 
can be likened sterically to protected peptide 
fragments, this result justifies the use of a resin such 
as (3) in the work described here and in the fragment 
condensation approach to the synthesis of ubiquitin in 
general, to which goal it is hoped the work described 
here will eventually lead. 
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2.8 SOLID PHASE SYNTHESIS OF PEPTIDES 
All of the peptides discussed here (see 
Experimental section for details) were assembled on the 
Applied Biosystems model 430A automated peptide 
synthesiser using, unless otherwise stated, Fmoc-amino 
acids and double coupling; the first with symmetrical 
anhydride (DId) and the second with active ester 
(DICl/HOBt). Final cleavage of peptide from the resin 
was achieved using TBAF which had to be fully dried as 
the presence of any water forms HF which would attack 
any acid-labile protecting groups on the peptide. It 
has recently been reported142, nevertheless, that 
Na_ protection can be retained intact after peptide 
cleavage with the commercially available TBAF trihydrate 
but this practice was not adopted here and the TBAF 
continued to be thoroughly dried before use. For small 
peptides, three TBAF treatments were found to be 
sufficient to remove the vast majority of peptide from 
the resin, with the third treatment producing only a 
fraction of that released by the first two. DMF was 
used as the solvent for these TBAF treatments as a polar 
solvent was required to ensure adequate solvation of 
peptide product while at the same time giving acceptable 
resin swelling, and previous studies in otr group'31  
showed DMF to be superior to others in this respect. 
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Dpp-Leu-Ile-Phe-Ala-Gly-OH (68) 
Having successfully obtained the resin-bound handle 
(57), it was utilised in its deprotected form (58) in 
the synthesis of a pentapeptide. Although the aim of 
the extended handle strategy was to produce fully 
protected peptide fragments, it was decided not to 
complicate matters too soon but to synthesise a short 
peptide with no side-chain functionality solely in order 
to test the amenability of the system to peptide 
	
synthesis. 	In 	keeping with the ubiquitin goal, the 
peptide chosen for synthesis was ubiquitin (43-47), with 
the N-terminal amino acid, leucine, having Dpp 
Na_protection. The completed coupling cycle of each 
amino acid was monitored quantitatively using the Kaiser 
test which showed reasonable, but not outstanding, 
coupling efficiencies (see Fig. 2.2). Capping was not 
performed during this synthesis as the machine cycles 
had not been altered to incorporate it at this stage. 
Amino Acid 
	




Phe [45] 	 98.7 
Ile [44] 	 98.0 
Leu [43] 	 99.5 
Figure 2.2 - Coupling Yields Observed in Synthesis of 
tJbiquitin (43-47) (68) using (58) 
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The amino acid analysis of the resin-bound peptide: 
N1e1 1.00, Gly1 0.91, Ala1 0.69, Phe1 0.62, lie1 0.57, 
Leu1 0.61 reflected the possible non-quantitative nature 
of the glycine-alanine coupling, however, the high 
glycine ratio perhaps alternatively indicated the 
presence of some capped glycine from the coupling of 
(47). Excepting this, the analysis also pointed to a 
reasonable homogeneity of peptide product, although the 
high leucine ratio with respect to isoleucine suggested 
some deletion peptide formation. After TBAF cleavage of 
the peptide, the amino acid analysis of the residue 
resin: N1e1 1.00, Gly1 0.16, Ala1 0.23, Phe1 0.26, 
lie1 0.15, Leu1 0.18 indicated very little peptide 
remaining on the resin. Purification of the crude 
cleavage product by gel filtration removed a trace 
amount of impurity to give the desired peptide (68) in 
40% yield. Even though on reflection this yield is not 
too bad, it was considered to be disappointing at the 
time and this prompted the investigation into the use of 
the extended handle (54) in place of (47). 
H-Leu-Ile-Phe-Ala-Gly-OH (69) 
This peptide was made using the resin-bound 
extended handle (63) in order to obtain some measure of 
comparison of the utility of the extended handles (47) 
and (54) in peptide synthesis. The only differences 
between here and the synthesis of (68) were that capping 
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after each amino acid was carried out so ensuring no 
deletion peptide formation and that the N-terminal 
leucine was deprotected before TBAF peptide cleavage. 
No amino acid analysis of the resin-bound peptide was 
carried out but that of the residue resin: G1y2 2.00, 
Ala1 0.43, Phe1 0.58, lie1 0.23, Leu1 0.29 suggested at 
first glance that there was more peptide remaining on 
the resin in this case than with (68), but little could 
be said in this instance about capped glycine since the 
carboxyl end of the extended handle (54) is also 
glycine. Purification of the crude cleavage product 
by gel filtration, however, gave the desired peptide 
(69) in 65% yield. It would thus appear that use of the 
extended handle (54) gives a better yield that that of 
(47), but as mentioned earlier (see section 2.7), (47) 
may have some points in its favour. 
H-Val-Lys-Giy-Arg-Gly-OH (70) 
In order to confirm the suitability of the system 
employing (54) towards peptide synthesis, it was 
considered necessary to prepare a second short peptide 
before tackling a fragment of ubiquitin; the one chosen 
here was the C-terminal fragment of giucagon-like 
peptide I. This time, however, amino acids with 
side-chain functionality were used necessitating the use 
of side-chain protecting groups so producing adducts 
with a much greater steric bulk than those used for 
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(69). For this example, the side-chain of lysine was 
protected with the Boc group while that of arginine was 
protected by the Pmc group, an acid-labile moiety 
developed recently in or research group117'118; the 
N-terminal valine was Boc-protected and the second 
active ester coupling was omitted for glycine to prevent 
any possible formation of a glycine-glycine sequence. 
Also, both couplings for arginine used the active ester 
and acetyl imidazole was used as the capping agent. 
Again, no amino acid analysis was performed on the 
resin-bound peptide and that of the residue resin : G1y3 
3.00, Argl 0.49, Lys1 0.44, Va11 0.48 showed that most 
of the peptide had been removed from the resin and, in 
addition, that excellent homogeneity of product had been 
obtained. The crude cleavage product was purified by 
gel filtration after which deprotection was carried out 
using aqueous TFA. 	Further purification by gel 
filtration and then by preparative reverse phase HPLC 
resulted in a 60% yield of the desired peptide (70). 
Fully Protected Ubiquitin (1-35) (71) 
Now that it had been clearly demonstrated that the 
extended handle (54) was suitable for solid phase 
peptide synthesis, an attempt could now be made to 
synthesise a fully protected fragment of ubiquitin. 
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Earlier work in our group-8'143 with the Applied 
Biosystems machine and the Wang resin (14) had involved 
the successful synthesis of unprotected ubiquitin 
(48-76) and indeed of the complete ubiquitin molecule 
itself, although the purification of the latter proved 
to be extremely difficult due to, amongst other things, 
several bad couplings on route; thus it was decided to 
tackle ubiquitin (1-35). As before, all couplings 
employed Fmoc-amino acids except for the last one where 
J3oc-methionine was used; TBAF is known to cleave the 
Fmoc group144 thus necessitating the use of an 
alternative protecting group for the N-terminus. The 
side-chains of glutamic and aspartic acids, threonine 
and serine were protected with the t-Bu group while that 
of lysine was Boc-protected. As for (70), glycine was 
single-coupled using the symmetrical anhydride, while 
for asparagine and glutamine both couplings employed the 
active ester with extended reaction times. 	The 
ultraviolet deprotection trace (see Experimental 
section) from the complete ubiquitin synthesis'43 helped 
to pinpoint the potentially problematic couplings in 
ubiquitin (1-35) which required checking and these were 
monitored using the previously described olefin 
determination test (see Fig. 2.3). 
% Coupling by Olefin Determination 
after Coupling Cycle No. 
Coupling 	 1 	2 	3 
Ile30]/Gln[311 	 102 	- 	- 
Ile[23]/Glu[241 	 68 	74* 	90 
Ile[13]/Thr[14] 	 72 	72 	- 
Gly[lO]/Lys[1l] 	 61 	- 	- 
*active ester coupling only repeated 
Figure 2.3 - Coupling Yields Observed in Synthesis of 
Ubiquitin (1-35) (71) using (63) 
When TBAF cleavage of the peptide from the resin 
was attempted, it was found that the crude mass obtained 
each time increased steadily over the first three 
treatments, hence the TBAF treatments were continued and 
seven were performed in all. The crude mass liberated 
reached a maximum with the fifth treatment after which 
it began to decline again. Since it was not immediately 
obvious how many treatments would be required to release 
all the available peptide, it was decided to stop after 
the seventh treatment as it was felt in any event at 
this stage that the quality of the product would 
deteriorate with repeated TBAF applications liberating 
an increasing proportion of impurity. This slow 
leeching of the peptide from the resin points to steric 
effects coming into play which is not entirely 
unexpected due to the highly significant increase in 
steric bulk from the presence of the side-chain 
protecting groups coupled with the considerable size of 
TBAF itself. Amino acid analysis of the residue resin 
was carried out after the fourth, fifth, sixth and 
seventh TBAF treatments (see Fig. 2.4). Glycine was 
used to standardise the figures and it can be seen 
clearly that the ratio of each amino acid to glycine 
decreased steadily with continuing TBAF treatment 
showing a steady loss of peptide from the resin. It can 
also be seen that a significant amount of peptide 
remained on the resin after the seventh treatment. 
As a consequence of the extremely fatty nature of 
the fully protected peptide, reverse phase HPLC of the 
product could not be performed on account of its very 
low solubility in acetonitrile and/or water; indeed its 
solubility in DMF was just sufficient enough to allow 
gel filtration to be carried out. Fortunately, the 
product was soluble enough in DCM to facilitate normal 
phase HPLC, and this indicated that the product from 
TBAF treatments one to four was of greater purity than 
that from the later treatments. These two batches of 
product were thus combined and purified separately by 
gel filtration: the first four TBAF treatments produced 
peptide of excellent quality while that from the later 
TBAF treatments contained small amounts of impurity (see 
Fig. 2.5) . A combined yield of 32% was achieved, but 
Amino Acid Analysis of 
Residue Resin after TEAF 
Treatment No. 
Amino Frequency in 
Acid Ubiquitin 	(1-35) 4 5 6 7 
Asp/Asn 3 9.19 7.70 6.10 4.46 
Thr 5 13.63 11.41 9.29 6.74 
Ser 1 3.63 2.78 2.39 1.74 
Glu/Gln 6 19.15 15.99 12.48 9.08 
Pro 1 4.27 2.71 - - 
Gly 2 10.00 10.00 10.00 10.00 
Ala 1 3.38 2.87 2.34 1.89 
Val 3 7.82 6.85 5.70 4.59 
Met 1 1.39 1.17 0.97 0.50 
Ile 4 10.09 8.92 7.47 5.61 
Leu 2 5.21 4.69 3.91 2.89 
Phe 1 1.92 1.51 1.38 1.09 
Lys 5 13.76 12.05 9.92 7.14 
Figure 2.4 - Amino Acid Analyses of Resin-bound Ubiquitin (1-35) (71) 
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Figure 2.5 - HPLC Traces of Gel Filtered Ubiquitin (1-35) (71) 
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as a third of the resin-bound product after the coupling 
of glutamine[2] was removed for other purposes, this 
amounted to a projected yield of 48% for the desired 
peptide (71). The amino acid analysis of the product: 
Asx3 3.06, Thr5 4.71, Ser1 0.93, G1x6 6.40, Pro1 1.13, 
G1y2 1.97, Ala1 1.05, Va13 2.95, Met1 0.59, 11e4 3.84, 
Leu2 1.95, Phe1 0.80, Lys5 5.03 gave a fair result and 
the presence of the required molecular ion was confirmed 
by high-resolution mass spectrometry. 	Proton NMR 
evidence also supported the existence of the desired 
product showing strong signals in the correct region for 
the Boc and t-Bu groups, and so it would appear that the 
synthesis of fully protected ubiquitin (1-35) (71) was 
successful which hopefully bodes well for any future 
attempts at a fragment assembly approach to the 
synthesis of ubiquitin. 
CHAPTER 3 : EXPERIMENTAL 
3.1 NOTES 
All amino acids used were purchased from the SlS 
group of companies, except for 11-aminoundecanoic acid 
which was purchased from Fluka, and used as supplied. 
Z-amino acid derivatives were prepared by literature 
methods. Melting points were taken in open capillaries 
on an electrically heated Buchi 510 melting point 
apparatus, or on microscope slides on an electrically 
heated Reichert 7905 melting point apparatus, and are 
uncorrected. Thin-layer chromatography (TLC) was 
carried out on plastic sheets coated with silica gel 
60GF-254 (Merck 5735) in the following systems: 
50/50, ether/petrol ether (40-60) 
100% ether 
50/50, ethyl acetate/petrol ether (40-60) 
100% ethyl acetate 
80/20, ethyl acetate/methanol 
60/40, ethyl acetate/methanol 
85/15, chloroform/isopropanol 
85/14/1, chloroform/methanol/acetic acid 
60/20/20, n-butanol/acetic acid/water 
Visualisation of the compounds was achieved by a 
suitable combination of the following methods: iodine 
vapour, ultraviolet absorption at 254 nm, neutral 
potassium permanganate and bromophenol blue sprays, 
Mary's reagent (4,4'-bis-(dimethylamino)-phenylcarbinol) 
for acid functions, and ninhydrin for peptides with free 
amino groups. High-performance liquid chromatography 
(HPLC) was carried out using either a waters system, 
i.e. 2 x 600A pumps, a U6K injector, a 680 automatic 
gradient controller, a model 441 ultraviolet detector, 
and a 308 computing integrator; or an Applied Biosystems 
system, i.e. 2 x 1406A solvent delivery systems, a 
1480A injector/mixer, and a 1783A detector/controller. 
Analytical separations were carried out on the following 
columns: 
ODS3 5p Partisil (4.6 x 250 mm) (reverse phase) 
ODS2 511 Spherisorb (4.6 x 250 mm) (reverse phase) 
i Porasil (3.9 x 300 mm) (normal phase) 
using with column (I) a gradient, as specified in 
parentheses, between solvent A (0.05% TFA in water) and 
solvent B (0.05% TFA in acetonitrile). The flow rate 
was 1 ml/min, and elution of the samples was monitored 
by ultraviolet absorption at 214, 229 or 254 nm as 
indicated. Amino acid analyses were carried out on an 
LKB 4150 alpha amino acid analyser following sealed tube 
hydrolysis in constant boiling hydrochloric acid at 
110°C for 18 hours. Infrared spectra were recorded on a 
Perkin Elmer 781 spectrophotometer in the solvent 
indicated, or by the nujol mull technique, using 
polystyrene as the standard (1603 cm'). Resin-bound 
samples were recorded using the KBr disk technique. 
Ultraviolet spectra were recorded in HPLC grade 
acetonitrile on a Varian Cary 210 spectrophotometer. 
Mass spectra were measured on a Kratos MS 50TC machine. 
Proton nuclea: magnetic resonance (NMR) spectra were 
recorded on either Bruker WP80 (80 MHz), WP200 
(200 MHz), or WH360 (360 MHz) machines in the solvent 
indicated, using tetramethylsilane* as the standard 
6= 0.00). Carbon-13 NMR spectra were recorded on a 
Bruker WP200 (50 MHz) machine in the solvent indicated, 
again using tetramethylsilane as the standard 
6 = 0.00). Elemental analyses were carried out on a 
Carlo Erba model 1106 elemental analyser. 	Halogen 
analyses were carried out using the oxygen flask 
combustion technique followed by mercurimetric 
titration. All solvents were distilled before use, and 
the following were dried using the reagents given in 
parentheses when required: acetonitrile (calcium 
hydride), 	chloroform 	(phosphorus 	pentoxide), 
dichloromethane (calcium hydride), diethylether 
(sodium wire), N,N-dimethylformamide/N,N-dimethyl-
acetamide (calcium hydride or 4A molecular sieves), 
ethyl acetate (anhydrous potassium carbonate), 
isopropanol (calcium hydride), methanol (magnesium-
iodine), tetrahydrofuran (benzophenone-sodium metal), 
benzene (sodium wire). Petrol ether (40-60) refers to 
that fraction which boils between 40°C and 60°C. 
3.2 EXPERIMENTAL 
4-Hydroxymethyl--3-(trimethylsilyl)hydrocinnamic acid (30) 
HO_®_C00H130  
HO_®_COOH (30) was prepared from -to1ualdehyde 
following the experimental procedure given by Ramage et 
al.130. 	The crude product thus obtained was 
recrystallised from aqueous ethanol to yield pure (30) 
as a white powder (overall yield 6%), m.p. 120-122°C 
(lit.130 123-124.5 0 C); 8H (80 MHz, (CD3)2C0) 7.24 (2H, 
d, J 8.0 Hz, aromatics), 7.04 (2H, d, J 8.0 Hz, 
aromatics), 4.56 (2H, s, benzyl alcohol CH2), 2.76-2.64 
(3H, m, cinnamate CH, CH2), -0.01 (9H, s, Si(CH3)3); m/z 
(FAB) 251, 235, 162, 147, 134; HPLC (I) (A:B, 50:50-B, 
100%; 28 mm; 254 nm) RT = 5.5 mm; TLC (D) Rf 0.40. 
Diphenyldiazomethane (31) Ph2CN2145  
Ph2CN2 (31) was prepared from benzophenone 
hydrazone (15.00 g, 76.5 mmol) following the exper-
imental procedure given by Miller145. The crude product 
thus obtained was crystallised from an oil by cooling in 
a refri gerator to yield (31) as a red crystalline solid 
-+ 
(7.80 g, 53%); Vmax (CH2C12) 2040 1590 cm' (C=N=N). 
Benzhydryl 4-(hydroxymethyl)-13-(trimethylsilyl)hydro- 
cinnamate (32) HO-®-CO-OBzh 
To a stirred solution of HO- ®-COOH (30)130 (10.1 
g, 40.0 rnmol) in chloroform (200 ml) and ethyl acetate 
(100 ml) at room temperature was added a solution of 
diphenyldiazomethane (31)145 (7.8 g, 40.0 mmol) in 
chloroform (100 ml) dropwise. The reaction mixture was 
stirred at room temperature for a further 4 hours, with 
the nitrogen gas evolved detected using a bubbler. 
During reaction, the colour of the solution changed from 
deep purple to pale pink after 4 hours. The reaction 
mixture was then kept at room temperature in the dark 
for a further 24 hours, by which time the solution was a 
pale yellow/green colour. After removal of the reaction 
solvent under reduced pressure, remaining starting 
materials were removed by dry flash silica 
chromatography using a petrol ether (40-60) to ether 
gradient, and the product was subsequently 
recrystallised (X3) from 50/50, petrol ether (40-60)/ 
ether to yield pure (32) (10.00 g, 88%), m.p. 90-91°C; 
(Found: C, 74.9; H, 7.31; N, 0%; C26H3003Si requires C, 
74.6; H, 7.22; N, 0%); Vmax (CH2C12) 3600 (OH), 2960 
2930 2870 (aliphatic C-H), 1730 (C=O), 865 845 cm' 
(aromatic C-H); 8H  (200 MHz, CDC13) 7.35-7.10 (10 H, m, 
aromatics), 6.87 (lH, s, benzhydryl CH), 4.63 (2H, s, 
benzyl alcohol CH2), 3.29 (lH, broad s, OH), 3.14-2.78 
(3H, m, cinnamate CH, CH2), 0.08 (9H, s, Si(CH3)3); 6c 
(50 MHz, CDC13) 172.3 (C=O), 141.4 (cinnamate C-l), 
140.1 (benzhydryl C-i (X2)), 137.7 (cinnamate C-4), 
128.3-127.0 (aromatic CH (X14)), 77.1 (benzhydryl CH), 
64.7 (benzyl alcohol CH2), 35.2 (cinnamate CH2), 32.5 
(cinnamateCH), -0.1 (Si(CH3)3);m/z (FAB) 419, 401, 
357, 226, 167, 117, 74; HRMS 419.2042, C26H3103Si (MH) 
requires 419.2042; HPLC (I) (A:B, 50:50-B, 100%; 28 mm; 
254 nm) RT = 21.4 mm; TLC (A) Rf 0.39. 
Benzhydryl 4_(Na_(  9f luorenylmethoxycarbonyl )glycyl-
oxymethy1)-B-(trimethylsily1)hydrocinnamate (33) Finoc-
Gly_O_Ø_CO_OBzh 
To 	a stirred solution of HO.  -® - CO-OBzh (32) 
(2.50 g, 6.0 mmol) in DCM (10 ml) cooled to 0°C was 
added a solution of Fmoc-Gly-OH (1.95 g, 6.6 mmol) in 
DCM (10 ml) and DMF (4 ml) cooled to 0°C. DCCI (1.36 g, 
6.6 mmol) in DCM (5 ml) cooled to 0°C was then added 
followed by a catalytic amount of solid DMAP. 	The 
reaction mixture was left stirring to come to room 
temperature overnight, after which time the precipitated 
DCU was filtered off and the reaction solvent removed 
under reduced pressure. Dissolving the product in ethyl 
acetate afforded a further precipitate of DCU which was 
removed by filtration, and the filtrate was washed with 
5% citric acid solution (X2), saturated sodium 
bicarbonate solution (X2), water (X2), brine (X2), and 
dried over anhydrous magnesium sulphate. Removal of the 
drying agent and the solvent gave the product as a pale 
yellow oil. 	Purification was carried out using dry 
flash silica chromatography with a petrol ether (40-60) 
to ether gradient, followed by recolumning with 
chloroform as the eluent to afford the product as a 
clear, colourless oil, which on lyophilisation yielded 
pure (33) as a fluffy white powder (4.09 g, 98%), m.p. 
47-49°C; (Found: C, 74.1; H, 6.66; N, 1.95%; C43H43N06S1 
requires C, 74.0; H, 6.21; N, 2.01%); max (CH2C12) 3460 
(N-H), 3040 2980 2920 2880 (aliphatic C-H), 1740 (C=O), 
1520 (urethane N-H), 875 855 cm' (aromatic C-H); Amax 
(CH3CN) 299 nm (E=6993), 289 (5944), 265 (21678), 
227 (23427), 220 (32867); H (200 MHz, CDC13) 7.82-7.08 
(22H, m, aromatics), 6.80 (1H, s, benzhydryl CH), 5.57 
(lH, t, J 5.6 Hz, Fmoc-Gly NH), 5.19 (2H, s, benzyl 
CH2), 4.46 (2H, d, J 7.1 Hz, Fmoc CH2), 4.28 (1H, t, J 
6.9 Hz, Fmoc CH), 4.04 (2H, d, J 5.7 Hz, Fmoc-Gly CH2), 
3.08-2.71 (3H, m, cinnamate CH, CH2), 0.01 (9H, s, 
Si(CH3)3); 	c (50 MHz, CDC13) 172.0 (benzhydryl ester 
C0), 169.8 (Fmoc-Gly C=O), 156.1 (Fmoc C=O), 143.6 
141.0 (Fmoc quaternary aromatic (2X2)), 139.8 
(benzhydryl quaternary aromatic (X2)), 142.7 (cinnamate 
C-i), 131.3 (cinnamate C-4), 128.3-119.8 (aromatic CH 
(X22)), 76.9 (benzhydryl CH), 66.9 (Fmoc CH2, benzyl 
CH2), 46.9 (Fmoc CH), 42.6 (Fmoc-Gly CH2), 34.7 
(cinnamate CH2), 32.4 (cinnamate CH), -3.4 (Si(CH3)3); 
m/z (FAB) 698, 532, 476, 400, 167; HRMS 698.2938, 
C43H44NO6Si (MH) requires 698.2938; HPLC (I) (A:B, 
50:50-B, 100%; 28 mm; 254 nm) RT = 26.4 mm; TLC (A) Rf 
0.26. 
Mm 
Methyl 11-aminoundecanoate hydrochloride (34) ClH2-
Au a - OM e 
Thionyl chloride (11.91 g, 100.1 mmol) was 
dissoved in methanol (50 ml) and cooled to below -40° C 
in a dry ice bath with stirring. 11-aminoundecanoic 
acid (10.00 g, 49.8 mmol) was added as a solid in small 
portions over a period of 40 minutes so as to maintain 
the low temperature. The reaction mixture was left 
overnight to rise to room temperature, giving a clear, 
colourless solution and a white precipitate. This was 
filtered off, and the solvent removed under reduced 
pressure from the filtrate to give the product as a 
white powder. Recrystallisation (X2) of the precipitate 
from methanol afforded further crops of product from the 
filtrate. All crops of the product were combined and 
recrystallised from DCM to yield pure (34) (10.16 g, 
81%), m.p. 158-160° C; (Found: C, 56.9; H, 10.44; N, 
5.57; Cl, 14.0%; C12H26NO2C1 requires C, 57.2; H, 10.41; 
N, 5.56; Cl, 14.1%); vmax (CHC13) 2980 2930 2860 (NH3, 
aliphatic C-H), 1730 cm' (C=O); 6H (80 MHz, CDC13) 
3.56 (3H, s, methyl ester CH3), 2.73 (2H, m, Aua CH2), 
2.26 (2H, m, Aua CH2), 1.75-1.23 (16H, m, Aua CH2 (X8)); 
Ec (50 MHz, CDC13) 173.3 (C=O), 51.0 (methyl ester CH3), 
38.6-24.3 (Aua CH2 (X10)); m/z (FAB) 216; HRMS 216.1963, 
C12H26NO2 requires 216.1963; TLC (F) Rf 0.50. 
Methyl N-(4-(hydroxymethyl)--(trimethylsilyl)hydro-
cinnamyl)-1l-aminoundecanoate (35) HO- ®-CO-Aua-OMe 
A solution of ClH2-Aua-OMe (34) (5.81 g, 
23.1 mmol) in DCM (70 ml) and DMF (70 ml) cooled to 0°C 
was added to a solution of HO- ®-COOH (30)130 (5.29 g, 
21.0 mmol) in DCM (40 ml) and DMF (10 ml) cooled to 0°C. 
DCCI (4.76 g, 23.1 mmol) in DCM (20 ml) cooled to 0°C 
was then added after a period of 5 minutes, followed by 
neat NMM (2.54 ml, 23.1 mmol) after a further period of 
5 minutes. The reaction mixture was left stirring to 
come to room temperature overnight, after which time the 
work-up was as for (33). The crude product was obtained 
as a yellow oil which was purified by dry flash silica 
chromatography (X2) using a petrol ether (40-60) to 
ether gradient to yield pure (35) after lyophilisation 
as a pale yellow oil (3.77 g, 40%); (Found: C, 67.0; H, 
9.83; N, 3.17%; C25H43NO4Si requires C, 66.8; H, 9.64; 
N, 3.11%); Vmax (CH2C12) 3600 (0-H), 3440 (N-H), 3040 
2930 2860 (aliphatic C-H), 1730 (ester C=0), 1665 1510 
(amide C=0, N-H), 865 845 cm' (aromatic C-H); 6 H 
(80 MHz, CDC13) 7.16 (2H, d, J 8.3 Hz, aromatics), 6.93 
(2H, d, J 8.4 Hz, aromatics), 5.63 (1H, broad s, 
handle-Aua NH), 4.52 (2H, s, benzyl alcohol CH2), 3.57 
(3H, s, methyl ester CH3), 2.95 (2H, m, Aua CH2), 2.70 
(1H, broad s, OH), 2.51 (3H, m, cinnamate CH, CH2), 2.22 
(2H, m, Aua CH2), 1.75-1.00 (16H, m, Aua CH2 (X8)), 
-0.14 (9H, s, Si(CH3)3); 6c (50 MHz, CDC13) 174.0 (amide 
C0), 172.3 (ester C0), 141.1 (cinnamate C-i), 137.5 
(cinnamate C-4), i26.9 (cinnamate C-3, C-5), 126.7 
(cinnamate C-2,C-6), 64.2 (benzyl alcohol CH2), 51.0 
(methyl ester CH3), 36.3 (cinnamate CH2), 32.4 
(cinnamate CH), 39.0-24.5 (Aua CH2 (Xi0)), -3.4 
(Si(CH3)3); m/z (FAB) 450, 432, 216, 145; HRMS 450.3039, 
C25H44NO4Si (MH) requires 450.3039; HPLC (I) (A:B, 




undecanoate (36) Fmoc_Gly_O_®-CO_Aua_OMe 
A solution of Fmoc-Gly-OH (1.29 g, 4.4 mmol) in DCM 
(20 ml) and DMF (5 ml) cooled to 0°C was added to a 
solution of HO_G)_CO-Aua_OMe  (35) (1.77 g, 4.0 mmol) in 
DCM (30 ml) cooled to 0°C. DCCI (0.90 g, 4.4 mmol) in 
DCM (10 ml) cooled to 0°C was then added after a period 
of 5 minutes, followed by a catalytic amount of solid 
DMAP. The reaction mixture was left stirring to come to 
room temperature overnight, after which time the work-up 
was as for (33). The crude product was obtained as a 
pale yellow oil which was purified by dry flash silica 
chromatography using a petrol ether (40-60) to ether 
gradient, followed by a chromatotron using ether as 
eluent, to yield pure (36) after lyophilisation as a 
WIN 
colourless, tacky oil (1.84 g, 64%); (Found: C, 68.8; 
H, 7.95; N, 3.98%; C42H56N207Si requires C, 69.2; H, 
7.74; N, 3.84%); v max (CH2C12) 3460 (N-H) , 3040 2950 
2870 (aliphatic C-H), 1740 (ureth.ne, benzyl ester, 
methyl ester C=O), 1670 (amide C=O), 1520 (urethane, 
amide N-H), 870 850 cm-1 (aromatic C_H); X max (CH3CN) 
300 nm (E=6461), 289 (5337), 266 (20225), 228 (18258), 
221 (21910); 5H (200 MHz, CDC13) 7.72-6.98 (12H, m, 
aromatics), 5.62 (2H, broad m, Fmoc-Gly NH, handle-Aua 
NH), 5.08 (2H, s, benzyl CH2), 4.35 (2H, d, J 6.8 Hz, 
Fmoc CH2), 4.20 (1H, d, J 6.9 Hz, Fmoc CH), 3.97 (2H, s, 
Fmoc-Gly CH2), 3.60 (3H, 5, methyl ester CH3), 3.03 (2H, 
m, Aua CH2), 2.56 (3H, m, cinnamate CH, CH2), 2.25 (2H, 
M, Aua CH2), 1.75-1.00 (16H, m, Aua CH2 (X8)), 
-0.08 (9H, s, Si(CH3)3); 8c (50 MHz, CDC13) 174.0 (amide 
C=O), 171.8 (methyl ester C=O), 169.6 (Fmoc-Gly C=O), 
156.1 (Fmoc C=O), 143.5 140.9 (Fmoc quaternary aromatic 
(2x2)), 142.9 (cinnamate C-i), 131.4 (cinnamate C-4), 
128.2-119.6 (aromatic CH (X12)), 66.9 66.6 (Fmoc CH2, 
benzyl CH2), 51.1 (methyl ester CH3), 46.8 (Fmoc CH), 
42.5 (Fmoc-Gly CH2), 36.4 (cinnamate CH2), 32.7 
(cinnamate CH), 39.1-24.6 (Aua CH2 (X10)), -3.3 
(Si(CH3)3); m/z (FAB) 729, 713, 506, 432, 179; HRMS 
729.3935, C42H57N207Si (MH) requires 729.3935; HPLC (I) 
(A:B, 50:50-B, 100%; 28 mm; 254 nm) RT = 23.2 mm; TLC 
(B) Rf 0.37. 
-91 - 1
N N -Benzyloxycarbonyl-11-aminoundecanoic acid (37) 
Z -Au a - OH 
A 4M solution of sodium hydroxide (100 ml, 
400 mmol) and 	1M solution of sodium bicarbonate 
(190 ml, 190 mmol) were added to 11-aminoundecanoic acid 
(25.01 g, 124.4 mmol). 	THF (400 ml) was also added. 
The resulting suspension was cooled to 0°C with 
mechanical stirring being applied. Benzyl chloroformate 
(23.32 g, 136.8 mmol) was added dropwise over a period 
of 1 hour and the reaction mixture was left stirring to 
come to room temperature overnight. The reaction 
mixture was filtered, and the filtrate was brought to 
pH2 with concentrated HC1 then stirred at room 
temperature for 1 hour. Aqueous and organic phases were 
separated and the aqueous phase was extracted with ethyl 
acetate. The combined organic phase was dried over 
anhydrous magnesium sulphate and removal of the solvent 
gave the product as a white powder. Recrystallisation 
from ethyl acetate yielded pure (37) as a white powder 
(41.68 g, 100%), m.p. 96-98°C; (Found: C, 68.2; H, 8.82; 
N, 4.12%; C19H29N04 requires C, 68.1; H, 8.66; N, 
4.18%); Vmax (mull) 3330 (N-H), 3100-2500 (0-H, 
aliphatic C-H, masked by nujol), 1685 (urethane, acid 
C0), 1530 (urethane N-H), 750 695 cm-1 (aromatic C-H); 
H (200 MHz, (CD3)2S0) 7.36-7.28 (5H, m, aromatics), 
7.17 (1H, broad s, NH), 5.03 (2H, s, benzyl CH2), 3.01 
-92- 
(2H, m, Aua CH2), 2.20 (2H, t, J 7.3 Hz, Aua CH2), 
1.60-1.20 (16H, m, Aua CH2 (X8)); 8c (50 MHz, (CD3)2S0) 
174.4 (acid C=0), 156.0 (urethane C=0), 137.2 
(quaternary aromatic), 128.1-126.7 (aromatic CH (X5)), 
65.0 (benzyl CH2),  40.1-24.4 (Aua CH2 (X10)); m/z (FAB) 
336, 292, 202, 181, 158; HRMS 336 .2175, C19H30N04 (MH) 
requires 336.2175; TLC (F) Rf 0.72. 
N-Benzyloxycarbonyl-11-aminoundecanoic anhydride (38) 
(Z-Aua) 20 
To a stirred solution of Z-Aua-OH (37) (5.00 g, 
14.9 mmol) and phenol (1.41 g, 14.9 mmol) in ethyl 
acetate (600 ml) at 0° C were added pyridine (1.21 g, 
15.2 mmol) (optional) at 0°C and DCCI (3.35 g, 
16.2 mmol) in ethyl acetate (100 ml) at 0°C. The 
reaction mixture was allowed to come to room temperature 
overnight, after which time glacial acetic acid (1 ml) 
was added and the reaction mixture stirred for 1 hour. 
DCU was then filtered off, and the work-up was as for 
(33). Removal of the drying agent and the solvent gave 
the product as a yellow/white powder. Treatment of this 
powder with hot ethyl acetate enabled residual DCU to be 
filtered off. 	Solvent removal from the filtrate 
afforded 	(38) as 	a white powder 	(2.91 	g, 60%), 	m.p. 
89-91°C; u max (mull) 	3330 (N-H), 	3100-2500 (aliphatic 
C-H, masked by nujol), 	1800 1740 	(anhydride C=0), 	1685 
-93- 
1530 (urethane C=O, N-H), 750 695 cm-1 (aromatic C-H); 
oH (80 MHz, (CD3)2S0) as for Z-Aua-OH (37); m/z (FAB) 
670, 541, 430, 336, 292, 281, 225, 202, 181, 158. 
Phenyl Na_benzyloxycarbonyl_11_aminoundecanoate (39) 
Z-Aua-OPh 
Z-Aua-OH (37) (3.11 g, 9.3 mmol) was covered in 
benzene (100 ml), and oxalyl chloride (1.42 g, 
11.2 mmol) and DMA(cata1ytic amount) were added. The 
reaction mixture was stirred at room temperature for 2 
hours, then the solvent was removed in vacuo. Benzene 
was reapplied and removed several times to ensure no 
oxalyl chloride remained. Phenol (0.88 g, 9.3 mmol) and 
NMM (0.94 g, 9.3 mmol) in DCM (100 ml) was then added to 
the product, and the reaction mixture was stirred at 
room temperature for 24 hours, after which time the 
work-up was as for (33). Removal of the drying agent 
and the solvent furnished the product as a white powder 
which was recrystallised from ether/DCM and washed with 
petrol ether (40-60) to yield pure (39) as a white 
powder (3.48 g, 91%), m.p. 63-65°C; (Found: C, 73.0; H, 
8.15; N, 3.37%; C25H33N04 requires C, 73.0; H, 8.03; N, 
3.41%); Vmax (CH2C12) 3440 (N-H), 2930 2850 (aliphatic 
C-H), 1755 (ester C=O), 1720 1510 cm-1 (urethane C=O, 
N-H); 0H (200 MHz, CDC13) 7.39-7.06 (10H, m, aromatics), 
5.21 (1H, broad s, NH), 5.10 (2H, s, benzyl CH2), 3.14 
-94- 
(2H, m, Aua CH2), 2.53 (2H, t, J 7.4 Hz, Aua CH2), 
1.78-1.30 (16H, m, Aua CH2 (X8)); 6 	(50 MHz, CDC13) 
171.9 (ester C=0), 156.4 (urethane C=0), 150.8 (phenyl 
ester quaternary aromatic), 136.8 (Z quaernary 
aromatic), 129.1 125.4 121.4 (phenyl ester aromatic CH 
(X5)), 128.3 127.8 (Z aromatic CH (X5)), 66.2 (Z Cl-I2), 
41.0-24.8 (Aua CH2 (XlO));m/z (FAB) 412, 332, 278, 210, 
184; HRMS 412.2488, C25H34N04 (MH) requires 412.2488; 
TLC (C) Rf 0.57. 
Phenyl 11-aminoundecanoate hydrobromide (40) BrH2-
Au a-op h 
Z-Aua-OPh (39) (25.00 g, 60.8 mmol) was dissolved 
in glacial acetic acid (650 ml) and 45% HBr in glacial 
acetic acid (54.8 g, 304.9 mmol) was added. 	The 
reaction mixture was stirred at room temperature for 24 
hours, after which time the solvent was removed to give 
a yellow/brown oil. Trituration of this oil with ether 
produced an off-white solid which was filtered off and 
recrystallised (X3) from acetonitrile and washed with 
ether to yield pure (40) 	as a white powder 	(16.60 g, 
76%), 	m.p. 	115-119°C; umax  (mull) 	3300-2500 	(NH3 11 
aliphatic C-H, masked by nujol) , 	1725 	(C0) , 	1605 	1585 
1500 cm- (NH3); 	8H  (200 	MHz, (CD3)2C0) 	8.30 	(3H, 	broad 
5, 	NH3) , 7.45-7.08 (5H, 	m, aromatics) , 	2.57 	(2H, 	t, 
J 7.4 Hz, Aua CH2), 2.26 (2H, t, J 7.3 Hz, Aua CH2), 
-95- 
1.85-1.28 (16H, m, Aua CH2 (X8)); m/z (El) 279, 184, 94; 
full characterisation not possible due to long-term 
instability of the product. 
11-Aminoundecanoic acid hydrobromide (41) Br-H2+-Aua-OH 
Br-H2+-Aua-OH (41) was formed quantitatively in the 
breakdown of BrH2+_Aua_OPh (40). Recrystallisation 
from acetonitrile and washing with ether yielded pure 
(41) as a white powder, m.p. 130-131°C; (Found: C, 46.0; 
H, 8.56; N, 4.98; Br, 28.3%; C11H24NO2Br requires C, 
46.8; H, 8.57; N, 4.96; Br, 28.3%);v max (mull) 3410 
(0-H), 3200-2500 (NH3, aliphatic C-H, masked by nujol), 
1720 (C=0), 1610 1590 1505 cm- (NH3); 6 H (80 MHz, 
(CD3)2S0) 7.87 (3H, broad s, NH3), 2.69 (2H, m, Aua 
CH2), 2.12 (2H, m, Aua CH2), 1.75-1.00 (16H, m, Aua CH2 
(X8)); 6c (50 MHz, (CD3)2S0) 174.3 (C=0), 38.6-24.3 (Aua 
CH2 (X10)); rn/z (FAB) 202 184 158 142; HRMS 202.1807, 
C11H24NO2 requires 202.1807; TLC (F) Rf 0.50. 
Phenyl 11-aminoundecanoate p-toluenesulphonate (42) 
TosOH2+_Aua_OPh 
Z-Aua-OPh (39) (3.88 g, 9.4 mmol) and 4-toluene-
suiphonic acid (1.88 g, 9.9 mrnol) were dissolved in DMF 
(25 ml) under nitrogen. 	The reaction mixture was 
hydrogenated at room temperature for 72 hours in the 
presence of 10% palladium on charcoal (0.39 g). 
Filtration through Celite was carried out and the 
solvent removed in vacua to give a pale green oil which 
was taken up in isopropanol. Addition of ether to this 
solution precipitated out the desired product which was 
filterei and washed with petrol ether (40-60) to yield 
pure (42) as a white powder (3.18 g, 75%), m.p. 95-98°C; 
(Found: C, 64.0; H, 8.12; N, 3.21%; C24H35N05S requires 
C, 64.1; H, 7.85; N, 3.12%);vmax (CH2C12) 3300-3000 
(NH3), 2930 2860 (aliphatic C-H), 1755 (C=O), 1595 1495 
(NH3), 815 crn' (aromatic C-H); 8H (200 MHz, CDC13) 
7.60 (3H, broad s, NH3), 7.76-7.04 (9H, m, aromatics), 
2.75 (2H, m, Aua CH2), 2.54 (2H, t, J 7.3 Hz, Aua CH2), 
2.35 (3H, s, tosyl CH3), 1.80-1.10 (16H, m, Aua CH2 
(X8)); Ec (50 MHz, CDC13) 171.6 (C=O), 150.3 (phenyl 
ester quaternary aromatic), 141.2 139.9 (tosyl 
quaternary aromatic), 128.8-121.0 (aromatic CH (X9)), 
39.5-24.4 (Aua CH2 (X10)), 20.8 (tosyl CH3);m/z (FAB) 
278, 202, 184, 158; HRMS 278.2120, C17H28NO2 requires 
278.2120; TLC (G) Rf 0.62. 
Phenyl Na_(4_(hydroxymethyl)_3_(trimethy1si1yl)hydro_ 
cinnamyl)-11-aminoundecanoate (43) HO-(?-CO-Aua-OPh 
A 	solution of HO- 0-COOH 	(30)130 	(2.61 g, 
10.3 mmol) 	in DCM (100 ml) 	and DMF (5 ml) cooled to 0°C 
was 	added 	to 	a solution 	of 	TosOH2+_Aua_OPh  (42) 
(4.73 	g, 	10.5 	mmol) in 	DCM 	(180 	ml) 	and 	DMF 	(10 ml) 
cooled 	to 0° C. DCCI (2.24 g, 	10.9 mmol) 	in 	DCM 	(20 ml) 
cooled to 0°C was then added after a period of 5 minutes 
-97-- 
followed by neat NMM (1.20 ml, 10.9 mmoi) after a 
further period of 5 minutes. The reaction mixture was 
left stirring to come to room temperature overnight, 
after which time the work-up was as for (33). The crude 
product was obtained as a pale yellow oil which was 
purified by wet flash silica chromatography using a 
petrol ether (40-60) to ether gradient, followed by a 
chromatotron using 50/50, ether/ethyl acetate as eluent. 
The chromatotron product was then further purified by 
gel filtration on Sephadex LH20 eluting with methanol to 
yield pure (43) after lyophilisation as a colourless oil 
(5.84 g, 68%); satisfactory microanalysis could not be 
obtained; Vmax (CHC13) 3600 (0-H), 3450-3200 (0-H, N-H), 
3000 2930 2860 (aliphatic C-H), 1750 (ester C=0), 1650 
1510 (amide C=0, N-H), 865 845 cm' (aromatic C-H); 8 H 
(200 MHz, CDC13) 7.31-6.91 (9H, m, aromatics), 6.01 (1H, 
broad s, handle-Aua NH), 4.48 (2H, s, benzyl alcohol 
CH2), 2.93 (2H, m, Aua CH2), 2.52-2.43 (5H, m, cinnamate 
CH, CH2; Aua CH2), 1.70-1.00 (16H, m, Aua CH2 (X8)), 
-0.12 (9H, s, Si(CH3)3); 8c (50 MHz, CDC13) 172.4 172.1 
(ester, amide C=0), 150.6 (phenyl ester quaternary 
aromatic), 141.3 (cinnamate C-i), 137.7 (cinnamate C-4), 
129.1 125.5 121.3 (phenyl ester aromatic CH (X5)), 127.1 
(cinnamate C-3, C-5), 126.8 (cinnamate C-2, C-6), 64.3 
(benzyl alcohol CH2), 36.6 (cinnamate CH2), 32.6 
(cinnamate CH), 39.2-24.7 (Aua CH2 (X10)), 0.01 
(Si(CH3)3); m/z (FAB) 512, 265, 132; HRMS 512.3196, 
C30H46NO4Si 	(MH) 	requires 512.3196; HPLC ( I ) (A: B, 




HO- 	-CO-Aua-Aua-OH (44) was obtained as a 
by-product in the formation of HO- ®_CO_Aua_OPh (43) 
when BrH2+_Aua_Oph (40) was used in place of TosOH2-
Aua-OPh (42). Recrystallisation from DCM and washing 
with ether yielded pure (44) as a white powder (1.02 g, 
16%), m.p. 111-113°C; (Found: c, 68.4; H, 10.58; N, 
4.99%; C35H62N205Si requires C, 67.9; H, 10.10; N, 
4.53%); V max (mull) 33803200 (OH, NH), 3100-2500 
(aliphatic C-H, masked by nujol), 1705 (acid C=O), 1660 
1640 (amide C=O), 1545 (amide N-H, masked by nujol), 870 
840 cm-1 (aromatic C-H); 8 H (200 MHz, (CD3)2S0) 7.76 
(2H, broad s, handle-Aua-Aua NH (X2)), 7.14 (2H, d, 
J 8.0 Hz, aromatics), 6.94 (2H, d, J 8.0 Hz, aromatics), 
4.41 (2H, s, benzyl alcohol CH2), 2.94 (4H, m, Aua CH2 
(x2)), 2.60 (3H, m, cinnamate CH, CH2), 2.10 (4H, m, Aua 
CH2 (X2)), 1.50-1.20 (32H, m, Aua CH2 (X16)), -0.11 (9H, 
s, Si(CH3)3); 8c (50 MHz, (CD3)2SO) 174.5 (acid C=O), 
172.1 171.3 (amide C=O (X2)) , 141.3 (cinnamate C-i), 
138.4 (cinnamate C-4), 127.0 (cinnamate C-3, C-5), 126.2 
(cinnamate C-2, C-6), 63.0 (benzyl alcohol CH2), 35.5 
(cinnamate CH2), 31.7 (cinnamate CH), 38.3-24.6 (Aua CH2 
(X20)), -3.0 (Si(CH3)3);m/z (FAB) 619, 601, 385, 225, 
216, 185, 145; HRMS 619.4506, C35H63N205Si (MH) 
requires 619.4506; TLC (D) Rf 0.25. 
N-(2,2-Bis(4-nitropheny1)ethoxycarbonyl)-glycine (45) 
Bnpeoc-Gly-0H132  
Glycine (5.53 g, 73.7 mmol) was dissolved in 20% 
sodium carbonate solution (78 ml, 147.2 mmol) and 
cooled to 0°C. To this solution was added 
Bnpeoc-ONSu'32 (26.3 g, 61.4 mmol) in DP4F (100 ml) 
cooled to 0°C. The resulting suspension was stirred at 
room temperature for 15 minutes before the addition of a 
quantity of water sufficient to obtain a clear solution. 
This solution was then extracted (X5) with ethyl 
acetate to remove any unreacted Bnpeoc-ONSu, and the 
aqueous phase was cooled to 0°C and acidified to pH 1-2 
with concentrated HC1. 	A white suspension was 
immediately formed which was extracted (X5) with ethyl 
acetate, and the organic fraction was washed with water 
(X2), brine (X2), and dried over anhydrous sodium 
sulphate. 	Removal of the solvent in vacuo gave a 
green oil which was recrystallised from acetone/petrol 
ether (40-60) to yield pure (45) as a white powder 
(20.92 g, 88%), m.p. 155-157°C (lit.132 156-1580C). 
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Method 2 
Bnpeoc-Gly-OH (45) was prepared from glycine 
(3.97 g, 53.0 mmol) following the experimental procedure 
given by Rich and Shute146 for the synthesis of 
Teoc-amino acids using, however, Bnpeoc-ONSu in place of 
Teoc-ONSu. 	The crude product thus obtained was 
recrystallised from acetone/petrol ether (40-60) to 
yield pure (45) as a white powder (17.32 g, 84%), m.p. 
155-157°C (lit.132 156_158 0 C);V max (CH2C12) 3460 (N-H), 
1730 (urethane, acid C=O), 1610 (aromatic C-C), 1520 
(urethane N-H; NO2), 1350 (NO2), 860 cm 	(aromatic 
C-H); 8 H  (200 MHz, (CD3)2S0) 8.19 (4H, d, J 8.6 Hz, 
Bnpeoc aromatics), 7.69 (4H, d, J 8.6 Hz, Bnpeoc 
aromatics), 7.49 (1H, t, J 6.0 Hz, NH), 4.82-4.67 (3H, 
m, Bnpeoc CH, CH2), 3.63 (2H, d, J 6.0 Hz, Gly CH2); 8c 
(50 MHz, (CD3)2S0) 171.3 (acid C=O) , 156.2 (urethane* 
C=O), 148.1 146.6 (Bnpeoc quaternary aromatic (2X2)), 
129.6 123.7 (Bnpeoc aromatic CH (2X4)), 65.2 (Bnpeoc 
CH2), 49.0 (Bnpeoc CH), 42.1 (Gly CH2). 
Phenyl N-(4-(N-(2,2-bis(4-nitrophenyl)ethoxycarbony1)-
glycyloxymethyl)-1B-(trimethylsilyl)hydrocinnamyl)-11-- 
aminoundecanoate (46) Bnpeoc_Gly_O_®_CO_Aua_OPh 
A solution of Bnpeoc-Gly-OH (45)132 (445 g, 
11.5 mmol) in DCM (60 ml) and DMF (15 ml) cooled to 0°C 
was added to a solution of HO- ®-CO_Aua--OPh  (43) 
(5.57 g, 10.9 mmol) in DCM (100 ml) cooled to 0°C. DCCI 
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(2.47 g, 12.0 mmol) in DCM (25 ml) cooled to 0° C was 
then added after a period of 5 minutes, followed by a 
catalytic amount of solid DMAP. The reaction mixture 
was left stirring to come to room temperature overnight, 
after which time the work-up was as for (33). The crude 
product was obtained as a green oil which was purified 
by wet flash silica chromatography using a petrol ether 
(40-60) to ethyl acetate gradient, followed by a 
chromatotron using 50/50, ether/ethyl acetate as eluent. 
Further purification was carried out using gel 
filtration on Sephadex LH20 eluting with methanol to 
yield pure (46) after lyophilisation as a yellow powder 
(8.73 g, 91%), m.p. 47-50°C; (Found: C, 64.4; H, 6.50; 
N, 6.45%; C47H58N4011Si requires C, 64.0; H, 6.58; N, 
6.35%); Vmax (CH2C12) 3460 (N-H), 2950 2870 (aliphatic 
C-H), 1735 (urethane, benzyl ester, phenyl ester C=O), 
1670 (amide C=O), 1525 (urethane, amide N-H; NO2), 1355 
(NO2), 865 845 cm' (aromatic C-H); 'max  (CH3CN) 274 nm 
(C = 33529), 229 (23529), 220, (22941); 6 H (200 MHz, 
CDC13) 8.21-7.01 (17H, m, aromatics), 5.33-5.10 (4H, m, 
Bnpeoc-Gly NH, handle-Aua NH, benzyl CH2), 4.68-4.56 
(3H, m, Bnpeoc CH, CH2), 3.94 (2H, d, J 5.5 Hz, 
Bnpeoc-Gly CH2), 3.05 (2H, m, Aua CH2), 2.59-2.50 (5H, 
m, Aua CH2, cinnamate CH, CH2), 1.73-1.05 (16H, m, Aua 
CH2 (X8)), -0.05 (9H, s, Si(CH3)3); 6c  (50 MHz, CDC13) 
171.9 171.8 (phenyl ester, amide C=O), 169.3 (Bnpeoc-Gly 
C=O), 155.5 (Bnpeoc C=O), 150.4 (phenyl ester quaternary 
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aromatic), 146.8 (Bnpeoc quaternary aromatic (X4)), 
143.0 (cinnamate C-i), 131.2 (cinnamate C-4), 
128.9-121.2 (aromatic CH (X17)), 66.7 (benzyl CH2), 65.7 
(Bnpeoc CH2), 49.4 (Bnpeoc CH), 42.4 (Bnpeoc-Gly CH2), 
36.3 (cinnamate CH2), 32.6 (cinnamate CH), 39.0-24.5 
(Aua CH2 (X10)) , -3.4 (Si(CH3)3) ; m/z (FAB) 883, 867, 
851, 789, 579, 568, 510, 494, 145; HRMS 883.3949, 
C47H59N4011Si (MH) requires 883.3949; HPLC (I) (A:B, 
50:50-B, 100%; 28 mm; 254 nm) RT = 23.8 mm; TLC (C) Rf 
0.48. 
Na_( 4 ( N-( 2, 2-Bis(4-nitrophenyl) ethoxycarbonyl)glycyl-
oxymethyl)--(trimethy1si1yl)hydrocinnamyl)-l1-amino- 
undecanoic acid (47) Bnpeoc-Gly-O- 	- CO-Aua-OH 
A solution of 100 volumes hydrogen peroxide 
(508.2 iii, 4.56 mmol) followed by a 0.1M solution of 
sodium hydroxide (22.83 ml, 2.28 mmol) was added to a 
solution of Bnpeoc-G1y-0--CO-Aua-OPh (46) (2.010 g, 
2.28 mmol) in 80/20, acetone/water (125 ml), and the 
reaction mixture was stirred at room temperature for 15 
minutes. Quenching of the reaction mixture to pH 2-3 
with a saturated aqueous solution of citric acid was 
then carried out, and the reaction mixture was 
partitioned between ethyl acetate and water. 	The 
organic fraction was washed with water (X2), brine (X2), 
and dried over anhydrous magnesium sulphate. 
Purification of the product was by wet flash silica 
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chromatography (X2) using a petrol ether (40-60) to 
ethyl acetate gradient, followed by gel filtration on 
Sephadex LH20 eluting with methanol to yield pure (47) 
after lyophilisation as an off-white powder (1.194 g, 
65%), m.p. 56-69 °C; (Found: C, 61.0; H, 6.80; N, 7.09%; 
C41H54N4011Si requires C, 61.0; H, 6.74; N, 6.94%); Vmax 
(CH2C12) 3470 (N-H), 3350-2500 (0-H, aliphatic C-H), 
1740 (urethane, ester, acid C=0), 1675 (amide C=O), 1530 
(urethane, amide N-H; NO2), 1360 (NO2), 870 855 cm' 
(aromatic C-H); Amax (CH3CN) 274 nm ( E = 40173), 230 
(24277), 220 (22832); 5H (200 MHz, CDC13) 8.14 (4H, d, 
J 8.8 Hz, Bnpeoc aromatics), 7.37 (4H, d, J 8.8 Hz, 
Bnpeoc aromatics), 7.16 (2H, d, J 8.2 Hz, cinnamate 
aromatics), 7.00 (2H, d, 3 8.2 Hz, cinnamate aromatics), 
5.56 5.43 (1H, broad s (X2), Bnpeoc-Gly NH, handle-Aua 
NH), 5.06 (2H, s, benzyl CH2), 4.68-4.58 (3H, m, Bnpeoc 
CH, CH2), 3.90 (2H, d, J 5.7 Hz, Bnpeoc-Gly CH2), 3.00 
(2H, m, Aua CH2), 2.57 (3H, m, cinnamate CH, CH2), 2.27 
(2H, t, J 7.4 Hz, Aua CH2), 1.60-1.00 (16H, m, Aua CH2 
(X8)), -0.09 (9H, s, Si(CH3)3); 6c (50 MHz, CDC13) 177.7 
(acid C=O), 172.4 (amide C=O), 169.6 (Bnpeoc-Gly C0), 
155.6 (Bnpeoc C=O), 147.0 146.8 (Bnpeoc quaternary 
aromatic (2x2)), 143.0 (cinnamate C-i), 131.3 (cinnamate 
C-4), 129.1 123.9 (Bnpeoc aromatic CH (2X4)), 128.4 
(cinnamate C-3, C-5), 127.4 (cinnamate C-2, C-6), 66.9 
(benzyl CH2), 66.0 (Bnpeoc CH2), 49.6 (Bnpeoc CH), 42.5 
(Bnpeoc-Gly CH2), 36.5 (cinnamate CH2), 32.8 (cinnamate 
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CH), 39.2-24.6 (AuaCH2 (X10)), -3.3 (Si(CH3)3);m/z 
(FAB) 807, 792, 506, 490, 476, 462, 450, 418, 404, 145; 
HRMS 807.3636, C41H55N4011Si (MH) requires 807.3636; 
HPLC (I) (A:B, 50:50-B, 100%; 28 mm; 254 nm) 
RT = 17.6 mm; TLC (D) Rf 0.45. 
N-Benzy1oycarbonyl-g1ycine (48) Z-Gly-OH135  
Z-Gly-OH (48) was prepared from glycmne (113.21 g, 
1.5 mol) following the experimental procedure given by 
Greenstein and Winitz135. 	The crude product thus 
obtained was recrystallised from ethyl acetate with 
petrol ether (40-60) to yield pure (48) as a white 
crystalline solid (280.50 g, 89%), m.p. 119-120° C 
(lit.135 120-121°C); umax (CH3CN) 3480 (N-H), 
3240 (0-H), 3000-2800 (aliphatic C-H), 1770 (acid C=0), 
1725 1525 (urethane C=0, N-H), 740 705 crn' (aromatic 
C-H); 8H (80 MHz, (CD3)2C0) 7.34 (5H, s, aromatics), 
5.09 (2H, s, benzyl OH2), 3.91 (2H, t, J 3.1 Hz, Gly 
OH2); m/z (El) 209, 108, 91; TLC (H) Rf 0.50. 
Ot 
Phenyl N - benzyloxycarbonyl-giycinate (49) Z-Gly--0Ph136  
Z-Gly-OPh (49) was prepared from Z-Gly-OH (48)135 
(61.60 g, 0.3 mol) following the experimental procedure 
given by Ramage et al.136. The crude product thus 
obtained was taken up in ethyl acetate and precipitated 
out by the addition of petrol ether (40-60) to yield 
pure (49) as a white powder (65.30 g, 78%), m.p. 66-67°C 
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(lit. 136 67-68°C);\)max (CH2C12) 3460 (N-H), 3040 2960 
(aliphatic C-H), 1775 (ester C=O), 1730 1515 cm ]-
(urethane CO 3 N-H); 6 H (80 MHz, CDC13) 7.46-7.01 (10H, 
m, aronu-tics), 5.36 (1H, broad s, NH), 5.15 (2H, s, 
benzyl CH2), 4.20 (2H, d, J 5.7 Hz, Gly CH2); m/z (FAB) 
286, 242, 185, 181, 152; TLC (D) Rf 0.60. 
Phenyl glycinate p-toluenesulphonate (51) TosOH2-
Gly-OPh 
Z-Gly-OPh (49)136 (11.39 g, 39.9 mmol) and 
4-toluenesuiphonic acid (8.35 g, 43.9 mmol) were 
dissolved in DMF (100 ml) under nitrogen. The reaction 
mixture was hydrogenated at room temperature for 72 
hours in the presence of 10% palladium on charcoal 
(1.14 g). Filtration through Celite was carried out and 
the solvent removed in vacuo to give a pale green oil 
which was recrystallised from isopropanol with petrol 
ether (40-60) to yield pure (51) as a white powder 
(9.54 g, 74%), m.p. 154-156°C; (Found: C, 56.0; H, 
5.26; N, 4.40%; C15H17N05S requires C, 55.7; H, 5.30; N, 
4.33%); 'max (mull) 3300-3000 (NH3), 3000-2500 
(aliphatic C-H, masked by nujol), 1780 (C=O), 1600 
(NH3), 815 755 685 cm' (aromatic C-H); 8H (80 MHz, 
(CD3)2So) 8.38 (3H, broad s, NH3), 7.60-7.05 (9H, m, 
aromatics), 4.14 (2H, s, Gly CH2), 2.30 (3H, s, tosyl 
CH3); 5c 	MHz, (CD3)2so) 166.2 (C=O), 149.6 (phenyl 
ester quaternary aromatic), 143.7 138.9 (tosyl 
quaternary aromatic), 129.5-121.3 (aromatic CH (X9)), 
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39.9 (Gly CH2) , 20.6 (tosyl CH3) ; rn/z (FAB) 324, 152, 
31; HRMS 324.0905, C15H18N05S (MH) requires 324.0906; 
152.0712, C8H10NO2 requires 152.0712; TLC (G) Rf 0.24. 
Methyl glycinate p-toluenesulphonate (50) TosOH2-
Gly-OMe 
The procedure for the formation of TosOH2-Gly-OMe 
(50) from Z-Gly-OPh (49)136 (52.40 g, 183.9 mmol) was 
exactly the same as that for TosOH2+_Gly_Oph (51) 
except that methanol (250 ml) was used as the solvent 
rather than DMF. Purification of the crude golden brown 
oil again was achieved by recrystallisation from 
isopropanol with petrol ether (40-60) to yield pure (50) 
as a white powder (36.80 g, 62%), m.p. 109-112°C; 
(Found: C, 46.3; H, 5.69; N, 5.41%; C10H15N05S requires 
C, 46.0; H, 5.79; N, 5.36%); v max  (mull) 3200-3000 
(NH3), 3000-2500 (aliphatic C-H, masked by nujol), 1760 
(C=O) , 1620 1530 (NH3) , 820 cm' (aromatic C-H) 	H 
(200 MHz, (CD3)2S0) 8.25 (3H, broad s, NH3), 7.50 (2H, 
d, J 8.0 Hz, aromatics), 7.12 (2H, d, J 8.0 Hz, 
aromatics), 3.83 (2H, s, Gly CH2), 3.74 (3H, s, methyl 
ester CH3), 2.30 (3H, s, tosyl CH3); 5 c (50 MHz, 
(CD3)2S0) 167.9 (C=O), 145.3 137.8 (tosyl quaternary 
aromatic), 128.0 125.5 (aromatic CH (2X2)), 52.4 (methyl 
ester CH3) , 39.7 (Gly CH2) , 20.7 (tosyl CH3) ; m/z (FAB) 
262, 185, 152, 92, 31; HRMS 262.0749, C10H16N05S 
requires 262.0749; TLC (E) Rf 0.24. 
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Phenyl N-(4-(hydroxymethyl)--(trimethylsi1y1)hydro-
cinnamyl)-qlycinate (52) HO_(')_CO_GlV_OPh131  
A solution of HO- 0 -COOH (30)30 (10.16 g, 
40.3 mmol) in DCM (48 ml) and DMF (12 ml) cooled to 0°C 
was added to a solution of TosOH2+-Gly-OPh (51) 
(13.28 g, 41.1 mmol) in DCM (160 ml) and DMF (80 ml) 
cooled to 0° C. DCCI (8.72 g, 42.3 mmol) in DCM (40 ml) 
cooled to 0°C was then added after a period of 5 minutes 
followed by neat NMM (4.65 ml, 42.4 mmol) after a 
further period of 5 minutes. The reaction mixture was 
left stirring to come to room temperature overnight, 
after which time the work-up was as for (33). The crude 
product was obtained as a yellow oil which was purified 
by dry flash silica chromatography (X2) using a hexane 
to ether gradient, followed by a chromatotron using 
ether as eluent, to yield pure (52) after lyophilisation 
as a white powder (10.09 g, 65%), m.p. 79-81°C (lit.131  
80-82°C); V max (CH2C12) 3610 (0-H), 3440 (N-H), 2960 
2900 2880 (aliphatic C-H), 1765 (ester C=O), 1675 1510 
(amide C=0, N-H), 865 845 cm 	(aromatic C-H); 8 H  
(80 MHz, CDC13) 7.36-6.91 (9H, m, aromatics), 6.04 (1H, 
broad s, handle-Gly NH), 4.54 (2H, s, benzyl alcohol 
CH2), 4.08 (2H, d, J 5.3 Hz, Gly CH2), 2.67 (4H, m, OH, 
cinnamate CH, CH2), -0.05 (9H, s, Si(CH3)3); m/z (El) 
385, 368, 292, 248, 205, 117, 73; HPLC (I) (A:B, 




glycinate (53) Bnpeoc-Gly-O- (' - CO-Gly-OPh 
A solution of Bnpeoc-Gly-OH (45)132  (9.67 g, 
24.9 mmol) in DCM (80 ml) and DMF (20 ml) cooled to 0°C 
was added to a solution of HO- 	- CO-Gly-OPh (52)131 
(8.69 g, 22.6 mmol) in DCM (20 ml) cooled to 0° C. 	DCCI 
(5.00 g, 24.9 mmol) in DCM (20 ml) cooled to 0° C was 
then added after a period of 5 minutes, followed by a 
catalytic amount of solid DMAP. The reaction mixture 
was left stirring to come to room temperature overnight, 
after which time the work-up was as for (33). The crude 
product was obtained as a yellow oil which was purified 
by dry flash silica chromatography (X2) using a hexane 
through ether to ethyl acetate gradient, followed by a 
chromatotron using 50/50, ether/ethyl acetate as eluent, 
to yield pure (53) after lyophilisation as a white 
powder (14.92 g, 87%), m.p. 68-71°C; (Found: C, 59.9; H, 
5.54; N, 7.11%; C38H40N4011Si requires C, 60.3; H, 5.33; 
N, 7.40%); umax (CH2C12) 3450 (N-H), 2970 2860 
(aliphatic C-H), 1735 (urethane, benzyl ester, phenyl 
ester C=O), 1680 (amide C=O), 1525 (urethane, amide N-H; 
NO2), 1350 (NO2), 865 845 cm' (aromatic C-H); Xmax 
(CH3CN) 274 nm ( E= 34483), 230 (19655), 220 (19655); 8 H 
(200 MHz, CDC13) 8.11-6.91 (17H, m, aromatics), 6.50 
(1H, broad s, handle-Gly NH), 5.57 (1H, broad s, 
Bnpeoc-Gly NH), 4.99 (2H, s, benzyl CH2), 4.64-4.56 (3H, 
m, Bnpeoc CH, CR2), 4.07-4.02 (2H, m, handle-Gly CH2), 
3.83 (2H, d, J 5.3 Hz, Bnpeoc-Gly CH2), 2.68-2.60 (3H, 
M, cinnamate CH, rH2), -0.09 (9H, s, Si(CH3)3); 5c 
(50 MHz, CDC13) 172.7 (amide C=O), 169.5 (Bnpeoc-Gly 
C=O), 168.4 (phenyl ester C=O), 155.9 (Bnpeoc C=O), 
150.2 (phenyl ester quaternary aromatic), 147.0 (Bnpeoc 
quaternary aromatic (X4)), 143.0 (cinnamate C-i), 131.5 
(cinnamate C-4), 129.1-121.1 (aromatic CH (X17)), 66.8 
(benzyl CH2), 66.0 (Bnpeoc CH2), 49.6 (Bnpeoc CH), 42.6 
(Bnpeoc-Gly CH2),  41.4 (handle-Gly CH2),  36.0 (cinnamate 
CH2), 32.4 (cinnamate CH), -3.2 (Si(CH3)3); m/z (FAB) 
757, 742, 664, 603, 442, 307, 226, 117; HRMS 752.2541, 
C38H41N4011Si (MH) requires 757.2541; HPLC (I) (A:B, 





A solution of 100 volumes hydrogen peroxide 
(740.0 jil, 6.64 mmol) followed by a 0.1M solution of 
sodium hydroxide (32.90 ml, 3.31 mmol) was added to a 
solution of Bnpeoc-G1y-0--CO-G1y-OPh (53) (2.500 g, 
3.31 mmol) in 80/20, acetone/water (250 ml), and the 
reaction mixture was stirred at room temperature for 15 
minutes. The reaction mixture was then diluted with 
-110- 
water (150 ml) and the acetone was removed in vacuo. 
Phenol formed as a by-product was removed with ether 
extraction, and the remaining aqueous reaction mixture 
was acidified to pH 2-3 with a saturated solution of 
citric acid in water. This quenching of the reaction 
took place after 45 minutes. The product mixture was 
then extracted with ethyl acetate, and the organic 
fraction was washed with water (X2), brine (X2), and 
dried over anhydrous magnesium sulphate. Purification 
of the product was by gel filtration on Sephadex LH20 
eluting with methanol, followed by rapid dry flash 
silica chromatography using an ethyl acetate to methanol 
gradient with approximately a one-inch bed of silica, to 
yield (54) after lyophilisation as an off-white powder 
(1.825 g, 81%), m.p. 105-107° C; (Found: C, 56.2; H, 
5.44; N, 7.86%; C32H36N4011S1 requires C, 56.5; H, 5.33; 
N, 8.23%); V max(CH2C12) 3450 (N-H), 3400-2500 (0-H, 
aliphatic C-H), 1730 (urethane, ester, acid C=0), 1660 
(amide C=0), 1525 (urethane, amide N-H; NO2), 1350 
(NO2), 860 845 cm' (aromatic C-H); Amax  (CH3CN) 274 nm 
= 33333), 230 (18027), 220 (16667); 6 H (200 MHz, 
CDC13) 8.14 (4H, d, J 8.7 Hz, Bnpeoc aromatics), 7.37 
(4H, d, J 8.7 Hz, Bnpeoc aromatics), 7.17 (2H, ci, 
J 7.9 Hz cinnamate aromatics), 7.00 (2H, d, J 7.9 Hz, 
cinnamate aromatics), 5.90 (1H, broad s, handle-Gly NH), 
5.35 (1H, broad s, Bnpeoc-Gly NH), 5.05 (2H, s, benzyl 
CH2), 4.66-4.57 (3H, m, Bnpeoc CH, CR2), 3.87 (2H, d, 
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J 5.6 Hz, handle-Gly CH2), 3.76 (2H, d, J 4.6 Hz, 
Bnpeoc-Gly CH2), 2.66-2.57 (3H, m, cinnamate CH, CH2), 
-0.07 (9H, s, Si(CH3)3); 8c (50 MHz, CDC13) 173.3 (acid 
C=O), 171.2 (amide C=O), 169.5 (Bnpeoc-Gly C=O), 155.8 
(Bnpeoc C=O), 146.7 146.6 (Bnpeoc quaternary aromatic 
(2X2)), 142.4 (cinnamate C- i), 131.2 (cinnamate C-4), 
128.9 123.5 (Bnpeoc aromatic CH (2X4)), 128.1 (cinnamate 
C-3, C-5) , 127.1 (cinnamate C-2, C-6) , 66.5 (benzyl 
CH2), 65.8 (Bnpeoc CH2), 49.2 (Bnpeoc CH), 42.3 
(Bnpeoc-Gly CH2), 40.8 (handle-Gly CH2), 35.6 (cinnamate 
CH2), 32.3 (cinnamateCH), -3.6 ( Si (CH3)  3)  ; m/z (FAB) 
703, 681, 664, 527, 364, 308, 292, 278, 117; HRMS 
681.2228, C32H37N4011Si (MH) requires 681.2228; HPLC 
(I) (A:B, 50:50-B, 100%; 28 mm; 254 nm) RT = 11.6 mm; 
TLC (F) Rf 0.32. 
N°-( 9-Fluorenylmethoxycarbonyl ) norleucyl aminomethyl 
resin (55) Fmoc-N1e-NHCH2-Ph- 
Aminomethyl resin (3)77 (Peninsula, 0.278 mmol/g) 
(2.52 g, 0.70 mmol) was swollen in DCM and then treated 
with a solution of Fmoc-Nle-OH (0.62 g, 1.77 mmol) in 
DCM/DMF, DCCI (0.36 g, 1.77 mmol) in DCM, and a 
catalytic amount of DP4AP. The reaction mixture was 
shaken for 12 hours in a manual peptide synthesiser of 
our own design. Agitation of the resin was by repeated 
inversion of the reaction vessel through 180°. After 12 
hours reaction time, the resin was washed with DMF (X3) 
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and DCM (X3). The above process was repeated a further 
three times, each coupling being monitored using the 
Kaiser test to detect unreacted primary amine sites on 
the resin. These tests indicated that complete 
functionalisation of the resin (3) occurred after the 
fourth coupling, after which the product resin (55) was 
thoroughly dried; Found: N, 0.71% (fourth coupling); 
Fmoc-Nle-NHCH2-Ph--® requires N, 0.71%; thus, after 
fourth coupling, coupling yield = 100%; product resin 
(55) functionality = 0.256 mmol/g. 
Norleucyl aminomethyl resin (56) H_Nle_NHCH2_Ph_0 
Fmoc_Nle_NHCH2_Ph_® (55) (0.256 mmol/g) (2.65 g, 
0.68 mmol) was swollen in DMF and then treated with a 
solution of 20% piperidine in DMF. The reaction mixture 
was shaken for 15 minutes in the manual peptide 
synthesiser, washed with DMF (X3), DCM (X3), and dried. 
A Kaiser test of the product gave a strongly positive 
result; product resin (56) functionality = 0.271 mmol/g. 
N-(4-(N-(2,2-Bis(4-nitropheny1)ethoxycarbony1)qly-
cyloxymethyl)--(trimethy1silyl)hydrocinnamy1)-11-amino-
undecanoylnorleucyl aminomethyl resin (57) Bnpeoc-Gly- 
0-®-CO-Aua-Nle-NHCH2--Ph_® 
H_Nle_NHCH2-Ph_Ø (56) (0.271 mmol/g) (2.46 g, 
0.67 mmol) was swollen in DCM and then treated with a 
solution of Bnpeoc_Gly_O_®-CO_Aua--OH (47) (1.08 g, 
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1.34 mmol) in DCM, DCCI (0.28 g, 1.34 mmol) in DCM, and 
a catalytic amount of DMAP. The reaction mixture was 
shaken for 12 hours in the manual peptide synthesiser, 
after which time the product resin was washed thoroughly 
with DMF (X3), DCM (X3), and dried. A second coupling 
was carried out exactly as above, each coupling being 
monitored using the Kaiser test. These tests indicated 
that incomplete functionalisation of the resin (56) had 
occurred, thus the product resin was swollen in DMF and 
then treated with a solution of acetic anhydride 
(0.63 ml, 6.7 mmol) and triethylamine (0.93 ml, 
6.7 mmol) in DMF. The reaction mixture was shaken for 4 
hours in the manual peptide synthesiser, after which 
time Kaiser testing indicated that capping was complete. 
Thus, the product resin (57) was washed thoroughly with 
DMF (X3), DCM (X3), and dried; Found: N, 1.72% (capped 
product); Bnpeoc-Gly-O-- 0-CO--Aua--Nle_NHCH2_Ph_® 
requires N, 1.88%; thus, after capping, coupling 
yield = 84%; amino acid analysis : Nle1 1.00, Gly1 0.87; 
thus, after capping, coupling yield = 87%. For the 
purposes of subsequent solid phase peptide synthesis, 
these two yields were averaged to give 86%; product 
resin (57) functionality = 0.196 mmol/g. 
Na_(4_(Glycyloxymethy1)_B_(trjmethylsilyl)hydrocjnnamy1)_ 
li-aminoundecanoylnorleucyl aminomethyl resin (58) 
H_Gly_0_0_CO_Aua_Nle_NHCH2_Ph_0 
Bnpeoc-Gly-O- 	-CO-Aua-Nle-NHCH2-Ph- 	(57) 
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(0.196 mmol/g) (2.81 g, 0.55 mmol) was swollen in DMF 
and then treated with a solution of DBN (136 p1, 
1.10 mmol) and acetic acid (63 p1, 1.10 mmol) in DMF. 
The reaction mixture was shaken for 15 minutes in the 
manual peptide synthesiser, washed with DMF (X3), DCM 
(X3), and dried. A Kaiser test of the product gave a 
strongly positive result; product resin (58) 
functionality = 0.209 mmol/g. 
N°-(2,2-Bis(4-nitropheny1)ethoxycarbonyl)glycyl chloride 
(59) Bnpeoc-Gly-C1 
Bnpeoc-Gly-OH (45)132 (63 mg, 0.16 mmol) was 
covered, in DCM (25 ml) along with thionyl chloride 
(0.12 ml, 1.63 mmol). The mixture was refluxed for 2 
hours, after which time complete solution was achieved; 
the solvent and excess thionyl chloride were removed 
under reduced pressure and the residue taken up in DCM 
and re-evaporated three times to ensure complete removal 
of thionyl chloride. The crude material was used 
without further purification; Vmax (CH2C12) 3450 (N-H), 
1805 (acid chloride C=O), 1740 (urethane C=O), 1525 
(urethane N-H; NO2), 1350 (NO2), 830 cm' (aromatic 
C-H). 
Na_(2,2_Bis(4_nitrophenyl)ethoxycarbonyl)glycyl amino-
methyl resin (60) Bnpeoc_Gly-NHCH2-Ph_® 
Aminomethyl resin (3)77 (Peninsula, 0.278 mmol/g) 
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(0.53 g, 0.15 mmol) was swollen in DCM (10 ml) and then 
treated with a solution of Bnpeoc-Gly-Cl (59) 
(0.16 mmol) in DCM (15 ml), NMM (0.49 ml, 4.44 mmol), 
and DMAP (1.0 mg, 0.01 mmol). The reaction mixture was 
sonicated for 2 hours, filtered, washed thoroughly with 
DMF then DCM, and dried; Found: N, 1.26% (uncapped 
product); Bnpeoc-Gly-NHCH2_Ph® requires N, 1.42%; 
thus, after first coupling, coupling yield = 83%; V max 
(KBr disk) 3410 (N-H), 1730 (urethane C=O), 1680 (amide 
C0), 1520 (urethane, amide N-H; NO2), 1345 (NO2), 
830 cm-1 (aromatic C-H). An attempt to carry out this 
coupling with pyridine (0.36 ml, 4.46 mmol) in place of 
NMM and DMAP gave very little functionalisation of (3). 
Aminomethyl resin (3)77 (Peninsula, 0.278 mmol/g) 
(5.06 g, 1.41 mmol) was swollen in DCM (40 ml) and then 
treated with a solution of Bnpeoc-Gly-OH (45)132 
(1.10 g, 2.83 mmol) in DMF (3 ml) and DCCI (0.58 g, 
2.83 mmol) in DCM (10 ml). The reaction mixture was 
sonicated for 4 hours, filtered, washed thoroughly with 
DMF then DCM, and dried. A second coupling was carried 
out as above except that the manual peptide synthesiser 
was used instead of sonication. 	Kaiser testing 
indicated incomplete functionalisation of the resin (3), 
thus the product resin was swollen in DCM (40 ml) and 
treated with a solution of acetic anhydride (1.40 ml, 
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14.8 mmol) and triethylamine (2.00 ml, 14.4 mmol) in DCM 
(10 ml). This reaction mixture was sonicated for 1 hour, 
after which time Kaiser testing indicated that capping 
was complete. Thus, the product resin (60) was washed 
thoroughly with DMF then DCM, and dried; Found: N, 1.32% 
(capped product); Bnpeoc-Gly-NHCH2-Ph-0 requires N, 
1.42%; thus, after capping, coupling yield = 90%; 
product resin (60) functionality = 0.230 mmol/g;\) max 
(KBr disk) 3410 (N-H), 1735 (urethane 0=0), 1680 (amide 
0=0), 1520 (urethane, amide N-H; NO2), 1345 (NO2), 830 
cm' (aromatic C-H). 
Glycyl aminomethyl resin (61) H_Gly_NHCH2_Ph_0 
Bnpeoc_Gly-NHCH2--Ph_0 (60) (0.230 mmol/g) (4.78 g, 
1.10 mmol) was swollen in DMF and then treated with a 
solution of DBU (328 1.11, 2.20 mmol) and acetic acid 
(126 ul, 2.20 mmol) in DMF. The reaction mixture was 
shaken for 15 minutes in the manual peptide synthesiser, 
washed with DMF (X3), DCM (X3), and dried. A Kaiser 
test of the product gave a strongly positive result; 
product resin (61) functionality = 0.248 mmol/g; Vmax 
(KEr disk) 3340 (N-H), 1680 (amide C=0), 1540 cm' 
(amide N-H). 
N-(4-(Hydroxymethyl)--(trimethylsi1yl)hydrocinnamy1)-
glycyl aminomethyl resin (62) HO_0 _C0_Gly._NHCH2-Ph_Ø 
H_Gly-NHCH2_Ph_® (61) (0.248 mmol/g) (6.01 g, 
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1.49 mmol) was swollen in DCM (55 ml) and then treated 
with a solution of HO- 0-COOH (30)130 (0.75 g, 
2.98 mmol) in DMF (2 ml) and DCCI (0.61 g, 2.98 mmol) in 
DCM (5 ml). The reaction mixture was sonicated for 5 
hours, filtered, washed thoroughly with DMF then DCM, 
and dried. 	A Kaiser test indicated that complete 
tunctionalisation of the resin (61) had occurred; Found: 
N, 	0.69% (uncapped product); HO- c-CO-Gly-NHCH2-Ph_® 
requires N, 0.69%; thus, after first coupling, coupling 
yield = 100%; product resin (62) functionality = 
0.235 mmol/g; umax  (KBr disk) 3410 3320 (N-H), 1675 
(amide C=O), 1545 (amide N-H), 850 cm-1 (aromatic C-H). 
Na_(4_(N_(2,2_Bis(4_ nitrophenyl)ethoxycarbonyl)gly_ 
cyloxymethyl)--(trimethy1silyl)hydrocinnamyl)glycy1 
aminomethyl resin (63) Bnpeoc_Gly_0_®-CO_Gly_NHCH2_ 
Ph-® 
Method 1 
HO- ®_CO-Gly_NHCH2--Ph-®  (62) (0.235 mmol/g) 
(0.51 g, 0.12 mmol) was swollen in DCM (5 ml) and then 
treated with a solution of Bnpeoc-Gly-OH (45)132  (93 mg, 
0.24 mmol) in DCM (5 ml)/DMF (1 ml) and DCCI (49 mg, 
0.24 mmol) in DCM (5 ml). The reaction mixture was 
sonicated for 4 hours, filtered, washed thoroughly with 
DMF then DCM, and dried. A second coupling was carried 
out as above except that the manual peptide synthesiser 
was used instead of sonication. A third coupling was 
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carried out as for the second coupling except that HOBt 
(32 mg, 0.24 mmol) in DMF (1 ml) and a catalytic amount 
of DMAP were used, the procedure being one of those 
successfully employed for coupling protected amino 
acids to the Wang resin (14); V max (KBr disk) - 
identical to that for (62) i.e. no product absorptions. 
Attempts to carry out this coupling using acid chloride 
methodology both with pyridine and with NMM and DMAP 
gave a similar result to above, i.e. no 
functionalisation of (62). 
Method 2 
To a solution of Bnpeoc_Gly_O-®_CO_Gly_OH (54) 
(1.22 g, 1.80 mmol) in DCM (10 ml) was added a solution 
of HOBt (0.24 g, 1.80 mmol) in DMF (2 ml). This mixture 
was shaken for 2 minutes, after which time a solution of 
DCCI (0.37 g, 1.80 mmol) in DCM (5 ml) was added, and 
the resulting mixture shaken for 2 minutes. 	This 
solution was then added to aminomethyl resin (3)77 
(Peninsula, 0.400 mmol/g) (3.00 g, 1.20 mmol) swollen in 
DCM (40 ml), and the reaction mixture was sonicated for 
5 hours, filtered, washed thoroughly with DMF then DCM, 
and dried. Second and third couplings were carried out 
exactly as for the first. Each coupling was monitored 
quantitatively in the three ways described in section 
2.6. Kaiser testing after the third coupling showed 
that complete functionalisation of the resin (3) had not 
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been achieved hence capping was performed by adding a 
solution of acetic anhydride (1.13 ml, 12.0 mmol) and 
triethylamine (1.67 ml, 12.0 mmol) in DCM (10 ml) to the 
product resin swollen in DCM (40 ml) and sonicating the 
mixture for 1 hour. After this time, Kaiser testing 
showed that capping was complete, thus the product resin 
(63) was washed thoroughly with DMF then DCM, and dried. 
The capped product (63) was also tested quantitatively 
in the manner described in section 2.6 (see Fig. 2.1); 
max (KBr disk) 3410 3330 (N-H), 1735 (urethane, ester 
C=O), 1670 (amide C=O), 1520 (urethane, amide N-H; NO2), 
1345 (NO2), 850 cm' (aromatic C-H). For the purposes 
of subsequent solid phase peptide synthesis and as 
explained in section 2.7, a yield of 47% was determined 
for this coupling step; product resin (63) 
functionality = 0.167 mmol/g. 
N-(4-(G1ycyloxymethyl)--(trimethy1silyl)hydrocinnamyl)-
glycyl aminomethyl resin (64) H_Gly_0_®_CO_Gly_NHCH2_ 
Ph-® 
Bnpeoc_Gly_0_®_CO_Gly_NHCH2_Ph_® (63) (unknown 
functionality) (3.73 g) was swollen in DMF (40 ml) and 
then treated with a solution of DBU (267 p1, 1.78 mmol) 
and acetic acid (102 p1, 1.78 mmol) in DMF (10 ml). The 
reaction mixture was sonicated for 2 hours, filtered, 
washed thoroughly with DMF then DCM, and dried. 
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Quantitative Kaiser testing gave product resin (64) 
functionality = 0.150 mmol/g;\) max (KBr disk) 3410 3310 
(N-H), 1745 (ester C=O), 1665 (amide C=O), 1515 (amide 
N-H), 850 cm' (aromatic C-H). 
N -(2,2-Bis(4-nitrophenyl)ethoxycarbonyl)pheny1alanyl 
chloride (65) Bnpeoc-Phe-Cl 
Bnpeoc-Phe-OH132 (0.25 g, 0.52 mmol) was dissolved 
in DCM (40 ml) along with thionyl chloride (0.38 ml, 
5.22 mmol). 	The solution was refluxed for 2 hours, 
after which time the solvent and excess thionyl chloride 
were removed under reduced pressure and the residue 
taken up in DCM and re-evaporated three times to ensure 
complete removal of thionyl chloride. The crude 
material was used without further purification; Vmax 
(CH2C12) 3430 (N-H), 1795 (acid chloride C=O), 1735 
(urethane C=O), 1525 (urethane N-H; NO2), 1350 (NO2), 
835 cm-1 (aromatic C-H). 
N - ( 2, 2-Bis ( 4-nitrophenyl )ethoxycarbonyl)phenylalanyl 
p-alkoxybenzyl alcohol resin (66) Bnpeoc_Phe_(OCH2_Ph)2-® 
p-Alkoxybenzyl alcohol resin (14) 	(Bachem, 
1.01 mmol/g) (0.47 g, 0.48 mmol) was swollen in DCM 
(10 ml) and then treated with a solution of 
Bnpeoc-Phe-Cl (65) (0.52 mmol) in DCM (5 ml), NMM 
(1.60 ml, 14.57 mmol), and DMAP (2.9 mg, 0.02 mmol). 
The reaction mixture was sonicated for 2 hours, 
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filtered, washed thoroughly with DMF then DCM, and 
dried. A second coupling was carried out exactly as for 
the first; Found: N, 0.68% (first coupling), 1.11% 
(second coupling); Bnpeoc_Phe_(OCH2_Ph)2_® requires N, 
2.89%; thus, after first coupling, coupling yield = 17%; 
after second coupling, coupling yield = 30%; umax (KBr 
disk) 3560 (resin 0-H), 3430 (N-H), 1725 (urethane, 
ester C=0), 1520 (urethane N-H; NO2), 1345 (NO2), 
830 cm' (aromatic C-H). Attempts to carry out this 
coupling with pyridine (1.15 ml, 14.24 mmol) in place of 
NMM and DMAP failed completely. 
cv 	Ot 
N -(4-(N -(2,2-Bis(4-nitrophenyl)ethoxycarbonyl)Ql 
cyloxymethyl)-3-(trimethylsily1)hydrocinnamyl)glycy1 
p-alkoxybenzyl alcohol resin (67) Bnpeoc-G1y-0--CO-
Gly- ( OCH2-Ph) 2® 
To a solution of Bnpeoc-Gly-O-®_Co_Gly_OH (54) 
(0.14 g, 0.20 mmol) in DCM (10 ml) was added a solution 
of HOBt (0.03 g, 0.21 mmol) in DMA (2 ml). 	This 
mixture was shaken for 2 minutes, after which time a 
solution of DCCI (0.04 g, 0.20 mmol) in DCM (2 ml) was 
added, and the resulting mixture shaken for 2 minutes. 
This solution was then added to -alkoxybenzyl alcohol 
resin (14) 	(Bachem, 1.01 mmol/g) (0.10 g, 0.10 mmol) 
swollen in DCM (10 ml), and the reaction mixture was 
sonicated for 4 hours, filtered, washed thoroughly with 
DMA then DCM, and dried. A second coupling was carried 
out exactly as for the first; Found: N, 0% (first 
coupling), 0.32% (second coupling); Bnpeoc_Gly_O_®_ 
CO_Gly_(OCH2_Ph)2_® requires N, 3.39%; thus, after 
first coupling, coupling yield = 0%; after second 
coupling, coupling yield = 6%. 
3.3 SOLID PHASE SYNTHESIS 
The automated peptide synthesiser used in the 
following syntheses was the Applied Biosystems model 
430A. The DMF used was supplied by Rathburn Chemicals 
Ltd. (peptide synthesis grade). 
Unless otherwise stated, each residue was double 
coupled; firstly by the symmetrical anhydride method 
and secondly by the HOBt active ester method. Preformed 
symmetrical anhydrides were prepared from Fmoc-amino 
acids (1.0 mmol) and DICI (0.5 mmol) in DMF with an 
activation time of 15 minutes, whilst simultaneous 
deprotection of the Fmoc-peptide-resin was achieved over 
a 10 minute period using 20% piperidine in DMF. The 
symmetrical anhydride was then reacted with the free 
amino resin for 1 hour. Subsequent activation of each 
Fmoc-amino acid (0.5 mmol) with DICI (0.5 mmol) and HOBt 
(0.5 mmol) was carried out over a period of 30 minutes 
before addition to the resin and allowing reaction to 
proceed for a further 2 hours. Capping of unreacted 
amino functions was then performed over a period of 6 
minutes using acetic anhydride and pyridine in DMF. The 
resin was washed thoroughly with DMF at the end of each 
-123-- 
cycle, and with DMF then DCM at the end of the 
synthesis. Each synthesis was commenced with a 
deprotection step. As a rough monitor of the couplings, 
the product solution from the deprotection steps was fed 
through an ultraviolet detector (276 nm) and recorder to 
give a series of peaks for the olefin liberated from 
each residue which should in theory have all had the 
same total peak area. Removal of peptide from the resin 
was accomplished using three separate 5 minute 
treatments with dry TBAF (0.25 mmol) in DMF. 	These 
cleavages were performed on the manual peptide 
synthesiser of our own design, after which the residue 
resin was washed thoroughly with DMF then DCM and dried. 
In the purification of the peptides by gel filtration, 
product containing fractions were identified by 
ultraviolet absorbance (276 nm) and optical rotation 
(589 nm). 
N -Diphenylphosphinylleucyliso1eucylphenylalanylalanyl_ 
glycine (68) Dpp-Leu-Ile--Phe-Ala-Gly-OH 
H_Gly_0_0_CO_Aua_Nle_NHCH2_Ph_® (58) (0.209 mmol/ 
g) (2.38 g, 0.50 mmol) was placed in the reaction 
vessel of the automated peptide synthesiser and 
thus, in this case, the amounts used of all reactants 
were doubled. All the Na-protected amino acids used 
were Fmoc-protected except for leucine which was 
Dpp-protected. Capping was not carried out. After the 
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completed coupling cycle for each amino acid, a small 
sample of resin-bound product was automatically removed 
for a quantitative Kaiser test (see Fig. 2.2). 
Resin-bound peptide amino acid analysis: Gly1 0.91, 
Ala1 0.69, lie1 0.57, Leu1 0.61, N1e1 1.00, Phe1 0.62. 
All three TBAF treatments were worked-up as 
follows: removal of solvent in vacuo to give a yellow 
oil, addition of water (20 ml) to give a white 
precipitate, and addition of one equivalent (50 ml) of 
0.01M HC1. The resulting white solids were filtered 
off and dried in vacuo over phosphorus pentoxide. 
Residue resin amino acid analysis: G1y1 0.16, Ala1 
0.23, lie1 0.15, Leu1 0.18, N1e1 1.00, Phe1 0.26. 
Amino acid analysis, mass spectrometry, and HPLC of 
the three product fractions indicated that the major 
component in each case was the desired product, thus all 
three fractions were combined and purified by gel 
filtration on Sephadex LH20 eluting with DMF to yield 
pure (68) after lyophilisation as an off-white powder 
(143 mg, 40%); amino acid analysis: G1y1 1.00, Ala1 
0.95, lie1 0.84, Leu1 0.88, Phe1 0.95; m/z (FAB) 742, 
720, 645, 574, 427, 400, 286, 201; HRMS 720.3526, 
C38H51N507P (MH) requires 720.3526; HPLC (II) (A:B, 
50:50-B, 100%; 28 mm, 214 nm) RT = 7.2 mm; TLC (I) Rf 




Bnpeoc_Gly_0_®_CO_Gly_NHCH2_ph_( 	(63) (0.167 mmol/ 
g) (1.50 g, 0.25 mmol) was placed in the reaction 
vessel of the automated peptide synthesiser. 
Leucine was deprotected before the TBAF treatments. 
Residue resin amino acid analysis: Gly2 2.00, 
Ala1 0.43, Ilel 0.23, Leu1 0.29, Phe1 0.58. 
HPLC of the three product fractions indicated that 
the first TBAF treatment was the most pure of the three, 
and that the second and third treatments were identical; 
hence the last two were combined. The first and 
second/third TBAF treatments were purified separately by 
gel filtration on Sephadex G15 eluting with 30% acetic 
acid in water, to yield pure (69) as a white powder 
(85 mg, 65%); amino acid analysis; G1y1 1.00, Ala1 0.99, 
Ile1 0.93, Leu1 0.94, Phe1 0.94; m/z (FAB) 520, 242, 
184, 142; HRMS 520.3135, C26H42N506 (MH) requires 
520.3135; HPLC (II) (A:B, 90:10-A:B, 40:60; 25 mm; A:B, 
40:60-B, 100%; 2 mm; 214 nm) RT = 18.6 mm; TLC (I) Rf 
0.31 (ninhydrin positive). 
Valyllysyiglycylarginyiglycine (70) H-Val-Lys-Gly--Arg-
Gly-OH 
H-G1y_O_®_CO_G1y_NHCH2_Ph_® (64) (0.150 mmol/g) 
(1.67 g, 0.25 mmol) was placed in the reaction vessel of 
the automated peptide synthesiser. All the Na-protected 
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amino acids used were Fmoc-protected except for valine 
which was Boc-protected; side-chain protection was as 
follows - Arg (Pmc), Lys (Boc). Single coupling only 
was employed for Fmoc-Gly-OH, the second HOBt active 
ester coupling being omitted. Both couplings for 
Fmoc-Arg(Pmc)-OH were performed using the HOBt active 
ester protocol, and acetyl imidazole was used as the 
capping agent. 
Residue resin amino acid analysis: G1y3 3.00, Val1 
0.48, Lys1 0.44, Arg1 0.49. 
All three TBAF treatments were combined and 
purified by gel filtration on Sephadex LH20 eluting with 
methanol to yield a white powder (295 mg) which on TLC 
in system (I) showed two major ultraviolet-active spots, 
neither of which was ninhydrin positive. Side-chain 
protection was then removed by treating the product with 
TFA/DCM/water, 50/45/5 (75 ml) and stirring the reaction 
mixture at room temperature for 1 hour, after which time 
the solvent was removed and the residue triturated with 
ether to give a white powder. This was dried in vacuo 
over phosphorus pentoxide to give a yield of 162 mg, and 
then purified by gel filtration on Sephadex G25 eluting 
with 30% acetic acid in water to yield a white powder 
(90 mg). 	Purification of this product was by 
preparative HPLC using a reverse phase Spherisorb ODS2 
5ii column (10 x 250 mm) with a gradient of A:B, 
90:10-A:B, 10:90 over 28 minutes and ultraviolet 
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detection at 254 nm, to yield pure (70) after 
lyophilisation as a white powder (78 mg, 60%); amino 
acid analysis: G1y2 2.00, Va11 1.02, Lys1 1.04, Arg1 
1.05; m/z (FAB) 517, 473, 242, 171, 147; HRMS 516.3258, 
C21H42N906 (MH) requires 516.3258; HPLC (I) (A:B, 
90:10-A:B, 10:90; 28 mm; 214 nm) RT = 4.7 mm. 
Fully protected ubiguitin (1-35) (71) 
Bnpeoc_Gly_0__Co_Gly_NHCH2_Ph_® (63) (0.167 mmol/ 
g) (1.50 g, 0.25 mmol) was placed in the reaction vessel 
of the automated peptide synthesiser. All the 
Na-protected amino acids used were Fmoc-protected except 
for the N-terminal methionine which was Boc-protected; 
side-chain protection was as follows - Lys (Boc); Glu, 
Asp, Thr, Ser (t-Bu). Single coupling only was employed 
for Fmoc-Gly-OH, the second HOBt active ester coupling 
being omitted. For Fmoc-Asn-OH and Fmoc-Gln-OH, both 
couplings employed the HOBt active ester protocol with 
the first coupling lasting for 1 hour and the second 
coupling lasting for 90 minutes. Cleavage of the fully 
protected peptide from the resin was done using seven 
TBAF treatments of 5 minutes duration - four with one 
equivalent followed by three with two equivalents of 
TBAF. After several selected couplings, small samples 
of resin-bound product were removed for quantitative 
olefin determination by ultraviolet absorbance (see Fig. 
2.3). Amino acid analyses of the residue resin were 
-128- 
carried out after the fourth, fifth, sixth, and seventh 
TBAF treatments (see Fig. 2.4). The product obtained 
from TBAF treatments (I)-(V) was a tacky white solid, 
wher€as that from (VI) and (VII) was a yellow oil, the 
crude yields being as follows: (I) 67 mg (5%), 
(II) 91 mg (7%), (III) 107 mg (8%), (IV) 135 mg (10%), 
(V) 300 mg (23%), (VI) 197 mg (15%), (VII) 159 mg (12%). 
TBAF treatments (I)-(IV) and (V)-(VII) were combined and 
purified separately by gel filtration on Sephadex LH20 
eluting with DMF to yield (71) after trituration as an 
off-white powder (416 mg, 32%). This yield, however, 
was recovered from only two-thirds of the resin-bound 
peptide obtained after the coupling of Gln [2] , and thus 
projected yield = 624 mg, 48%; amino acid analysis: Asx3 
3.06, Thr5 4.71, Ser1 0.93, G1x6 6.40, Pro1 1.13, Gly2 
1.97, Ala1 1.05, Va13 2.95, Met1 0.59, 11e4 3.84, Leu2 
1.95, Phe1 0.80, Lys5 5.03; 8 H (360 MHz, (CD3)2S0) 
1.50-0.82 (indeterminate H, m, t-Bu and Boc); m/z (FAB) 
HRMS 5179.1716, C250H436N43069S (MH) requires 
5179.1716; HPLC (III) (isocratic-0.1% isopropanol in 
DCM, 254 nm) RT = 2.75 mm (see Fig. 2.5). 
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COMPOUND INDEX 
HO- ®-COOH 	 83 
Bnpeoc-Gly-OH 	 99 
Ph2CN2 	 83 
HO-®-CO_OBzh 	 83 
Frnoc-G1y-O-®-CO-OBzh 	 85 
ClH2+-Aua-OMe 	 87 
HO_G)-CO_Aua--OMe 	 88 








HO- ®_CO_Aua_Aua_OH 98 
Bnpeoc_Gly_O-®-.CO_Aua_OPh 100 
Bnpeoc_Gly_O_®_CO_Aua_OH 102 
Z-Gly-OH 	 104 
Z-Gly-OPh 	 104 
TosOH2+-G1y-OPh 	 105 
TosOH2+-G1y-OMe 	 106 
HO-Ø-CO-Gly-OPh 	 107 
Bnpeoc_Gly_O_®_CQ_Gly_oph 	 108 
Bnpeoc.-Gly_O_®_CO_Gly_OH 	 109 
Fmoc-Nle-NHCH2-Ph-Ø 	 111 




H_Gly_0_0_CO_Aua_N1  e-NHCH2-Ph- 	 113 
Bnpeoc-Gly--C1 	 114 
Bnpeoc_Gly_NHCH2_Ph_® 	 114 
H_Gly_NHCH2-Ph_® 	 116 
HO_®_CO_Gly_NHCH2_ph_® 	 116 
Bnp eoc_Gly_O_®_CO_Gly_NHCJ-1 2-Ph_0 	 117 
H-G1Y-O--Co-G1y_NucH2_Ph_Ø 	 119 
Bnpeoc-Phe-C1 	 120 
Bnpeoc_Phe_(0CH2_Ph)2_® 	 120 
Bnpeoc_Gly_O_®_CO-Gly_(0CF12-ph)2-® 	 121 
Dpp-Leu-Ile-Phe-Ala-Gly.-OH 	 123 
H-Leu-Ile-Phe-Ala-Gly-OH 	 125 
H-Val-Lys-Gly-Arg-Gly-OH 	 125 




RESFUNC-UV sample output 	 II 
RESFUNC-KAISER listing 	 III 
RESFUNC-KAISER sample output 	 Iv 
RESFUNC-CHN listing 
RESFUNC-CHN sample output 	 VI 
10 HOME 	: INVERSE 
20 NORMAL : 	PRINT 	TAB( 	10)" 	" ; : 	INVERSE 	PRINT  
30 NORMAL : PRINT TAD( 10)" ; : INVERSE : PRINT 	'RESIN FUNCTIONALITY" 
40 NORMAL 	: PRINT 	TAB( 	10 )" 	" ; INVERSE 	PRINT  
50 YS = "o" : 
60 A = B 	C= 11= E= F= G = H 	I = X= Y 	Z = O:H = 42 
70 PRINT : PRINT 	: PRINT "INPUT FUNCTIONALITY OF STARTING RESIN INMMOL/G" 	PRINT INPUT A 	PRINT 
80 PRINT "INPUT MOLECULAR WEIGHT OF PROTECTED": PRINT "AHINOACID SPECIES BEING LOALEI': PRINT 	INP UT C: PRINT 
90 Li = C - 18 
100 PRINT "INPUT AMINO PROTECTING GROUP USED": 	PRINT 	: INPUT Y$ 	PRINT 
110 IF Y$ = "FMOC" THEN C = 900: GOTO 140 
120 IF Y$ = "BNPEOC" THEN C = 163,75: GOTO 140 
130 GOTO 100 
140 PRINT "INPUT MASS OF RESIN-BOUND PRODUCT IN MC" 	PRINT : INPUT E 	PRINT 
150 PRINT "INPUT OBSERVED UV ABSORBANCE AT 3001411" : PRINT 	: INPUT F PRINT 
160 PRINT "INPUT IF SAMPLE IS CAPPED OR UNCAPPED" #' 	PRINT "(C OR U)": PRINT INPUT W$ 	PRINT 
170 IF W* = "U" THEN 	COTO 210 
180 IF W 	= "C" THEN GOTO 200 
190 GOTO 160 
200 B= 	((100*: 	F (1000 	+ (A 	*: Nfl) / (A 	* ((E 	*: C) 	+ (H 	* F) - (B 	* F)))) + 0.5:5 = 	INT 
100 - s: GOTO 220 
210 B = 	((100000 *: 	F) / 	(A 	* ((E 	* G) 	-. (B 	* F)))) 	+ 0.5 tB 	= INT (B ):I 	= 100 - B 
220 X= (A * B * 10 00 /((A * B * LI) + (A * H * I) + 100000)X 	(X * 1000) + o,5>: = 	INT 	(X)X 
X / 1000 
230 1 = X 
240 IF W$ = "C" THEN 	GOTO 260 
250 Z= 	(1000 * A *: B) /(100000 + (A * B *: tlfl:Z = (Z *1000) 	+o.s:z = 	INT (Z:Z 	= 7 	/ i000 
260 11$ = CHR 	(4): 	PRINT D$"PRtl" 
270 PRINT 	"***:***:**:*:*::*:****:**:** ***:**:**:**:****'***" : 	PRINT 
280 PRINT " RESIN LOADING/COUPLING PERCENTAGE 	" ; TAD( 	22)" 	";B' 	PRINT 
290 PRINT 	"*:**:**:*:****:*:*:*:***:**:*:***:*:**:*:***:*:*:*):***:" PRINT : PRINT 
300 PRINT "**:*:***:*:**:**:*:**:**:*:**:**:***:*:*:*:*:*******:" PRINT 
310 PRINT "PRODUCT RESIN FUNCTIONALITY IN HMOL/C:" 	TAB( 	22)" 	" 
320 IF I 	1 THEN 	GOTO 350 
330 PRINT Y"( CAPPED)": IF W$ = "C" THEN 	GOTO 400 
340 GOTO 360 
350 PRINT "0" 	Y"( CAPPED )" : 	IF W$ = "C" THEN 	GOTO 400 
360 IF Z 	1 THEN 	GOTO 390 
370 PRINT TAB( 60)" " ;Z;"( UNCAFPED )" 
380 GOTO 410 
390 PR I NT 	TAB( 	60)" 	" i "0" 	Z"( UNCAPPED )" : 	COTO 410 
400 PRINT 
410 PRINT 	"** *:*:****:***U***:**:**:*:*:****:*:**:*:*" : 	PRINT 	: PRINT 	PRINT 
420 PRINT "YOUR DATA WERE AS FOLLOWS:": PRINT 	: PRINT 
430 PRINT "FUNCTIONALITY OF STARTING RESIN IN MM0L/c:"; TAB( 	18)"  
440 P = 	A: GOSULI 540 
450 PRINT "MOLECULAR WEIGHT OF PROTECTED AMINO ACID:" ; TAD( 	19)" "C 	PRINT 
460 PRINT "ANINO PROTECTING GROUP:"; 	TAB( 	37)" 	";Y$: 	PRINT 
470 PRINT "MASS OF RESIN-BOUND PRODUCT IN MG:" TAB( 26)" 
480 II = E: GOSUB 540 
490 PRINT "OBSERVED UV ABSORBANCE AT 300141M:"; 	TAB( 	23)" 
500 Li = 	F: 60308 540 
510 PRINT 	"LAPPED 	OR LINcArpEn 	( F; OR 	U)1.11 ; 	TA[i( 	32)" 	" ;Wt'. 	PRINT 
520 PRINE 14"FRI0" NORMAL 	: HONE 
530 END 
540 IF B 	1 THEN 	GOTO 50 
550 60111 '70 
560 IF 	U 0 	(FILM 	GOTO 530 
Sb FR S NT Li IF: TNT CorN 	590 
550 PRINT 	"oil'; 	F'RIUl 
590 RE I UkN 
II 
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'-.-TIUR EFfIA WERE 	- L.LukU_ 
FI_INC:TIONHL_IT'Y 	 INU RE -U1 IN NNUL.G 	 04 
MOLECULAR WEIGH I UI- 	EL. i LL HI1INU HL: IL: Ll 
AM iN't FR :1 EC: HG GkUUI 	 EHFEC;C: 
I1A 	CF RE.),I•-E__dJL:. I I 	L 	I IiA, lkjz 
JU 	li:,LIUrjNi_.b. H; 	.iLIjI 	 ;.i - 
_lf 	I_.I . F!L.L 	'.:_. 	. 	:_) 	 LI 
	
REI II LOFIDIIl3.C:OUE-LING PERC:EN1AUE 	 1O1i 
.f::+::+::+::.:f::f::f::.f::+::4::.t.::4.::..::f: 
FROE:IJC:T RESIN' FL4C:T I UIAL I 	Hi IU1UL.0 	 Ij - 
'1'CILIF DATA WERE Al. FULLUWl. 
FUNC:TIC;NHLITY OF 1 HRT 1HU REIIN IN 1HUL.0 	 1.01 
HCLEC.LILAR WE I GHT OF F:RO  EL: FEL. Ali I Flu HL:I L.: 	 197 
ArIPAID FROTEC:i 110 GRCU_iF 	 FMOC: 
rI,:s 	Cli 	F:E I t-E:LIUIIL. F-RIJL.U:_. I 	 1 	1 
lJE:EFl,.lEL. LI'.! HE;UkL-;HiIL.E H F 	OC.UI 	 0_ 
10 HOME 	: INVERSE 
20 NORMAL PRINT 	TAB( 	10)" 	"; 	INVERSE 	PRINT 
30 NORMAL : 	PRINT TAB( 10)" " : INVERSE PRINT 	'RESIN FUNCTIONALITY" 
40 NORMAL PRINT 	TAB( 	10)" 	'i 	INVERSE 	PRINT  
50 LI* = 	"0" 
60 A = B C = Li = E = F = 	I = K = X = Y 	2 = 0H 	426 = 314 
70 PRINT PRINT 	: PRINT "INPUT FUNCTIONALITY OF STARTING RESIN ItThLIOL/C" 	F'R);NT 	: INPUT A 	PRINT 
80 PRINT "INPUT MOLECULAR WEIGHT OF PROTECTED" 	PRINT "AHINQACIL' SPECIES BEING LQAUEO" 1. PRINT : 	JNP UT c: PRINT 
90 Li = C 	- 18 
100 PRINT "INrur MASS OF RESIN-BOUND PRODUCT IN tiC" 	PRINT 	INPUT E 	PRINT 
110 PRINT "INPUT UV ABSORBANCE OF BLANK AT 570Ntl" : PRINT : INPUT F: PRINT 
120 PRINT "INPUT UV ABSORBANCE OF SAMPLE AT 57ONM" 	PRINT : INPUT K 	PRINT 
130 PRINT "INPUT IF SAMPLE IS CA PPELi/LIEPROTECTELi ORLINCAPPELI/PROTECTELI (C OR U )" : PRINT TNPUT WI: 
PRINT 
140 X= (K -F)!(E* 3:X = (X 	1000)+ 0,5:x= 	INT 	x:X=x/ 1000 
150 IF WI = "LI" THEN 	GOTO 180 
160 IF W = "C" THEN 0010 190 
170 GOTO 130 
180 B = ((100000 . (A 	- X)) 	1 ((1000*: 	A) + 	(A Li 	X))) 	+ 0,5:B 	INT 	(B)I 	= 100- 	8 SOTO 200 
190 B =((100 * X *: (1000 + (A * H))) / (A * (1000 f (X *: (H 	I C - rwm i 0. 5.'B 	INT 8:s 	too 
- B 
200 Y = 	(A * B * 1000)! ((A * B * Li) + 	(A I H I I) 1- 	100000)'i' = (1*: 	I 	05Y 	INT (Y )Y 	= 
I 1 1000 
210 2 = 	(A * B * 1000) / ((A I B I Li) + iO000O)Z 	(2 1 1000) + 05Z = 	TNT (Z)7 = 2 / 1000 
220 LII = CHRI (4): 	PRINT LiI"PRIl" 
230 PRINT "***I*:*****:I***:II***: 	**II***:**:*:*:I*:*:**:$:*" : 	PRINT 
240 PRINT RESIN LOADING/COUPLING PERCENTAGE 	:" TAB( 	22)" 	" ;B1. 	PRINT 
250 PRINT "**:**:***:*:*:**:I*:***:*: 	I*:***I*:***:I14:**:": 	PRINT : PRINT 
260 PRINT "I**:** 	*:*:*:*:*::**:**:***:**:*:*:*:*:*I" PRINT 
270 PRINT "PRODUCT RESIN FUNCTIONALITY IN MM0L/C:" i 	TAB( 	22)" 
280 IF I 1 THEN 	0010 310 
290 PRINT Y;"(CAPPELI )" : 	IF WI = "C" THEN 	0010 360 
300 GOTO 320 
310 PRINT "0" ;Y;"(CAPPED )" : 	IF WI = "C" THEN 	GUTO 360 
320 IF 2 1 THEN 	GOTO 350 
330 PRINT TAB( 60)" " ui "( LINCAFPELI )" 
340 GOTO 370 
350 PR I NT TAB( 	60)" 	" "0" i Zi"( UNCAPPELI )" : 	GUTO 370 
360 PRINT 
370 PRINT "*:**:***:******:**:*:*:*:*:****: 	*:****:**:" : 	PRINT 	: PRINT 	PRINT 
380 PRINT "YOUR DATA WERE AS FOLLOWS:": PRINT 	PRINT 
390 PRINT "FUNCTIONALITY OF STARTING RESIN IN MM0L/c:"; TAB( 	18)" 
400 Ii = 	A: GOSUB 510 
410 PRINT "MOLECULAR WEIGHT OF PROTECTED AMINO ACID."; TAB,', 	19)" 	";c: PRINT 
420 PRINT "MASS OF RESIN-BOUND PRODUCT IN MC" 	TAB( 	26)" " 
430 LI = 	E GOSUB 510 
440 PRINT "UV ABSOR.BANCE OF BLANK AT 570NM:"; TA BI 	28)" 
450 It = 	F: GOSUB 510 
460 PRINT "UV ABSORBANCE OF SAMPLE AT 570NM"i TAB( 	27)" 
470 Li 	= K: GOSUB 510 
480 PRINT "CAPPELI/LIEPROTECTELI OR UNC.APF'ELI/PROTECTEO ( C OR UP '." ; 	TAC( 	10)` 	" PRINT 
490 PRINT tI$"PRIO": NORMAL 	: HONE 
500 END 
510 IF 	It 1 THEN 	0010 530 
520 coro  540 
530 IF 	It > 0 11-1EN 	0010 50 
540 PRINT LI 	PRINT ONTO :o 
550 PRINT "0" ;i': 	F'RIttr 
560 RETURN 
Iv 
F.:E 1 I Lr_rHL: I It._._It_IF'L I HC rEF.:C:E1 I HUE 
P 	- 	I,-. - RE-DIN . 	ti. - 4 	I1'+11'11-;'L--".'C1 3- 	 U . 11 -:' 	L. H P rE- 1 
0. 11B':Ut-.IORFF'ED) 
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PRODUCT RES I N FLINC:T I ONAL I TV 1 - 4 illlUL/3 	 0. 14G--'.0 IPPED) 
'...'OUR, DATA LIERE AS I- ULLUldS 
Fu-i'::.T i CINFIL Ii 	OF SI ART i RES i4 	i N 	IHOL. - U 
I1OLECULFIR 	1.0EIGH1 LII- 	F-KU I EL: I EL.' 	HH I NO 	AL.! U: 
MASS CF RESIH-EOUNL. FKI_i[.'UL.:I iN 1. 
IlJ 	HLF:F: 	I.E 	uf bLHN- 	H -4M : ci. 1711 
LIU 	HE1SCiRbi1I-1C.L 	f z.I--UF-LE 	Hl L4NI1 0. 
EL---I-.L.'j.L-.L  
In 
10 HOME INVERSE 
20 NORMAL : PRINT TAB( 10 )" " 	INVERSE 	PRINT  
30 	NORMAL 	PRINT TAB( .10)" " ; : INVERSE PRINT "RESIN FUNCTIONALITY" 
40 NORMAL P'INT TAB( 10)" " ; * INVERSE 	PPIT " 
50 W$ = '0,  
60 A = B 	C = 8 = E = F = I = K = Y = Z = 0:H = 42:G 	14 
70 PRINT : PRINT : PRINT "INPUT FUNCTIONALITY OF STARTING RESIN IMMMOL/C" PRINT 	INPUT A PRINT 
80 PRINT "INPUT MOLECULAR WEIGHT OF PROTECTED" PRINT "AMINOACILi SPECIES BEING LOADED" PRINT 	INF 
UT C: PRINT 
90 [I = C - 18 
100 PRINT INPUT NUMBER OF NITROGEN ATOMS IN": PRINT "SPECIES BEING LOADED". PRINT : INPUT E PRINT 
PRINT "INPUT % NITROGEN IN STARTING RESIN": PRINT : INPUT F PRINT 
PRINT "INPUT Z NITROGEN IN PRODUCT RESIN" PRINT 	INPUT K PRINT 
PRINT "INPUT IF SAMPLE IS CAPPED OR UNCAPF'ED" PRINT "(C OR U)" PRINT 	INPUT W: PRINT IF W$ = "U" THEN GOTU 180 
IF W$ = "C" THEN GOTO 190 
GOTO 130 
B = ((100000 * (K - F)) / (A * ((100 * E * G) - (8 * K)))) + 05:B = I NT 8:I 	100 - s: CC, TO 
B= uoO* 	1000 *K)+ (A *H*K)-':looa * Ffl)/ (A * ((100 *E *: G + (H  
0,5:8 = INT (B.:I = 100 - B 
1= (A *8 * 1000) i((A* B * LI) +(A *H * I) + 100000):Y 	(Y *1000) + O."i = INT (Y)+'y
1000 
2 	(A *: B * 1000) / ((A *: B * 8) + 100000)Z = (2 * 1000) +  
11$ = CHR$ (4): PRINT P$"PR$i' 
PRINT "**********'**** *:*:********:***:m**'***" PRINT 
PRINT " RESIN LOADING/COUPLING PERCENTAGE :"; TAB( 22 )" ";B: PRINT 
PRINT "***:**** **:*******:*:***** ******* ****" : PRINT 	PRINT 
PRINT "**:*:** 	 : PRINT 
PRINT "PRODUCT RESIN FUNCTIONALITY IN MI1OL/G"; TAB( 22)" 
IF Y 	1 THEN GOTO 310 
PRINT i;"(CAPPED )" IF W$ = "C" THEN GOTO 360 
GOTO 320 
PRINT "0" ;Y;"( CAPPED)": IF W$ = "C" THEN GOTU 360 
IF 2 	1 THEN GOTO 350 
PRINT TAB( 60)" " ;Z; "( UNCAPPED )" 
GOTO 370 
PRINT TAB': 60)" ";'o";z;"(uNLAPPED)" UCTO 370 
PRINT 
PRINT "***:*:**:***:*:*****'*:*:*:***:*** ** *:* 	*:***" 	PRINT : PRINT : PRINT 
PRINT "YOUR DATA WERE AS FOLLOWS:" PRINT : PRINT 
PRINT "FUNCTIONALITY OF STARTING RESIN IN NHUL/C 'i TAB': 18)" "i 
0 = A: GOSUB 510 
PRINT "MOLECULAR WEIGHT OF PROTECTED AMINO ACID:"; TB( 19)" ';c: PRINT 
PRINT "NUMBER OF NITROGEN ATOMS IN SPECIES BEING LOADED."; TAB': 11)" 
LI = E: GOSUB 510 
PRINT "Z NITROGEN IN STARTING RESIN" i TAB': 31)" 
LI = F GOSUB 510 
PRINT "7 NITROGEN IN PRODUCT RESIN:"; TAB': 32)" 
II = K: GOSUB 510 
PRINT "CAPPED OR UNCAF'PED (C OR U)'."; TAB': 321" " 	PRINT 
PRINT LV PRIO" : NORMAL : HOME 
END 
IF Li 	1 THEN GOTO 530 
GOTO 540 
IF Ii> 0 THEN COTO 550 
PR [NT ii: PRINT : GOTU 560 
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COURSES ATTENDED 
Organic Research Seminars (Various Speakers) 
Current Topics in Organic Chemistry (Various Speakers, 
University of Edinburgh) 
X-Ray Crystallography/Cambridge Structural Database (Dr. 
0. Kennard et al., University of Cambridge) 
X-Ray Crystallography (Dr. R.O. Gould & Dr. A.J. Blake, 
University of Edinburgh) 
NMR Spectroscopy (Dr. I.H. Sadler, University of 
Edinburgh) 
Mass Spectroscopy (Dr. G. Elliot & Dr. A. Ashcroft, 
Kratos) 
Mass Spectroscopy (Prof. K.R. Jennings, University of 
Warwick) 
Medicinal Chemistry (Various Speakers, ICI & Beecham 
Pharmaceuticals) 
Medicinal Chemistry (Prof. P.G. Sammes, SK & F) 
Cell Biology (Dr. J. Philips, University of Edinburgh, 
Department of Biochemistry) 
